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The number of patients who survive severe brain injuries are increasing. While 
some of the survivors make a good progress, some may suffer from severe 
disorders of consciousness (DOC) which may last from weeks to months and in 
some cases for life-long. These patients show none or minimal sign of awareness 
of themselves or their environment but have presence of sleep-wake cycles as 
they open/close their eyes for periods of time. However, a handful of studies, 
which investigated sleep in DOC, indicated that these patients may have 
abnormal sleep patterns as well as circadian rhythms (Cologan et al., 2013, 
Bekinschtein et al., 2009b, Isono et al., 2002). 
On the other hand, growing number of studies indicate that sleep is not a mere 
state of rest-time for humans but also a state where memory processing, learning 
and memory consolidation, brain plasticity and memory reconsolidation occur 
(Stickgold and Walker, 2007, Stickgold et al., 2001, Walker and Stickgold, 2006). 
Therefore, one may hypothesize that improving sleep patterns/ circadian rhythms 
of patients with DOC may help with recovery of consciousness. To our 
knowledge, there are no previous studies performed examining the influence of 
circadian rhythm optimization on brain functions of patients with DOC. Could such 
optimization be achieved by using simple and inexpensive measures such as light 
treatment, melatonin and caffeine administration which may eventually lead to 




Sleep that knits up the ravel’d sleeve of care, 
The death of each day’s life, sore labour’s bath, 
Balm of hurt minds, great nature’s second course, 
Chief nourisher in life’s feast. 




Sleep is a physiological state where memory processing, learning and brain 
plasticity occur. Patients with prolonged disorders of consciousness (PDOC) 
show no or minimal signs of awareness of themselves or their environment but 
appear to have sleep-wake cycles.  
The main aim of this thesis was to investigate effect of circadian rhythm and 
sleep optimization on brain functions of patients with PDOC. 
In the first instance, sleep and circadian rhythms of patients with PDOC were 
investigated using polysomnography and saliva melatonin measurements. The 
investigations that were performed at the baseline suggested that both 
circadian rhythmicity and sleep were severely deranged in PDOC patients.  
This was followed by the interventional stage of the research where an attempt 
was made to optimize circadian rhythm and sleep by giving blue light, caffeine 
and melatonin in a small cohort of patients. To measure the effects of the 
intervention, we used a variety of assessments:  Coma Recovery Scale-Revised 
(CRS-R) to measure changes in awareness; PSG for assessment of sleep, 
melatonin for assessment of circadian rhythm; and, event-related potential 
measures including mismatch negativity (MMN) and subject’s own name (SON) 
paradigms.  
Our results showed that it is possible to improve sleep and circadian rhythms 
of patients with PDOC, and most importantly, this improvement leads to 
increase in Coma Recovery Scale-Revised scores. Individually, those patients 
who responded well to the intervention also showed improvements in their 









Acquired brain injury is a worldwide public health problem with a significant 
impact on people with brain injuries themselves, others involved in their care, and 
more widely in society. While the clinical presentations of the brain injured 
patients vary from post-concussion syndrome to vegetative state, the severely 
brain injured patients who present with disorders of consciousness are the most 
vulnerable.  Their best interests need to be determined and their care provided 
by others. Furthermore, the scientific knowledge in this area is scarce and 
unravelling the mechanisms behind this most severe and bizarre neurological 
condition may help to develop treatment options and improve outcomes for many 
other diseases of the brain. 
This research was driven by the health needs of the patients with PDOC. Our 
interventions were simple and inexpensive which could be implemented in a wide 
range of healthcare settings both nationally and internationally. The results of this 
research suggest that improving sleep and circadian rhythms of patients with 
PDOC enable them to be in a better aroused and optimized neural network state 
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Chapter 1 INTRODUCTION: PROLONGED 
DISORDERS OF CONSCIOUSNESS 
With the improvements in health services the number of patients who survive 
severe brain injuries such as traumatic brain injury, stroke and subarachnoid 
haemorrhage are increasing (Kelly et al., 2015, Ganesh et al., 2016, Gerber et 
al., 2013). While some severe brain injury survivors make good progress, 
some enter a prolonged disorders of consciousness (PDOC) state which 
includes vegetative state/ unresponsive wakefulness syndrome (VS/ UWS) 
and minimally conscious states (MCS) (Giacino et al., 2002, Jennett and Plum, 
1972). These conditions are known to have a very poor clinical outcome and 
despite extensive research are still poorly understood (Steppacher et al., 2014, 
Royal College of Physicians of London, Bernat, 2006, Giacino et al., 2014). To 
be able to understand the pathophysiology and clinical features of prolonged 
disorders of consciousness and to be able to design treatment protocols for 
this peculiar condition, an understanding of consciousness as well as 
knowledge of the structural and functional systems of the brain that contributes 
to consciousness are needed. 
1.1 CONSCIOUSNESS 
The Oxford dictionary defines consciousness as the state of being aware of 
and responsive to one’s surroundings (University). In medical terms, it can 
simply be defined as a state where the following two components are intact; 
arousal/ wakefulness and awareness. Impairment of either or both may result 
in disorders of consciousness. Therefore, these two components of 
consciousness will be discussed below. 
1.1.1 Arousal 
The ascending pathways from monoaminergic cell groups in the brain stem 
and hypothalamus to the cerebral cortex and thalamus increase wakefulness 
and vigilance, as well as the responsiveness of cortical and thalamic neurons 
to sensory stimuli, a state known as arousal (Fellinger et al.). 





After exiting the brainstem, the ascending arousal system (ARAS) divides into 
two major branches at the junction of the midbrain and diencephalon. One 
branch enters thalamus, where it activates and modulates thalamic relay nuclei 
as well as intra-laminar and related nuclei with extensive diffuse cortical 
projections. The other branch travels through the lateral hypothalamic area 
and is joined by the ascending output from the hypothalamic and basal 
forebrain cell groups, all of which diffusely innervate the cerebral cortex.  
Injury to either branch of the ascending arousal system whether it is through 
thalamus or hypothalamus can impair consciousness. For example, a lesion 
of the posterior lateral hypothalamus interrupts the pathway through 
hypothalamus and causes profound slowing of the electroencephalogram and 
behavioural un-arousability even if the pathway through thalamus is intact. 
Injury to thalamus or its reticular input prevents the brain achieving a 
desynchronized or wakeful state. The neurotransmitters acetylcholine, 
norepinephrine, serotonin, and dopamine play a role in the regulation of the 
ARAS where alertness is maintained (Saper et al., 2001, Saper et al., 2005). 
(see figure 1-1) A key component of this ascending arousal system is the 
cholinergic neurons in the pedunculopontine (PPT) and laterodorsal (LDT) 
tegmental nuclei. These cholinergic neurons play a key role within the 
ascending arousal system by providing excitatory signals from the upper 
brainstem to the thalamic relay nuclei and the reticular nucleus; consequently, 
improving thalamocortical transmission. (shown with blue lines in figure 1-1) 
 












Awareness on the other hand is regulated by a group of complex network 
systems. Recently published research studies indicated that awareness is 
generated by three main networks: internal awareness network, external 
awareness network and thalamocortical network.  
The internal awareness network is also known as the Default Mode Network 
(DMN) and based on midline fronto-parietal networks. The internal awareness 
network includes midline structures posterior cingulate cortex (PCC)/ 
precuneus (Pr) and anterior cingulate (ACC)/medial prefrontal cortices 
(MPFC). (Figure 1-2) The external awareness network encompasses 
dorsolateral prefrontal cortices (DLPFC) and posterior parietal cortices (PPC) 
(Demertzi et al., 2013). (Figure 1-3) (Figures 1-2 and 1-3 are based on the 
drawings from Demertzi, Athena et al. “Consciousness supporting 
networks.” Current Opinion in Neurobiology 23 (2013): 239-244.) 
 
 
Figure 1-1: Schematic diagram of ascending reticular activating system illustrating key 
nuclei and the neurotransmitters that take in the regulation of the arousal. (This image 
was drawn based on the information and illustrations from Saper et al. Hypothalamic 
regulation of sleep and circadian rhythms. Nature. 2005;437:1257–1263) 
ACh= Acetylcholine, NA= Noradrenaline, HIST= Histamine, 5HT= Serotonin, Gal= 
Galanin, LDT=Laterodorsal tegmental nucleus, PPT= Pedunculopontine tegmental 
nucleus, TMN= tuberomammillary nucleus, LC= locus coeruleus  
 











The cortico-thalamo-cortical network which has millions of connections 
between the thalamus and cortices also plays an important role in generation 
of consciousness. By using positron emission tomography (PET) scans 
Thibaut et al. showed that in VS/UWS there is a metabolic dysfunction in the 
thalamus, external and internal awareness networks. The degree of metabolic 
dysfunction was to a lesser extent in MCS patients, mainly showing 
dysfunction of the internal awareness networks. Moreover, it was shown that  
behavioural assessment scores correlated with activity in the extrinsic network 
and part of the intrinsic network (Thibaut et al., 2012). 
Naro et. al. considered use of repetitive transcranial magnetic stimulation 
(rTMS) paradigms targeting structures belonging to default mode network (the 
anterior cingulate cortex – ACC) and external awareness network (the 
dorsolateral prefrontal cortex – dlPFC).  They were able to differentiate 
patients with MCS from those with UWS at a group level, with the remarkable 
exception of two persons with UWS which then raised the question of 
misdiagnosis of these two subjects and the possibility of using rTMS technique 
to detect covert signs of awareness (Naro et al., 2017). 
Despite the constantly growing knowledge base on brain networks which are 
responsible for generation of consciousness, and the increasing possibility of 
Figure 1-2: Brain areas which are part 
of internal awareness network 
(Demertzi et al. 2013) 
Figure 1-3: Brain areas which are part 
of external awareness network 
(Demertzi et al. 2013) 





use of neuro-imaging techniques for diagnosis of disoders of consciousness, 
all current definitions and diagnostic criteria remain based on bedside clinical 
assessment methods.  
1.2 DEFINITIONS AND DIAGNOSTIC CRITERIA FOR 
PROLONGED DISORDERS OF CONSCIOUSNESS 
Severe disorders of consciousness include coma, vegetative state (VS) and 
minimally conscious state (MCS). 
Coma is a state of unarousable unconsciousness due to dysfunction of the 
brain’s ascending reticular activating system (ARAS), which is responsible for 
arousal and the maintenance of wakefulness (Laureys and Tononi, 2009). 
Coma results from global brain dysfunction. A patient who is in a state of coma 
fails to open eyes to stimulation, presents motor responses no better than 
simple withdrawal type of movements and a verbal response no better than 
simple vocalization of non-word sounds (Plum and Posner, 1966). This state 
must last at least one hour to be differentiated from similar but transient states 
such as syncope or delirium. Coma may last up to two to four weeks. 
Emergence from coma is followed by outcomes that range from the vegetative 
state to complete recovery. The severity of damage to the cerebral cortex, the 
thalamus or their integrated function, determines the outcome from coma.  
Structural brain lesions, metabolic/ nutritional/ toxic encephalopathies, 
systemic and central nervous system infections, hyperthermia and 
hypothermia and trauma are common causes of coma. Regardless of the 
aetiology, patients initially present in a state of coma following a brain injury. 
Spontaneous eye opening occurs after recovery of brain-stem reticular 
formation, which takes about one week after non-traumatic brain injury and 
about two to three weeks after traumatic brain injury. Once the eyes are open 
patients may recover consciousness to a degree or remain in a vegetative 
state, which is then diagnosed by the presence of reflex responses as well as 
preservation of autonomic functions but lack of any evidence of awareness.  





The VS was first coined in the early 1970s by Jenner and Plum and the 
diagnostic criteria for MCS were first published in 2002 (Giacino et al., 2002). 
Other terms such as the “apallic syndrome” have been used previously and 
more recently “unresponsive wakefulness syndrome” as a less emotive 
synonym for the VS (Laureys et al., 2010). 
The vegetative state results from profound damage to cerebral hemispheres 
and in most cases to thalami, with relative preservation of the brain stem, and 
is defined as a state of wakefulness without awareness. In other words, it is a 
state where there is dissociation between arousal and awareness. Three main 
patterns of brain damage were found to be associated with vegetative state: 
widespread destruction of the cortical ribbon, widespread damage to white 
matter tracts, and damage to the thalamus (Kinney and Samuels, 1994).  
However, as outlined in the awareness section above, in light of recent 
research, disorders of consciousness are thought to be the result of damage 
to internal awareness, external awareness and thalamo-cortical networks. The 
severity of damage to these networks determines the level of consciousness 
present in disorders of consciousness. Therefore, these conditions are 
considered to be part of a continuum which explains the variability in the 
observed behavioural signs of overt consciousness.  
The difference between vegetative and minimally conscious state depends on 
the detection of reproducible and purposeful behaviours. There is no evidence 
of sustained, reproducible or purposeful behavioural responses in VS. 
However, there is inconsistent but clearly discernible behavioural signs of 
awareness such as visual tracking, simple command following, gestural yes/no 










Table 1-1: Clinical features of coma, VS and MCS 





Coma No No No purposeful 
behaviour 









Disorders of consciousness are now considered as a continuum, ranging from 
VS to high minimally conscious state (Bekinschtein et al., 2005). It was 
suggested that MCS can be further divided into low and high MCS categories 
due to the wide range of behaviours observed within the same diagnostic 
category. Low MCS is characterized by the presence of single low complexity 
behaviour such as visual pursuit or localization following noxious stimulation. 
High MCS on the other hand is characterized by the presence of clearly 
discernible evidence of one or more of the following behaviours: simple 
command following, gestural or verbal yes/no responses, intelligible 
verbalization or contingent behavioural responses (Giacino and Kalmar, 2005). 
The distinction between MCS and VS is important as it may influence 
treatment, as well as the way family and societies perceive the condition. 
The incidence and prevalence of the vegetative state and minimally conscious 
state are not certain as both conditions are not formal diagnoses under 
International Classification of Diseases (ICD 10, World Health Organization) 





and hence national statistics are not available. Difficulties with reaching a 
certain diagnosis which are due to either shortfall of assessment methods or 
inadequate time spared for observations, and effect of medications, contribute 
to the fact that no clear epidemiological data are available for these conditions 
(Strens et al., 2004). There are also significant national variations which are 
related to socio-economical as well as cultural factors. The incidence of 
vegetative state varies between 5 and 25 per million population. In the United 
States (US), the prevalence of VS in adults is reported to be between 40 and 
168 per million population according to the published data. Although the figure 
may be lower in the United Kingdom (UK) and other European countries; 
accurate figures are not available.  
Based on numbers of patients with PDOC in nursing homes, it was estimated 
that there are 4,000 to 16,000 patients in VS, with three times as many in MCS 
in the UK (2015, March 2015). It was suggested that the UK Rehabilitation 
Outcomes Collaborative (UKROC) incorporates a PDOC database which 
includes  a minimum clinical dataset and longitudinal outcome data for patients 
in PDOC (Royal College of Physicians of London). At the time of writing this 
thesis work on creating PDOC database was ongoing. Even with the creation 
of a database, knowledge of the number of people in different disorders of 
consciousness states with certainty will be difficult due to the challenges in 
differentiating vegetative and minimally conscious states. The next section of 
this thesis outlines clinical features of PDOC and how observed behaviours 
can make the differential diagnosis problematic. 
1.3 DIAGNOSIS AND CLINICAL FEATURES OF 
PROLONGED DISORDERS OF CONSCIOUSNESS 
Currently, diagnosis of vegetative state requires demonstrating lack of 
behaviours that reflect cortical activity.  In practice, this is difficult as some 
reflexive behaviours observed may be mistaken as conscious behaviours. For 
example, behaviours like the eyes and head turning briefly towards strong 
visual or auditory stimuli does not require cortical integration. Similarly, 





touching a patient may produce a general startle reaction called startle 
myoclonus. All these responses may be mistaken with behaviours of cortical 
activity. While patients with higher level of responses habituate to sudden 
stimuli and produce less and less response, patients in vegetative state do not 
habituate. Similarly, brief fixation and even brief following of an object can 
occur in vegetative state. It is clear that, diagnosis of vegetative state is 
challenging for healthcare professionals and difficult to accept for patients’ 
relatives especially in the presence of non-cortical responses such as the 
above. Significant effort, therefore, has been put into establishing clear 
diagnostic criteria for vegetative state.  
Consistent and sustained visual pursuit is considered as one of the first 
observable signs of recovery in patients who go on to regain consciousness 
(Jennett et al., 2002). Some consider that those show this phenomenon, are 
no longer in vegetative state. However, occasionally patients who gained 
sustained visual pursuit develop no other behavioural evidence of 
consciousness. In 1996, an International Working Party suggested that 
isolated visual tracking could not be considered as evidence of emergence 
from vegetative state (Andrews, 1996). Hence, extreme caution is required 
when there is sustained visual pursuit, consistent and reproducible visual 
fixation, or response to threatening gestures in making a diagnosis of 
vegetative state. It was shown that assessment of visual pursuit with a mirror 
is superior to that with moving person or object (Thonnard et al., 2014, 
Vanhaudenhuyse et al., 2008).  
Other clinical features of vegetative state which can lead to confusion of 
healthcare professionals and relatives are as follows; 
- Increased muscle tone of the limbs and spontaneous movements 
- Grasp reflex 
- Facial grimacing and even groan to painful stimuli 
- Smiling, frowning, occasionally laughing or weeping 





In 1994, the Task Force Criteria (1994)  has become the benchmark for 
American practice. In 1996, the Royal College of Physicians of London (RCP) 
(1996) produced a statement in response to a request from a parliamentary 
committee following Bland –the first case where withdrawal of artificial nutrition 
and hydration was considered by courts in the UK [Airedale NHS Trust v Bland 
(1993) AC 789 1 All ER 821]. See table 1-2 and 1-3. 
Table 1-2: Statement of the Multi-Society Task Force 1994 
Definition 
The vegetative state is a condition of complete unawareness of the self and the 
environment accompanied by sleep-wake cycles with either complete or partial 
preservation of hypothalamic and brain stem autonomic functions. 
Criteria 
No evidence of awareness of themselves or their environment; they are incapable 
of interacting with others. 
No evidence of sustained reproducible, purposeful or voluntary behavioural 
responses to visual, auditory, tactile or noxious stimuli. 
No evidence of language comprehension or expression. 
Intermittent wakefulness –sleep-wake cycles. 
Sufficient preserved hypothalamic and autonomic functions to survive. 
Bowel and bladder incontinence. 
Variably preserved cranial nerve reflexes (pupillary, oculocephalic, corneal, 












Table 1-3: Royal College of Physicians of London 1996 
Three clinical criteria all to be fulfilled 
No evidence of awareness of self or environment. No volitional response to visual, 
auditory, tactile or noxious stimuli. No evidence of language comprehension or 
expression. 
Cycles of eye closure and opening simulating sleep and waking. 
Sufficiently preserved hypothalamic and brain stem function to maintain respiration 
and circulation. 
Other clinical features 
Incontinence of bladder and bowel. Spontaneous blinking and usually retained 
pupillary and corneal responses. Conjugate or dysconjugate tonic response to ice-
water caloric testing. 
No nystagmus to caloric testing. No visual fixation, tracking of moving objects with 
eyes or response to menace. 
May be occasional movements of head and eyes towards sound or movement, and 
of trunk and limbs in purposeless way. May have startle myoclonus. May smile; 
may grimace to pain. May have roving eye movements. 
 
Minimally conscious state was only described in 2002. Therefore, neither 1994 
Multi-society Task Force not 1996 RCP guidelines covered this condition 
(Giacino et al., 2002). The latest guidelines for VS and MCS was published in 
2013 by the Royal College of Physicians. The diagnostic criteria for VS and 
MCS have been summarized in table 1-4. The UK guidelines were due to be 
updated and new clinical guidelines for the US were being written at the time 









Table 1-4: Diagnostic Criteria for Prolonged disorders of consciousness states (RCP 
Guidelines 2013) 




- No evidence of awareness of self or environment or the ability 
to interact with others 
- No evidence of sustained purposeful or voluntary behaviours, 
either spontaneously or in response to visual, auditory, tactile 
or noxious stimuli 
- No evidence of language, comprehension or meaningful 
expression. 
Usually present: 
- Cycles of eye closure and eye opening, giving appearance of 
sleep-wake cycle 
- Spontaneous respiration and circulation. 
Compatible features: 
- Spontaneous movements (chewing, smiles, grimaces, 
shedding tears, grunting or groaning sounds 
- Reflexive movements (brainstem, corneal, oral/facial, grasp 
reflexes) 
- Generalized arousal response to various stimuli 
- Eyes may turn fleetingly towards sound or visual target, react 
to menace. 
- Compatible but atypical features include isolated fragments 
of behaviour (i.e. utterance of a single inappropriate word).  
Incompatible features: 
- Evidence of discriminative perception, 
- Purposeful actions, 
- Anticipatory actions, 
- Communicative acts. 








Limited but clearly discernible evidence of self- or environmental 
awareness      must be demonstrated on an inconsistent but 
reproducible or sustained basis by one or more of the behaviours 
below: 
- Following simple commands 
- Gestural or verbal ‘yes /no’ responses (regardless of 
accuracy) 
- Intelligible verbalisation 
- Purposeful or discriminating behaviours 
- Evidence of behaviours that is only explicable through some 
awareness being present: 
- Episodes of crying, smiling or laughter in response to 
linguistic or visual content of emotional topics or stimuli 
- Vocalization or gestures in response to the linguistic content 
of comments or questions 
- Reaching for objects in a manner that demonstrates a clear 
relationship between object location and direction of reach 
- Touching or holding objects in a manner that accommodates 
the size and shape of the object 
- Sustained pursuit eye movement or sustained fixation 






Reliable and consistent responses need to be demonstrated which 
include; 
- Functional use of objects 
- Consistent discriminatory choice-making 










RCP guidelines also lists the following preconditions for diagnosis of VS and 
MCS: 
- The cause of the condition should be established as far as possible, 
- The possibility of reversible causes must be excluded, 
- Assessments should be made under appropriate conditions by a trained 
assessor using structured assessment tools such as Coma Recovery 
Scale- Revised (CRS-R), Wessex Head Injury Matrix (WHIM) or 
Sensory Modality Assessment and Rehabilitation Technique (SMART). 
Barker re-iterates the importance of answering three main questions during 
assessment of a patient presenting with loss of awareness (Barker, 2005). 
- Are there any focal deficits which help localize the main site of injury 
and which may be complicating the interpretation of patient’s 
responses? 
- Is the patient in a persistent vegetative or minimally conscious state? 




















Table 1-5: Clinical features of coma, VS, MCS and Locked-in syndrome 
Condition                                                                                           Coma VS MCS Locked-in 
syndrome 
Awareness Absent Absent Present Present 
Sleep-wake 
cycle 

























Variable Preserved Preserved Preserved 








Poor Variable Full recovery 
unlikely 
 
It is clear that, clinical diagnosis of vegetative state is rather difficult and 
misdiagnosis rate is high. Therefore, there has been great effort to identify and 
establish electro-physiological and radiological investigations that would 
support the clinical decision-making process. 
Several research studies have shown that it is possible to detect the presence 
of higher level cerebral functions in such patients, by utilizing 
electrophysiological methods and/or functional neuroimaging techniques in 
cases where clinical assessments are unable to detect any behavioural sign 
of awareness (Cruse et al., 2011, Bekinschtein et al., 2011, Bruno et al., 





2011b, Monti et al., 2010). Even though there have been exciting and 
promising developments in research, currently diagnosis of vegetative state 
and minimally conscious states remain on clinical grounds alone.  
1.4  CLINICAL ASSESSMENTS TOOLS IN 
DIAGNOSING DISORDERS OF CONSCIOUSNESS 
Due to high percentages of clinical misdiagnosis of vegetative state- up to 
43%, (Andrews et al., 1996, Schnakers et al., 2009) it has been suggested that 
diagnosis should be made only after an adequate period of observation and 
based on findings of formal and structured assessment tools such as Sensory 
Modality Assessment Rehabilitation Technique (SMART) (Gill-Thwaites, 
1997) or Coma Recovery Scale- Revised (CRS-R) (Giacino et al., 2004). 
Wessex Head Injury Matrix (WHIM) can also be used to track changes in 
patient’s consciousness levels (Shiel et al., 2000). RCP guideline recommends 
one or more of the above assessment tools in reaching diagnosis in PDOC.  
Factors that may temporarily reduce consciousness, such as metabolic 
disturbances, medication side effects and concurrent infections, require due 
attention. While obtaining collateral information from care givers, therapists 
and relatives can be very useful in reaching diagnosis, possible 
misinterpretation of reflex activity by family should be kept in mind. At the stage 
of history taking particular attention should be paid to type of insult, site of 
injury, time since injury, age of patient, time of day and previous activities in 
that day, and medication. During the neurological examination; the size and 
responsiveness of pupils, eye movements, oculo-cephalic movements, visual 
tracking, and response to painful stimuli should be recorded. 
The most commonly used clinical assessments tools are SMART, WHIM and 
CRS-R. These three assessment tools will be reviewed here, and their pros 
and cons will be summarized as the subjects of this research were assessed 
with these tools at the time of their diagnosis and throughout the research 
project.  





1.4.1 Sensory Modality Assessment Rehabilitation Technique 
(SMART) 
SMART was designed by Gill-Thwaites and Munday in late 1990s as both an 
assessment and a treatment tool to identify signs of awareness in patients 
diagnosed in vegetative state (Gill-Thwaites, 1997). Later on it was shown that 
SMART is a very detailed assessment tool and is more effective than other 
assessment tools in distinguishing VS patients from those in MCS (Godbolt et 
al., 2012). 
SMART Assessment is completed in seven stages; 
Stage 1: SMART Informal Assessment 
Stage 2: SMART Formal Assessment 
Stage 3: SMART Assessment review 
Stage 4: SMART Sensory treatment 
Stage 5: SMART Re-assessment 
Stage 6: SMART Sensory treatment review 
Stage 7: SMART Monitoring OR upgrade of SMART programme 
The informal component of SMART includes a Communication and Lifestyle 
questionnaire as well as gathering information from family and staff (SMART 
“informs”) in order to establish premorbid interest/ dislikes, to involve relatives 
in the assessment process, to establish behaviours in different settings, to 
establish relative interpretation of behaviours, to identify frequency of 
behaviours and to allow comparison with formal assessment.  
The formal components include SMART Behavioural Observation Assessment 
and SMART Sensory Assessment. Assessment phase of SMART is 










complete. Equal numbers of morning and afternoon sessions are allocated for 
SMART assessment and the assessor remains same.  
Behavioural observation assessment is performed at the beginning of each 
assessment session and aims to establish patient’s unique behavioural 
repertoire at rest, patient’s arousal levels and reflexive/ spontaneous 
behaviours that occur without stimulus. 
SMART sensory assessment is a structured and graded assessment of a 
patient’s responses in eight domains; behavioural response to sensory stimuli 
across the five senses (visual, auditory, tactile, olfactory and gustatory) in 
addition to wakefulness/ arousal, motor and communicative responses. It uses 
29 standardised techniques using standardised stimuli.  
A 5-point hierarchical scale is employed for each assessment domains and 
patient responses are rated from no response (Level 1) through a 
differentiating response (Level 5). Emergence from VS is indicated if a 
consistent Level 5 response is observed in any modality except wakefulness, 
on at least five consecutive occasions.  
SMART Hierarchical Scale for Sensory Modalities: 
- Level 1: No response from any stimulus 
- Level 2: Reflex (reflexive, generalized response to stimuli) 
- Level 3: Withdrawal (turn head/ eyes away or withdraw limbs from 
stimuli) 
- Level 4: Localizing (turn head or move upper limbs towards stimuli) 
- Level 5: Differentiating (follow visual or auditory commands/ use objects 
appropriately) 
Further categorization of responses is made as follows: 
- Consistent response: a response occurs that in at least 5 consecutive 
assessment sessions 





- Frequent inconsistent response: a response occurs 5 times or more but 
not consecutive 
- Highest inconsistent response: highest response observed in the 
modality that occurs on 1-4 sessions over the assessment stage. 
For example, responses to light might be recorded as: 
SMART Level: 2 
Category: consistent (number of occurrences consecutively: 6; Total number 
of occurrences: 8) 
Direction/ side: left 
Type of response: eye blink 
Following the completion of assessment all information obtained through 
informal and formal components are reviewed and analysed. An indicative 














Table 1-6: SMART responses and corresponding indicative diagnosis 
SMART Level Frequency of 
responses 
Type of response Indicative 
diagnosis 

















4 Highest inconsistent, 
Frequent inconsistent, 
Consistent 




MCS- or MCS 










MCS or MCS+ 
 
Following the SMART assessment, treatment block is delivered in eight weeks 
period. It aims to explore impact of any pre-requisite factors, differences 
between formal and informal findings as well as between verified and 
unverified responses. It also aims to enhance level of responses and potential 
to use them at functional level.  





Following the completion of SMART treatment, a re-assessment is conducted. 
SMART sensory treatment review is completed to review the patient’s 
progress including responses recorded by the family and team members 
(informs). Results, conclusions and future directions are discussed with the 
family and the team members. 
1.4.2 Wessex Head Injury Matrix (WHIM)  
Wessex Head Injury Matrix was developed by Shiel et al. in 2000. The scale 
was developed by observing recovery of 88 patients with brain injury (age 
Mean=30 years, range 14-67; coma duration median= 6 days; duration of post-
traumatic amnesia median= 30 days) (Shiel et al., 2000). 62 behaviours or 
steps relating to social behaviour, cognition, attention, and communication 
were included in the scale which is administered by observation, presenting 
patients with meaningful stimuli and recording their responses to stimuli. Types 
of behaviours are examined by WHIM are spontaneous behaviours, responses 
to naturally occurring stimuli such as tracking of source of sound and 
responses to presentation of standard stimuli such as performing a physical 
movement in response to command. WHIM mainly focuses on behaviours 
rather than diagnostic features and carries potential of being able to be used 
by all members of the multi-disciplinary treatment team. Therefore, it has a 
value on monitoring the changes during natural recovery as well as 
rehabilitation. WHIM requires simple test materials that include everyday items 
such as coin, key, magazine pictures. Administration starts at item 1 and 
continues until the occurrence of 10 consecutive failures.  
Inter-rater reliability of WHIM was also examined with an independent sample 
of 25 patients. In this study two novice raters underwent brief training on 
administration of WHIM. Another inter-rater reliability study was conducted 
after providing raters with more detailed training session. The results of this 
study revealed that while inter-rater and test-retest reliabilities between novice 
raters were low (kappa = 025 to 0.84 for inter-rater reliability and – 0.66 to 0.12 
for test–retest reliability), after a training session, both inter-rater and test-





retest reliabilities reached acceptable levels. Mean kappa scores were 0.86 for 
interrater reliability and 0.74 for test–retest reliability. Training of the assessor 
is required to ensure reliability. 
Psychometric properties of WHIM was explored in detail by Majerus et al. using 
a 66 item version of WHIM in 23 patients who suffered from stroke or traumatic 
brain injury (Majerus, 2000). This study also indicated that WHIM is sensitive 
to subtle changes in patients with disorders of consciousness. Inter-rater 
agreement was excellent for 73% of the 66 items (K = 0.8–1), fair to good for 
20% (K = 0.4–0.73) and poor for 7% (K = –0.1–0.07). Test–retest reliability 
which was assessed with Spearman rank order correlation between the WHIM 
scores obtained in the test and re-test sessions was 0.981 (P < .0001).  
Recently published studies provided further insight into this tool where re-
ordering of the hierarchical items is recommended (Turner-Stokes et al., 
2015). Nevertheless, WHIM is a valuable assessment tool especially when it 
is used alongside another assessment tool- SMART (Morrissey et al., 2017). 
At the time of writing of this thesis, WHIM-2 was being developed in order to 
resolve the problems with ordering of hierarchical items of the scale. 
1.4.3 Coma Recovery Scale- Revised (CRS-R) 
JFK Coma Recovery Scale (CRS) was developed in 1991 by Giacino et. al.  
with the purpose of creating an assessment tool that could differentiate 
between patients in the vegetative state and those who are minimally 
conscious (Giacino et al., 1991). CRS was used for many years in clinical and 
research settings. Therefore, there was a considerable amount of feedback 
received from CRS users which led to further analysis of CRS and eventually 
the development of CRS-Revised (CRS-R). 
CRS-R comprises six subscales: Auditory, Visual, Motor, Oro-motor/ Verbal, 
Communication, and Arousal. The responses are elicited with standardized 
instructions which are provided in the Administration and Scoring Guidelines 
manual. The lowest level responses within a subscale represent reflex activity 





and the highest-level responses represent “cognitively mediated” behaviours. 
Administration of the scale requires some test materials such as comb, mirror, 
ball and time required for administration is 20 to 25 minutes. The total score 
ranges from 0 to 23 and scores can be converted to a classification of VS, 
MCS or emergence from MCS. 
According to CRS-R, emergence from VS is denoted by the presence of the 
following behavioural responses: 
- Reproducible movement to command, 
- Visual fixation, 
- Motor localization to noxious stimuli 
- Intelligible verbalization 
- Intentional (even if non-functional) communication. 
Emergence from MCS requires additional criteria of: 
- Functional object use, and/or 
- Accurate/ functional communication. 
CRS-R has excellent content validity and showed substantial evidence of good 
interrater reliability.  It was suggested that CRS-R may be used to assess DOC 
with minor reservations (whereas SMART and WHIM with moderate 
reservations) (Seel et al., 2010). 
1.5 REHABILITATION AND TREATMENT OPTIONS IN 
PDOC 
Currently there is not a recommended treatment or a therapeutic intervention 
for PDOC. Several medications with neuro-stimulant properties (i.e. 
dopaminergic medications, GABA-ergic drugs, serotonin and/or noradrenalin 
reuptake inhibitors) were trialled and the outcomes mainly reported in the form 
of case reports or series of cases.  





Amongst all the medications trialled Amantadine has the most rigorous 
scientific evidence suggesting it can be beneficial in precipitating recovery in 
VS and MCS. A multicentre, prospective, double-blind randomized, placebo-
controlled study which involved 184 patients showed that recovery was 
significantly faster in the amantadine group than in the placebo group (Giacino 
et al., 2012). 
Currently, there is not enough evidence to recommend a particular medication 
for treatment of PDOC, but clinicians often try different medications to improve 
arousal levels and aid to recovery of brain functions. 
Neurostimulation with electrical and magnetic stimulation have attracted 
attention recently with some research indicating promising and some 
disappointing outcomes. 
For example, a recently published study showed that neuromodulation with 
Transcranial Direct Current Stimulation (tDCS) which was repeated for 5 days 
in the left prefrontal area, improved the recovery of consciousness in some 
chronic patients in MCS, up to 1 week after the end of the stimulations (Thibaut 
et al., 2017). On the other hand, another study which used repeated tDCS over 
the left dorsolateral pre-frontal cortex did not exert remarkable short-term 
clinical and Electroencephalography (EEG) effects. Furthermore, clinical 
features and visual analysis of EEG did not distinguish patients who improved 
from those who didn't. It was concluded that further studies should ascertain 
whether tDCS might promote clinical recovery in the long-term period  
(Estraneo et al., 2017). 
In another study, Repetitive Transcranial Magnetic Stimulation (rTMS) of the 
left dorsolateral prefrontal cortex for ten consecutive days was given to 16 
patients with prolonged disorders of consciousness. Following treatment, a 
significant enhancement of CRS-R scores (p=0.007) were observed in all MCS 
patients (five out of five) and four out of eleven VS patients (Xia et al., 2017). 





Although studies exploring use of methods like tDCS and rTMS suggest some 
promising outcomes, they remain to be research methods and further 
validation of these techniques with a cohort of larger sample size are needed.   
1.6 PROGNOSIS IN PROLONGED DISORDERS OF 
CONSCIOUSNESS 
RCP guidelines in 2013(Royal College of Physicians of London) covered the 
diagnostic criteria and definitions for VS, MCS and emergence from MCS in 
relation to passage of time since brain injury and prognostic predictors. 
According to the guidelines, if the disorders of consciousness (VS or MCS) last 
more than one month it is described as Prolonged Disorders of Consciousness 
(PDOC). If the vegetative state lasts more than 6 months following non-
traumatic brain injury or more than 12 months following traumatic brain injury 
it is deemed to be permanent. The guidelines also say that after these time 
points, recovery is deemed ‘highly improbable’. MCS, on the other hand is 
deemed permanent if it lasts more than 3-5 years- depending on clinical 
circumstances of a patient. At the time of publication, the RCP guidelines 
recommended consideration of application to courts for withdrawal of clinically 
assisted nutrition and hydration (CANH) when permanent VS or MCS is 
diagnosed. A recent ruling in the case of M v. a Hospital [2017] EWCOP 19, 
lifted this necessity and left decisions to withdraw CANH to the clinicians who 
need to obtain the agreement of the families and act in accordance with  
prevailing professional guidance. 
Our current knowledge of long-term outcome in severe DOC is incomplete 
largely because once a diagnosis is made, patients are discharged to diverse 
care settings and their follow up rarely extends beyond 12 months after brain 
injury (Binkley, 1994, Steppacher et al., 2014, Yelden et al., 2017b). A recent 
study examined the long-term prognosis (for a mean of 25.7 months from onset 
of brain injury) in 50 patients with VS.  This study reported that late recovery 
was detected in 25% of the patients; suggesting that late recovery of 
responsiveness may occur more frequently than previously appreciated 





(Estraneo et al., 2010). This study also demonstrated a higher chance of 
recovery in the post-anoxic brain injury sub-group (21.4%) than in earlier 
published studies which were in the form of case reports (Arts et al., 1985, 
Sancisi et al., 2009, Childs and Mercer, 1996, McMillan and Herbert, 2004, 
Avesani et al., 2006, Sara et al., 2007, Estraneo et al., 2014). Luauté et al. 
showed that a third of patients in MCS with mixed aetiologies improved more 
than 1-year post ictus (Luauté et al., 2010). In this study however, Glasgow 
Outcome Scale was used as the main outcome measure with no specific 
attention to improvement of awareness/ responses to given stimuli.  
In our recently published study, we were able to show that that late 
improvements in awareness are not exceptional even in non-traumatic PDOC 
(Yelden et al., 2017a). It highlights the importance of long term follow up of 
patients with PDOC, regardless of the aetiology, age and time passed since 
the brain injury. Long term follow-up will help clinicians to identify patients who 
may benefit from further assessment and rehabilitation. In this study, although 
only one patient achieved recovery of function, recovery of awareness may 
have important ethical implications especially where withdrawal of artificial 
nutrition and hydration is considered. 
1.7 CHAPTER SUMMARY AND CONCLUSIONS 
This chapter of the thesis illustrates that the concept of consciousness is 
difficult to define, measure and quantify which makes the understanding of 
disorders of consciousness difficult. Diagnosis and prognostication of 
vegetative and minimally conscious states are challenging for clinicians as well 
as neuro-scientists. Therefore, in the last decades there has been a desire to 
explore the use of different neurophysiological and neuro-imaging techniques 
to measure consciousness levels of people with disorders of consciousness 
as diagnostic and prognostic markers in addition to bedside clinical 
assessment tools. The next chapter will review the most commonly researched 
neuro-physiological techniques to assess consciousness in this patient group. 





Chapter 2 INTRODUCTION: ASSESSING 
CONCIOUSNESS WITH 
ELECTROPHYSIOLOGICAL AND 
NEURO-IMAGING TECHNIQUES  
As discussed in chapter 1, distinguishing between vegetative and minimally 
conscious states depends on discriminating reflexive and voluntary responses. 
Although bedside behavioural assessment tools aim to achieve this, they are 
often limited due to severe motor impairments, the possible presence of 
aphasia, confounding medical factors such as tracheostomy, as well as 
fluctuations of arousal levels. Neuro-imaging and neuro-physiological 
techniques may provide valuable information and may help to detect covert 
signs of awareness and any brain activity linked to consciousness. In most 
research projects, they are often used as additional means of obtaining 
objective measures of brain activity, in addition to outcomes of clinical 
assessment tools such as CRS-R and SMART. However, researchers need to 
choose the most appropriate technique, which can help to answer their 
research question in the most effective and practical way.  
The aim of this chapter is to provide a general review of techniques that can 
help to assess changes in brain activity in PDOC, so that the most beneficial 
tool(s) can be identified for this research project. 
These techniques may be divided into three broad categories based on 










Table 2-1: Techniques to measure brain activity 













Resting state Functional 
MRI (fMRI) to assess 
default mode network 
Brain activity during 
passive paradigms 
(stimulation given) 
EEG responses to deviant 




Brain activity during 
active paradigms 
(stimulation and 
instructions given to 
perform a task) 
Counting deviant stimuli 
during ERPs. 
Motor imagery tasks 




The general principles and the advantages and disadvantages of using these 
techniques in disorders of consciousness patients will be summarized below. 
2.1 ELECTROPHYSIOLOGICAL TECHNIQUES 
2.1.1 Electroencephalography (EEG) 
EEG measures the synaptic potentials from pyramidal cells of brain cortex 
using scalp electrodes. The EEG trace obtained represents potential 
differences between two electrodes. The routine EEG is usually performed 
over 20-30 minutes and can give useful information about brain’s baseline 
activity and may help to identify any epileptiform activity,  especially if it is 
performed repeatedly (Marsan and Zivin, 1970). EEG scalp electrodes are 





applied according to 10-20 system which uses four anatomical landmarks 
(nasion, inion and the preauricular points bilaterally) from which 
measurements are made and electrodes are placed 10% or 20% of the 
distances (figure 2-1). 
 
The EEG can be recorded using a bipolar (longitudinal or transverse) or 
referential montage methods (table 2.2). 
Table 2-2: Most commonly used EEG montages (adapted from Behavioural Neurology 
and Neuropsychiatry, Cambridge University Press, 2013) 
Longitudinal bipolar 








Figure 2-1: EEG electrode placement according to 10-20 system (redrawn from Norani 
et.al. 2010) 
 





Once recorded, interpretation and reporting of an EEG involves description of 
waveforms and discharges using following parameters (Lee-Chiong, 2006): 
- Amplitude: how high the voltage is in microvolt (µV), 
- Duration: how long the discharge is in milliseconds (ms) or seconds, 
- Frequency: how frequently the identified waveform repeats itself per 
second in Hertz (Hz), 
- Morphology: shape and structure of the discharge, 
- Latency: the delay between an event and another event in milliseconds, 
- Location: where the discharge happens, 
- Reactivity: what affects the discharge. 
During EEG recording the electrodes may capture other activity in addition to 
electrical activity of the brain. These additional activities captured on EEG are 
called artefacts and can be classified as physiological and extra-physiological 
artefacts. Physiological artefacts may be due to muscle activity, eye 
movements, electrocardiographic activity, pulse, respiration or sweating. 
Extra-physiological artefacts may be due to electrode ‘pop’, alternating current 
artefact arising from power lines, interference from electrical equipment, 
movements in the environment i.e. from respirators. EEG artefacts need to be 
identified and eliminated by the neurophysiologist if possible.  
In a normal EEG, the following patterns during wakefulness are seen (Lee-
Chiong, 2006); 
- Alpha Rhythm: Frequency 8-12 Hz; located posteriorly; with the 
morphology of rhythmic, regular, waxing and waning; amplitude 
between 20 and 100 µV; best seen with the eyes closed. 
- Beta Activity: Frequency greater than 13 Hz (typically between 18-25 
Hz); located mostly in frontocentral; morphology is usually rhythmic, 
waxing and waning and symmetric; amplitude between 5-20 µV, 
boosted during sleep stages 1 and 2. Beta activity is usually increased 





in amount and voltage in the EEGs of people who use benzodiazepines 
and barbiturates. 
- Mu Rhythm: Frequency 7-11 Hz; located in centroparietal area; arch 
like shape or like letter “m”; mostly asymmetric but may be unilateral; 
attenuates with movement of contralateral extremity, thought of a 
movement or with tactile stimulation. 
Two other EEG rhythms that can be identified in EEGs are (Sanei and 
Chambers, 2007);  
- Delta waves: have frequency 0.5–4 Hz. These waves are primarily 
associated with deep sleep and may be present in the waking state in 
brain injured patients. They may be confused with artefact signals 
caused by the large muscles of the neck and jaw. 
- Theta waves:  have frequency of 4–7.5 Hz and originate from thalamic 
structures. Theta waves appear as consciousness slips towards 
drowsiness. A theta wave is often accompanied by other frequencies 
and seems to be related to the level of arousal. The theta wave plays 
an important role in infancy and childhood but large amounts of theta 
wave activity in the waking adult are abnormal and are caused by 
various pathological problems.  
EEG provides a direct measure of the behaviour of large-scale neuronal 
networks with a millisecond temporal resolution and gives information on 
functional properties and states of brain functioning and information 
processing. For example, Fingelkurts et al. found that the EEG microstates 
(transient, patterned, quasi-stable states or patterns of 
an electroencephalogram lasting  from milliseconds to seconds) and spectral 
patterns of EEG (i.e. the repertoire, duration and oscillatory type of EEG 
microstates in resting) were quantitatively related to level of conscious 
expression in brain-damaged patients and healthy/ conscious subjects 
(Fingelkurts et al., 2012). In the same study, it was shown that patients with 





disorders of consciousness had EEGs characterized by lack of fast-alpha-
rhythmic spectral pattern types (normal>=MCS>VS) and predominance of 
delta- and theta-rhythmic spectral pattern types (VS>MCS). It was suggested 
that, EEG fast-alpha-rhythmic microstates were necessary for full-fledged 
consciousness and may be considered a minimally sufficient neural condition 
for consciousness to be expressed. 
2.1.2 Sleep EEG/ Polysomnography 
Sleep causes distinctive changes in EEG. Therefore, EEG recordings can be 
extended to longer periods to capture electrical activity of brain during 
wakefulness and sleep. Depending on the purpose of the study, the study may 
be performed overnight, over 24 hours, or even, for few days continuously. In 
addition to EEG, further data is usually obtained via electromyography (EMG), 
electro-oculography (EOG) and respiratory muscle (plethysmography) 
electrodes. 
Stages of sleep can be identified by examining EEG recordings during sleep. 
Based on the EEG features (waveforms, EMG changes and eye movements), 
sleep can be divided into two categories: non-rapid eye movement (NREM) 
and rapid eye movement (REM) sleep.  
NREM sleep then further divided into three subcategories (stages 1, 2, 3 & 4) 
which are roughly representative of the depth of the sleep. For example, while 
arousal threshold is very low in stage 1 (light sleep); in stage 3 & 4 it is the 
highest (state of deep sleep). Since the publication of the American Academy 
of Sleep Medicine (AASM) Manual in 2007 (Silber et al., 2007), stages 3 & 4 
of the sleep are combined as stage N3. (Please note: from here on, both the 
terms of stage 3 & 4 and stage N3 will be used to keep in line with the 
terminology of literature referred.) The EEG features of NREM sleep include 
sleep spindles, K-complexes (stage N2) and high-voltage slow waves (stage 
N3). 





REM sleep is characterized by typical EEG desynchronization, muscle atonia 
and episodic bursts of rapid eye movements. This is the state of a sleep where 
dreaming occurs. In other words, REM sleep is a state where brain is active, 
and body is almost completely paralyzed.  
EEG features of different sleep stages are shown in figure 2.2. Time spent in 
different stages of sleep in healthy adults and EEG, EOG, EMG characteristics 
of sleep stages in healthy adults (Attarian, 2012) are summarized in figure 2-3 











Figure 2-2: EEG features of different sleep stages (Modelling the variability of 
electrical activity in the brain - Scientific Figure on ResearchGate. Available from: 
https://www.researchgate.net/figure/Brain-activity-during-different-sleep-stages-
The-detection-of-transient-sleep-spindles_fig7_280647883) 























Stage 1 Stage 2 Stage 3+4 REM Awake
Figure 2-3: Night sleep- percentage of time spent in different sleep states 




Table 2-3: Sleep stages observed during sleep EEG and their characteristic features. (TST= Total Sleep Time, EOG=Electrooculography, EMG= 
Electromyography) 
Sleep Stage % of TST EEG characteristics EOG EMG 
Stage N1 
“Drowsiness” 
3-5 %  Attenuation of posterior dominant alpha activity with overall slowing of 
background frequencies to theta (4-7 Hz) for more than 50% of the 
epoch. Slow-rolling eye movements. Sometimes vertex sharp waves. 
Slow Decreased from 
awake 
Stage N2 50-60 %  Sleep Spindles: series of distinct waves with frequency of 11-16 Hz, 
duration ≥0.5 seconds, usually over central regions. 
K Complexes: Well-defined negative sharp-wave, immediately 
followed by a positive component, duration ≥ 0.5 seconds, mostly over 
frontal regions. 
Background EEG has less than 20% delta activity. 
None Decreased from 
awake 
Stage N3 /4 
“Deep Sleep” 
10-20 %  High amplitude (≥75 µV) and slow frequency (0.5-2 Hz) delta activity. 
Stage 3 has delta activity in 20-50% of the epoch. Stage 4 has delta 
activity more than 50% of the epoch.  




10-25% Low amplitude and mixed frequency activity in EEG channels; 
presence of rapid eye movements; low muscle to in the chin EMG 
channel. Saw-tooth theta waves may be present. 
Rapid Nearly absent 




Following evaluation of sleep EEG epochs by a neurophysiologist, a 
polysomnography report is produced, and values are given for several 
parameters in addition to description of EEG waves and stage data. The most 
commonly reported sleep parameters are (Pressman, 2000): 
- Total Recording Time (TRT): Total amount of time in minutes, during 
which the patient is in bed with recording equipment activated. 
- Total Sleep Time (TST): Total amount of sleep time scored during TRT.  
- TST= Stage 1 + Stage 2 + Stage 3 + REM Sleep. 
- Sleep Efficiency (SE): Percentage of Total Recording Time which 
actually spent in sleep. 
SE= (TST/ TRT) x 100 
TST and SE increase with use of hypnotic and sedative medications, during 
rebound sleep and with lack of usual time cues. 
TST and SE decrease with recent intake of alerting medications, caffeine or 
nicotine, anxiety and depression and environmental disturbances. 
- Total Wake Time (TWT): Amount of wake time during TRT. This does 
not distinguish multiple short periods of wakefulness from long and 
sustained periods of wakefulness. 
- Wake After Sleep Onset (WASO): Wakefulness occurring after defined 
sleep onset. A good measure of how much wakefulness occurred 
during sleep and hence, a better reflection of sleep disruption. 
- Sleep Latency: Time in minutes from light out to the first epoch scored 
as sleep. 
- REM Latency: Time from sleep onset to the first epoch scored as REM 
sleep. 
Although, the wakefulness and presence of sleep–wake cycle is an indicator 
of emergence from coma and is part of the definition of the disorders of 
consciousness, recent studies have demonstrated absence of 




electrophysiological characteristics of normal sleep in PDOC patients  For 
example, it has been shown that the presence of EEG sleep spindles and REM 
sleep is highly correlated with better clinical scores and that more structured 
sleep is associated with more positive clinical outcomes (Arnaldi et al., 2016, 
de Biase et al., 2014, Aricò et al., 2016). The topic of sleep EEG/ 
polysomnography in disorders of consciousness will be reviewed in depth in 
chapter 4. 
2.1.3 Event Related Potentials (ERPs) 
Event Related Potential experiments investigate brain responses to specific 
stimuli such as auditory tones, words or pictures. Paradigms may be designed 
as passive paradigms which do not require any active involvement of the 
subject; or as active paradigms which the subject is required to perform a task, 
such as counting a target word in a list of other words presented during the 
experiment. During active ERP paradigm experiments the subjects are asked 
to perform some tasks to detect violations of auditory or visual regularities. 
Event related potential techniques have the advantage of having very good 
(1ms or better) temporal resolution which cannot be achieved by 
hemodynamic investigations like fMRI or PET scanning. Voltages recorded at 
the scalp by using the ERP technique reflect what is happening in the brain 
almost at the same moment of time, due to the speed of electrical conduction. 
On the other hand, spatial resolution is ERP technique is not well-defined. In 
other words, we cannot definitively localize the neural generators of ERP 
effects within the head from the data recorded outside of it (Woodman, 2010). 
ERPs reflect post-synaptic potentials which last up to hundreds of milliseconds 
rather than action potentials which last only about a millisecond. Post-synaptic 
potentials on the other hand, are largely confined to the dendrites and cell 
body. These factors allow post-synaptic potentials to summate rather than 
cancel each other- making measurement of voltage from distant scalp 




electrodes possible. Another advantage of the ERP technique is its ability to 
provide continuous measure of neural processing.  
Following a stimulus several ERP waveforms are produced. These waveforms 
are described according to their latency and amplitude. ERP waveforms are 
named according to their voltage deflections (positive [P] and negative [N]), 
followed by a number which indicates its latency. For example, N100 is a 
negative ERP waveform which occur approximately 100ms after the stimulus. 
The early waves (waveforms produced within the first 100 milliseconds after 
stimulus) are termed ‘sensory’ or ‘exogenous’ as they depend largely on the 
physical parameters of the stimulus (Sur and Sinha, 2009). 
For example, following an auditory stimulus, within the first 10ms auditory 
brainstem responses occur and they are useful for assessing auditory 
pathology. Brainstem auditory responses are followed by mid-latency 
components between 10 and 50ms which most likely arise from the medical 
geniculate nucleus and primary auditory cortex. These are then followed by 
the auditory P1 wave at 50ms which are the largest at frontal electrode sites 
and N1 wave which peaks around 100ms. 
The N2 waveform is observed in response to a repetitive, non-target auditory 
stimulus (stimulus detection). If deviant tones are presented, a larger 
amplitude N2 wave is elicited (Simson et al., 1977). 





Figure 2-4: ERP waveforms following auditory stimuli. Please note that the ERP is 
plotted with negative voltages upward, a common, but not universal, practice in ERP 
research. (redrawn based on available creative commons images) 
ERPs generated in later parts reflect the manner in which the subject evaluates 
the stimulus and are termed ‘cognitive’ or ‘endogenous’ ERPs as they examine 
information processing (Sur and Sinha, 2009). Mismatch Negativity (MMN) 
and P300 waveforms are examples of cognitive ERPs and can be generated 
in response to both auditory and visual stimuli. 
ERP and MMN studies can be designed to measure brain responses to 
different types of stimuli. Due to the nature of their clinical presentation patients 
with disorders of consciousness are unlikely to perform tasks during the 
experiments using visual stimuli. Therefore, experiments using auditory stimuli 
are more commonly used in DOC research.  
The MMN is observed when subjects are exposed to identical stimuli 
repetitively with occasional mismatching stimuli. The mismatching stimuli is 
expected to elicit a negative- going wave at central midline scalp sites reaching 
to its peak between 160 and 220ms. MMN is observed best if the subject is 
not using the stimulus stream for the task in other words if there is a competing 
sequence of stimuli. MMN reflect a reasonably automatic response that 
compares the incoming stimuli to a sensory memory trace of another stimulus 
which was previously presented.  





Figure 2-5: Mismatch Negativity (MMN) (Adapted from Sams et al. (Sams et al., 1985) 
MMN is regarded as an indicator of pre-attentive sensory memory process. In 
the recent years several studies examining MMN in disorders of 
consciousness uniformly have suggested that MMN has potential value in 
predicting clinical improvement in patients with PDOC, as it may indicate 
presence of preserved neuronal connections (Qin et al., 2008, Boly et al., 
2011, King et al., 2013, Wijnen et al., 2007, Morlet and Fischer, 2013, Fischer 
et al., 2010). 
The P3 (or P300) entirely depends on the task performed by the subject and 
is not directly influenced by the physical properties of the stimulus presented. 
P3 is sensitive to target probability. The P3 amplitude gets larger if target 
probability gets smaller. For example, if the target letter A is presented on 10 
percent of the trials and the non-targets are the rest of the letters present in 
the alphabet, the target will elicit a very large P3 wave. This is most likely due 
to allocation of more resources to the task. The P3 wave amplitude also 
increases when subject dedicate more effort to the task and gets smaller if the 
subject is not sure of whether the stimulus was a target or not. Therefore, the 
difficulty of task needs special consideration when designing the experiments. 
For example, a very difficult task may lead to devote more effort to the task 
and therefore, may increase the amplitude but it may also result in decrease 
on P3 amplitude by making subjects less certain.  
The P300 can often be considered to include two distinct subcomponents: the 
P3a and the P3b. P3a is frontally centred, usually peaking at 250–300 ms and 
known to be elicited in a “bottom-up” manner, by novel, unpredictable stimuli, 




even if they are irrelevant to the task being performed. P3b is a more posterior 
waveform, peaking at around 300–350 ms and is thought to be elicited in a 
“top-down” manner, as a result of response to paying selective attention to 
stimuli- deemed as task-relevant, and their subsequent entry to conscious 
awareness and working memory (Chennu and Bekinschtein, 2012). 
 
Figure 2-6: P300 waveform. Adapted from Comerchero et al. (Comerchero and Polich, 
1999) 
N400 waveforms are generated as a result of semantic processing and N600 
waveforms are as a result of syntactic processing. These two waveforms are 
rarely examined in PDOC research studies due to complexity of cognitive 
processing required to produce these waveforms.  
The MMN and P3 ERP components provide objective information on the 
functional state of the brain without the need to any active participation (Morlet 
and Fischer, 2014). 
Several studies showed that presence of MMN responses is a predictor of 
awakening and functional outcomes in comatose patients (Kane et al., 1993, 
Fischer et al., 2006, Fischer et al., 2004, Luaute et al., 2005). The interest then 
was extended to the patients in vegetative and minimally conscious states. It 
was found that presence of MMN was associated with better clinical outcomes 
and also may be used as an additional tool to differentiate VS and MCS 
(Kotchoubey, 2007, Kotchoubey et al., 2005, Wijnen et al., 2007). 




P3 responses obtained during novelty oddball paradigms may help to predict 
outcomes in comatose patients, and also, to differentiate VS and MCS patients 
by enabling detection of islands of cognition (Fischer et al., 2008, Fischer et 
al., 2010). Schnakers et. al. examined P3 responses to subjects’ own name 
stimuli in both active and passive conditions and showed that MCS patents 
had a larger P3 to own name stimuli, even larger in active conditions. In this 
study, all healthy subjects, all MCS patients and, 3 out of 5 VS patients had P3 
responses in passive conditions with no difference to the responses in active 
conditions. The authors suggested that active own name ERP paradigms may 
help to detect voluntary brain function in patients with PDOC (Schnakers et al., 
2008). 
ERP techniques seem to have a significant prognostic and diagnostic role in 
coma and disorders of consciousness.  
2.2 NEUROIMAGING TECHNIQUES 
Structural MRI studies can give valuable information about the extent of the 
brain damage, especially when combined with additional imaging techniques 
such as diffusion tensor imaging (DTI), which provides additional information 
on the state of the brain’s white matter tracts, which are not usually visible on 
conventional neuro-imaging techniques, such as computerized tomography 
and MRI. DTI technology is based on the molecular diffusion physical principle: 
any molecule in a fluid is randomly displaced by means of thermal energy 
(Brownian motion) (Cavaliere et al., 2014). DTI technique has been most 
commonly used to assess white matter tracts after a traumatic brain injury and 
brain ischaemia. In the recent years, however, the role of DTI has been 
extended to developmental disorders and even to psychiatric illnesses. 
However, DTI scanning is not only susceptible to artefacts from gradient 
hardware and motion, but also carries significant limitations for the 
interpretation of the images regardless of the robustness of the tracking 
algorithms used (Le Bihan et al., 2006). There is a growing interest in using 
DTI technique to explore the pathophysiological basis of DOC as well as to 




monitor change (Bruno et al., 2011a, Fernandez-Espejo et al., 2011, 
Fernandez-Espejo et al., 2010). Despite the current technical difficulties 
associated with DTI, it has a potential to be used more frequently in the future 
for assessment of pathophysiology and progress in DOC. 
 
Figure 2-7: A DTI imaging showing white matter tracks. (from 
http://www.martinos.org/neurorecovery/technology.htm) 
 
Single photon emission tomography (SPECT) and positron emission 
tomography (PET) are nuclear medicine scintigraphy techniques which enable 
assessment of regional brain function based on its metabolic activity. Both are 
non-invasive techniques. Compared to SPECT technology, PET offers a 
higher spatial resolution and the possibility of true quantitative assessment of 
physiological processes (Beuthien-Baumann et al., 2005). 
Positron emission tomography (PET technique is based on the detection of 
radioactivity emitted after injection of a small amount of radioactive tracer 
(usually labelled with oxygen-15, fluorine-18, carbon-11, or nitrogen-13) 
(Berger, 2003). The brain uses glucose for its energy metabolism. Therefore, 
18-fluorodeoxyglucose (18F FDG) is a commonly used radiolabelled glucose 
analogue which measures of glucose consumption rate in the tissues. PET 
scans may also be used to measure the blood flow and oxygen consumption 




in different parts of the brain (stroke and dementia evaluation) as well as by 
tracking chemical neurotransmitters (for example tracking dopamine to 
evaluate Parkinson's disease).  
 
Figure 2-8: PET scanning principles (from Berger,2003) 
 
Using 18F FDG, it has been demonstrated that in VS there is a widespread 
metabolic dysfunction. On the other hand, in MCS the thalamus and intrinsic 
network (also known as Default Mode Network (DMN) and based on midline 
fronto-parietal networks) is impaired (see chapter 1 for further information on 
intrinsic network). As the consciousness levels increase, the volume of 
dysfunctional structures decreases (Thibaut et al., 2012). 





Figure 2-9: Metabolic activity in external and internal awareness networks in severely 
brain-damaged patients (From Thibaut et al.  J Rehabil Med 2012; 44: 487–494) 
 
PET scans may also help to differentiate reflex and non-reflex behaviors in 
disorders of consciousness. For example, in a study performed by Bruno et.al. 
it was concluded that visual fixation is not a sign of consciousness as VS 
patients with and without visual fixation had identical brain metabolism in their 
PET scans (Bruno et al., 2010). 
In another study H2¹5O PET blood flow studies were used to study pain 
processing in 18 VS patients. In this study, noxious somatosensory stimuli 
activated midbrain, contra-lateral thalamus and primary somatosensory cortex 
in all patients even in the absence of detectable cortical evoked potentials.  In 
healthy controls however, the noxious stimuli activated both primary and 
secondary somatosensory cortices as well as bilateral insular, posterior 
parietal and anterior cingulate cortices. Therefore, it was suggested that 
primary somatosensory cortex was activated VS patients, but this was 
functionally disconnected from ‘higher order’ associate cortical areas (Laureys 
et al., 2002). 




Despite of the promising studies PET scanning has significant limitations. First 
of all, as it is a tomography technique, PET scanning expose patients to 
radiation (similar to the amount of radiation exposed during computerized 
tomography scans) and therefore repeated investigations often cannot be 
instigated. There are also difficulties in relation to lack of statistical criteria for 
disorders of consciousness patients as this requires group studies which are 
difficult to perform in heterogeneous and small patient population of disorders 
of consciousness (Coleman et al., 2009). 
Functional MRI studies have attracted the attention of clinicians and neuro-
scientists who are interested in the topic of detecting covert signs of 
consciousness in PDOC patients or in patients who actually suffer from 
complete locked-in syndrome and cannot show any motor sign of 
consciousness. fMRI data can be obtained in both resting conditions and also 
during active paradigms where patients are presented with stimuli and tasks 
to perform. 
Resting fMRI can measure the brain’s default activity looking at spontaneous 
haemodynaemic fluctuations in blood-oxygen-level-dependent (BOLD) signal 
in specific areas of the brain. For example, internal self-related thoughts result 
in activation in midline cortical structures and external sensory perceptions 
result in activation in lateral fronto-parietal areas. Based on this principle, Boly 
et al. were able to show that VS patients had partially preserved ‘default mode 
network’ connectivity but none in brain death patients (Boly et al., 2009). In 
another study, it was shown that default network connectivity reflected the level 
of consciousness in non-communicative brain damaged patients 
(Vanhaudenhuyse et al., 2010). 
On the other hand, active paradigm fMRI scans are used as almost like a brain-
computer interface technique using motor and spatial imaginary tasks. 
Functional MRI motor and spatial imaginary tasks were previously validated in 
healthy control subjects. These tasks are associated with distinct activity in the 




supplementary motor area and the parahippocampal gyrus.  In a study which 
used fMRI motor and imagery tasks, 5 out of 54 patients (four VS, one MCS) 
were wilfully able to modulate their brain activity. One patient was even able to 
apply the imaginary technique in order to answer yes/no questions (Monti et 
al., 2010). 
These results suggest that different structural and functional imaging 
modalities (especially when used in combination) may provide a powerful 
means for reaching diagnosis and prognostic prediction in PDOC patients.  
Near infrared spectroscopy (NIRS) is another non-invasive bed side technique 
which measures changes in brain tissue oxygenation and recently was used 
to detect residual cognitive functions in patients with prolonged disorders of 
consciousness (Kempny et al., 2016). This study demonstrated the feasibility 
of using NIRS for the assessment of brain function in PDOC patients using a 
motor imagery task however, further studies are needed to form an evidence 
base.  








We have seen that, there have been significant amount of research using 
different fMRI or PET techniques in order to detect covert consciousness in 
Figure 2-11: MRI scanner 
(creativecommons.org/licenses
/by/2.0/deed.en_GB) 
Figure 2-10: EEG system 
(creativecommons.org/licenses 
/by/2.0/deed.en_GB) 




patients who appear to be in vegetative state on the basis of clinical 
assessments. As shown in Figure 2-11 the equipment required to perform 
neuro-imaging tests are large pieces of equipment only which can be housed 
in neuro-radiology departments. Due to cost and maintenance issues they are 
not widely available. Patients need to be transported to the units where 
equipment is available. Most patients with severe brain injuries have 
contraindications and/or patient related difficulties for MRI scanning such as 
pieces of metal in the body, connection to clinical machines, severe involuntary 
movements and sometimes even severe contractures of lower limbs which can 
prevent going in the MRI scanner. PET and fMRI scanning procedures may 
result in increased stress in brain injured patients due to noise, long duration 
and other technological circumstances which in turn may influence the brain 
functional state. Tomography based techniques carry additional problem of 
radiation exposure.  
Apart from practical difficulties, these techniques present a significant 
challenge of accurate mapping of responses onto available reference atlases, 
since complex and severe brain injuries often result in secondary atrophy and 
loss of both grey and white matter volume loss. They provide indirect measures 
of brain activity. Whereas the EEG signals recorded at single sensor location 
are the product of activity arising from part or parts of brain and neutral with 
respect to the problems of localization of primary source and volume loss.  
EEG techniques have several advantages over fMRI. First of all, EEG is much 
less expensive than fMRI and can be used at the bedside of patients. These 
make it easily accessible for many centres and also, eliminate the difficulties 
arising from transferring patients to another centre. Even if the initial EEG 
recordings are sub-optimal, they can be repeated another time as once the 
system is set-up, the cost of running is minimal. EEG studies can be performed 
even in intensive care units, if necessary by using only few electrodes. 
Recently, with the use of cap systems which contain 32 to 256 electrodes 
preparation time is greatly reduced. 




ERP techniques have the advantage of having very good (1 ms or better) 
temporal resolution which cannot be achieved by hemodynamic investigations 
like fMRI or PET scanning. Voltages recorded at the scalp by using the ERP 
technique reflect what is happening in the brain almost at the same moment of 
time due extremely high speed of electricity. On the other hand, spatial 
resolution of ERP technique is undefined as several sources are activated 
during an ERP experiment. ERP technique, however, is not an invasive 
technique and is inexpensive in comparison with hemodynamic measures.  






(PET, DTI, fMRI) 
Electro-physiological 
Techniques  
(EEG, ERP studies) 
Spatial Resolution Excellent Poor 
Temporal resolution Poor (up to minutes) Excellent 
(milliseconds) 
Bedside testing No Yes 
Equipment Cost Up to £3 million Up to £100k 
Repeatability in practice Possible but not 
easy 
Easy 
Direct marker of brain 
activity 
No Yes 
Data   Based on statistics Actual neural activity 
Subjectivity to motion 
artefacts 
High Low 











2.4 CHAPTER SUMMARY AND CONCLUSIONS 
Both EEG based techniques and neuro-imaging techniques can aid 
assessment of consciousness. Both have their own advantages and 
disadvantages and give information which can complement the whole 
diagnostic and prognostic work-up in this particular patient group. In an ideal 
world, the clinicians and researchers would have wanted to perform a battery 
of tests which can enable them to understand this peculiar condition, minimize 
misdiagnosis and predict clinical outcomes more precisely. However, due to 
several constraints which can be, patient, resource or even time related, there 
is often a need to choose a few amongst them, so the research and clinical 
questions on the table can be answered most accurately.  It should also be 
kept in mind that most of the techniques summarized above are mainly 
available for research purposes and not routinely used in most clinical settings 
even in the most developed countries. The results presented on research 
papers need to be interpreted cautiously as all of them have significant 
limitations due to technical and analytic difficulties associated with them. As 
the research study presented in this thesis is about optimizing circadian rhythm 
and sleep of patients with disorders of consciousness, EEG techniques which 
reflect brain’s electrical activity directly, will be most informative as they can 
inform both electrical activity during sleep and, brain re-activity in response to 
stimuli given. The next chapter will focus on regulation of sleep and circadian 










Chapter 3 INTRODUCTION: REGULATION OF 
SLEEP AND CIRCADIAN RHYTHM IN 
HUMANS 
The aim of this thesis is to find out if circadian rhythm and sleep-wake cycle 
normalization lead to improved brain functions of people with disorders of 
consciousness. This chapter therefore, will focus on how the sleep and 
circadian rhythm are regulated in normal subjects, which will then help to 
understand how the assessments and interventions can be planned on 
patients with PDOC.  
Almost the entire temporal organization of human life is orchestrated by the 
inputs from main circadian clock which is located in the suprachiasmatic 
nucleus (SCN), and sleep-wake state of an individual which is regulated by the 
homeostatic regulatory system (Kryger et al., 2011). Inputs from peripheral 
circadian clocks, external environment, person’s lifestyle and habits contribute 
to the regulation of these two systems. For example, the timing of food intake, 
travel between time zones, shift-work all affect the regulation of sleep- wake 
state and circadian rhythmicity. In this chapter, regulation of the sleep- wake 
state, circadian rhythm, interactions between different systems and other 
factors that contribute to their regulation will be summarized.  
3.1 REGULATION OF SLEEP- WAKE STATE 
The sleep-wake state is regulated by two mechanisms: the homeostatic 
regulatory system of the hypothalamus and a circadian clock. While the 
homeostatic regulatory system manages acute changes in sleep duration and 
quality, for the changes that occur in longer time frames the circadian clock 
intervenes. For example, if a person is acutely deprived of sleep, the 
homeostatic system manages the situation by initiating recovery sleep. If the 
sleep-wake cycle changes, in a repetitive and chronic manner, such as in the 
event of shift-work, the circadian system adapts to the situation and changes 




how it regulates the related temporal events. Alterations to the circadian clock 
can lead to sleep disorders.  
3.1.1 Homeostatic regulation of sleep 
The regulation of sleep and arousal is dependent on the interactions between 
the sleep and arousal promoting systems (Ono and Yamanaka, 2017). It was 
shown that the ventrolateral preoptic nucleus (VLPO) and the monoaminergic 
cell groups form a flip-fop switch which is stabilized by orexins. (Saper et al., 
2001).  It was suggested that these two areas of the hypothalamus inhibit each 
other, which then results in promotion of stable wakefulness and sleep patterns 
(hypothalamic switch). The VLPO inhibits the ascending arousal regions and, 
is in turn inhibited by them, thus forming a mutually inhibitory system 
resembling what electrical engineers call a “flip-flop switch.” 
3.1.2 Circadian regulation of sleep 
In Latin “Circa” means about, and “dies” means day. The term of “circadian 
rhythm” therefore describes behavioural and physiological events that occur 
and repeat themselves in a period of a day/ 24 hour.  
Human circadian rhythm has two control mechanisms: internal and external. 
Human circadian rhythm is mainly regulated by the internal clock in the SCN 
and environmental stimuli (time cues or zeitgebers) contribute greatly to the 
regulation of human circadian rhythm. 





Figure 3-1: Human circadian clocks. SCN= Suprachiasmatic nucleus. The organs 
labelled in red represent peripheral clocks. SCN is the central/ master circadian clock. 
 
While the internal clock consists of an endogenous component of human 
circadian rhythm, exogenous component is driven by the individual’s lifestyle 
and environmental factors.  Both endogenous and exogenous components 
interact with each other closely. Entrainment of circadian rhythm can be 
achieved by use of environmental factors known as zeitgebers (time-givers) 
such as light, temperature, social cues and rhythmic feeding (Arendt, 1995). 
For example, secretion of melatonin is suppressed by bright light; the levels of 
several hormones are modified by food ingestion. The SCN in mammals drives 
the circadian rhythms that entrain to the daily 24-hour light-dark cycle. It is 
widely believed that the SCN is the main pacemaker that orchestrates 
synchrony among the circadian oscillators of peripheral organs such as the 
liver, lungs, heart, and kidneys, as well as limbic, cerebral, and cerebellum 
brain (Shibata, 2007). 
Most peripheral clocks of human circadian rhythm are mainly entrained by 
feeding cycles rather than light- dark cycles. It was shown that human 




molecular clocks may be regulated by feeding time and timed meals therefore 
play a role in synchronizing peripheral circadian rhythms in humans. The two-
way interaction between the central and peripheral clock of humans appear to 
be complex as food intake influences activity of enzymes and hormones 
involved in metabolism as well as circadian gene expression (Froy, 2011, Froy, 
2007, Wehrens et al., 2017, Johnston, 2014). 
3.1.3 Study of circadian rhythmicity 
Chronobiology is a field of science that studies the biology of time and internal 
biological clocks such as circadian rhythms. Medical chronobiology is a 
developing field of medicine, and is concerned with two most important issues: 
(1) chronopathology—the effect of circadian rhythms and the manifestations 
of disease; and (2) chronopharmacology as many pharmacologic agents 
influence biological rhythms (Chokroverty, 2009).  
If a person is suspected to have a long-term abnormality of sleep-wake cycles 
(chronic sleep problems) examination of circadian rhythmicity as well as any 
medications that they are on, is essential.  The information gathered then 
informs the treatment options. The following sections of this chapter will focus 
on the tools that can be used in assessment of circadian rhythmicity as well as 
medications that can influence it, and finally what can clinicians do to resolve 
circadian sleep disorders. 
3.1.4 Markers of circadian rhythmicity 
Internal clock not only regulates the sleep rhythms but also the body 
temperature and endocrine cycles. Thus, assessment of human circadian 
rhythm can be done not only by studying sleep wake cycles but also by 
studying the temperature cycle and endocrine cycles (Hofstra and de Weerd, 
2008). 
In practice, the most widely used measures used as markers of circadian 
rhythm are cortisol levels, melatonin levels, and core body temperature 
changes.  




When doing so, the following parameters are used to describe characteristics 
of a circadian rhythm and report chronobiological events during a cycle:  
• Phase (φ) of a circadian rhythm refers to any point within a cycle. 
• Acrophase is the phase angle corresponding to the maximal value of 
the rhythmic parameter studied. 
• Rate of cycling (τ) characterizes the time elapsed between each 
successive occurrence of a phasic event. 
• Amplitude refers to range of values throughout the cycle. It is the 
measure of one half of the extent of the rhythmic change estimated by 
the mathematical model (e.g., cosine curve) best fitting the data (e.g., 
the difference between the maximum and the rhythm-adjusted mean of 
the best fitting curve). 
• Peak is the highest point in a series of measurements obtained as a 
function of time. For example, melatonin peak occurring at 2 am. 








Figure 3-2: Key properties of a circadian rhythm. (Adopted from Biological rhythms 
workshop-1 by Khulman et. al. Cold Spring Harb Symp Quant Biol. 2007; 72:1-6) 
 
3.1.4.1 Cortisol 
Cortisol is a corticosteroid hormone that is produced in the adrenal cortex. 
Cortisol shows a circadian rhythmicity through multi-synaptic suprachiasmatic 
nucleus-adrenal pathway (Buijs et al., 1999). Its levels can be measured in 




serum and saliva; however, several factors influence the secretion of cortisol 
such as physical and psychological stress and high-protein diet and therefore 
it is unlikely to be a first choice tool to assess circadian rhythms in patients with 
multiple medical problems and on artificial nutrition and hydration (see 
methods development chapter for further discussion). 
3.1.4.2 Melatonin 
Melatonin is a hormone, which is secreted by the pineal gland, and it plays a 
crucial role in regulation of circadian rhythm. Melatonin levels can be 
influenced by posture, exercise, caffeine and certain drugs such as non-steroid 
anti-inflammatory drugs (NSAIDs) and beta blockers. However, its rhythmicity 
remains reasonably preserved. Not only measuring levels of melatonin can be 
used as a marker of human circadian rhythm, it can also be given to people 
with circadian rhythm disorders as a treatment. It is secreted in the pineal gland 
which is located deep in the centre of brain. It was once called “the third eye”. 
3.1.4.2.1 Pineal Gland 
The existence of the pineal gland has been known for more than 2000 years- 
with the earliest anatomical description by Galen (130-200AD). Most 
remarkably, in 1662 the French philosopher Descartes thought that the pineal 
gland coordinated the psychophysiological functions of humans and the 
stimulus for pineal function arose from the visual input to the retina, which is 
effectively true today. 





Figure 3-3: Descartes: The Nervous System. Diagram of the brain and the pineal 
gland,1662 (Wellcome Library, London) 
 
The mammalian pineal gland is a small, singular, central structure with 
secretory function. The average adult weight of the human gland has been 
reported as 100mg to 150mg (Arendt, 1995). It originates as an evagination of 
the diencephalon and it is closely associated with the third ventricle of the 
brain. It has a very rich vascularization, but it lacks an endothelial blood-brain 
barrier enabling it to react to peripherally acting medications.  
The human pineal gland consists of a central core composed of lobules and a 
cortex with a more diffuse distribution of neurons. The principal cell type of the 
pineal parenchyma is the pinealocyte. Human pinealocytes are not capable of 
direct light sensitivity but they retain many characteristics of pineal 
photoreceptors found in other species such as lizards and birds (the third eye).  
Another interesting histological feature of the pineal gland is the presence of 
calcareous deposits on both parenchymal and intercellular tissue which gives 
the most distinguishable radiographic characteristic of the pineal gland 
(Macchi and Bruce, 2004). 
Sympathetic and parasympathetic fibres, as well as fibres originating from 
central nervous system peripherally innervate pineal gland. Sympathetic fibres 




arising from the superior cervical ganglion are the most important afferents for 
the pineal gland. These neurons receive regulatory input from the 
suprachiasmatic nucleus of the hypothalamus, which receives direct input from 
retinal ganglion cells (European Pineal Study Group et al., 1979). Described 
noradrenergic sympathetic innervation of the gland is essential for the 








3.1.4.2.2 Secretion and metabolism of melatonin 
Melatonin is synthesized from tryptophan in the pinealocytes of pineal gland 
under the control of master circadian clock located in the suprachiasmatic 
nucleus as illustrated below. 
 
Figure 3-5: Synthesis of melatonin 
Figure 3-4: Melatonin. This image brings together a timepiece, a brain and a melatonin 
molecule to represent the connection between melatonin, the brain and the body clock. 
The watch is placed more or less in the brain region of the pineal gland which is where 
melatonin is produced in mammals. Anna Tanczos, Wellcome Images 




Melatonin levels start to increase before sleep in the evening, peak in the early 
hours of the morning and decrease after waking. Hence, dim light melatonin 
onset (DLMO) and dim light melatonin offset (DLMOff) are commonly used as 
circadian phase markers. Although, within individual subjects the timing, 
duration and amount of melatonin secretion are very stable, there is a large 
variability between subjects. For example, peak saliva melatonin values 
ranging from 2 to 84 pg/ml in healthy subjects were reported (Burgess and 
Fogg, 2008). 
Following the synthesis, melatonin is released into capillaries and mainly 
metabolized in the liver but also in the kidney. Therefore, liver and kidney 
pathologies alter the clearance rate of melatonin. The main metabolite of 
melatonin in the urine is 6-sulfatoxymelatonin which reflects the qualitative and 
quantitative aspects of melatonin secretion in humans (Arendt, 1995). 
3.1.4.2.3 Light and control of melatonin synthesis 
The most prominent regulator of melatonin synthesis is the daily changes of 
light and darkness. Light has both visual and non-visual effects on human 
physiology. Its non-visual effects include resetting the timing of circadian 
pacemaker- SCN, acutely improving subjective and objective measures of 
alertness and suppressing pineal melatonin production (Lockley and Foster). 
SCN not only controls the melatonin production but also receives feedback 
from melatonin via its melatonin sensitive receptors. This contributes to proper 
synchronization of internal rhythms. 
Recently, in addition to the rods and cones, a third class of photoreceptor 
system called photosensitive retinal ganglion cells (pRGCs) were discovered. 
pRGCs are involved in irradiance detection and non-image-forming responses 
to light including pupil constriction, circadian entrainment and regulation of 
sleep as well as visual information processing and contain a light-sensitive 
pigment called melanopsin (Hughes et al., 2012). Retinal photic signals then 
reach the SCN through the monosynaptic retinohypothalamic tract, which 
originates from retinal ganglion cells (Berson et al., 2002, Hattar et al., 2002). 











Melanopsin has a peak sensitivity of approximately 480 nm (blue light). Light 
intensity, duration of exposure to light, wavelength and timing of exposure are 
the factors that can have an effect on circadian rhythms. Light not only shifts 
the timing of the circadian clock but also suppresses melatonin production, 
reduces sleepiness and improves reaction times. In the absence of light as a 
synchroniser, the melatonin circadian rhythm free-runs and becomes out of 
phase with the external light-dark cycle. This phenomenon is clearly seen in 
blind individuals who completely lack light perception (Lewy et al., 2004). 
 
Figure 3-6: An isolated retinal ganglion cell. This is a type of neuron typically located 
near the inner surface of the retina of the eye that receives visual information from 
photoreceptors via two intermediate neuron types. Retinal ganglion cells collectively 
transmit visual information from the retina to several regions in the thalamus, 
hypothalamus, and midbrain. They vary significantly in terms of their size, 
connections, and responses to visual stimulation but they all share the defining 
property of having a long axon that extends into the brain. These axons form the optic 
nerve, optic chiasm, and optic tract. Annie Cavanagh, Wellcome Images 
 





Figure 3-7: Light and the control of melatonin synthesis 
 
3.1.4.3 Body temperature as a marker of circadian rhythm 
Thermoregulatory and sleep regulatory system are driven by two independent, 
but closely interacting physiological principles: homeostasis and circadian 
system (Kryger et al., 2011). 
The human body achieves stable body temperature levels by balancing the 
production and loss of heat. Heat loss is mainly achieved by the peripheral 
tissues of the body and affected by environmental temperature. 
Thermoregulatory distal skin blood flow is the main regulator of the heat loss. 
For example, to achieve a more efficient heat exchange from core to the distal 
skin (to increase heat loss) dilatation of arteriovenous anastomoses happen in 
the distal body parts which then promotes the rapid onset of sleep (Kräuchi et 
al., 2000). 
Core body temperature (CBT) includes the temperature of the brain and other 
internal organs and usually regulated around 37⁰ C. CBT displays a circadian 
oscillation as circadian signals are transmitted from suprachiasmatic nucleus 
to the pre-optic anterior hypothalamus which is responsible for 




thermoregulation. The interaction between the hypothalamic thermoregulatory 
and suprachiasmatic circadian systems was described by Moore et. al. in 
2002. It was shown that suprachiasmatic nucleus makes three projections to 
the different parts of hypothalamus: dorsal projections to the paraventricular 
hypothalamus which control pineal melatonin production; rostral projections to 
the anterior hypothalamic/preoptic areas which mediate the CBT rhythm and 
finally caudal projections to the subparaventricular zone and hypothalamic 
arousal systems located in the posterior and lateral hypothalamic areas which 
control the rhythm in rest-activity (Moore and Danchenko, 2002). 
CBT exhibits a daily decline in the evening and rise in the morning. Distal skin 
temperatures on the other hand, show an inverse circadian rhythm activity in 
comparison to the of core body temperatures. In addition to this inverse relation 
between the circadian rhythms of core and peripheral body temperature, it was 
shown that peripheral circadian activity is ahead about  100 minutes (Krauchi 
and Wirz-Justice, 1994). Distal-proximal skin temperature gradient provides a 
selective measure of distal skin blood flow and again shows an inverse 
circadian activity of the CBT under constant routine conditions (constant bed 
rest, no sleep, regular food and drink consumption). Proximal skin 
temperatures (thigh, infraclavicular area, abdomen, and forehead) follow a 
similar change to CBT (Krauchi and Wirz-Justice, 1994) (see figure 3.8). A 
change from standing position to supine position induces redistribution of heat 
from core to the peripheral tissues and therefore, increase of skin 
temperatures, decrease of CBT and increase of sleepiness in healthy subjects 
(Krauchi et al., 1997). 





Figure 3-8: Simple representation of time course of core, distal and proximal body 
temperatures (Adapted from Krauchi K et al. Functional link between distal 
vasodilatation and sleep-onset latency? Am J Physiol Regul Integr Comp Physiol. 2000; 
278 (3)) CBT= Core Body temperature, DBT= Distal Body Temperature, PBT= Proximal 
Body Temperature 
 
3.2 REGULATION OF SLEEP, PHYSIOLOGICAL AND 
PATHOLOGICAL CHANGES OF SLEEP 
3.2.1 Regulation of sleep 
Regulation of sleep is complex. Interactions between the homeostatic and 
endogenous circadian processes, habits and behavioural factors as well as 
environmental factors influence sleep regulation. Abnormality of one or more 
of these factors may lead to temporary dysregulation of sleep and circadian 
rhythm sleep disorders if they are not normalized effectively and promptly. 
This homeostatic process is influenced by prior wakefulness and plays an 
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awake during the day, the deeper the following sleep period will be, which will 
be evidenced by increased slow wave activity on sleep EEG (Dijk et al., 1990). 
On the other hand, the endogenous circadian process which is regulated by 
the internal clock in the suprachiasmatic nuclei affects sleep quantity and 
duration which is mostly influenced by when a person goes to sleep.  
Habits and behaviours have a great impact on sleep. Examples of such habit 
and behaviours include going to bed at regular hours thinking that we need to 
get up early to go to work or resisting the urge of an afternoon nap while 
working at our desks knowing that it is not appropriate to do so. Daily activity 
and stimulation levels and consumption of stimulants such as coffee are also 
part of habits and behaviours. Habits and behaviours play a strong role in sleep 
regulation and may even take priority over homeostatic and circadian 
processes.  
Similarly, environmental factors –zeitgebers whether they are part of habits or 
behaviours or occurring because of events, which are not in the control of 
individuals, form external circadian factors and affect sleep regulation in great 
extent.  
All of the factors listed above impact on sleep regulation. In order to have a 
well-timed and high quality and quantity sleep a person needs to meet the 
following requirements: 
• To have intact neural structures and pathways to regulate circadian 
rhythm and sleep regulation, 
• To be able to keep awake for a substantial amount of time during the 
day in order to reach high quality sleep at night evidenced by slow wave 
sleep/ deep sleep activity, 
• Improved habits and behaviours to facilitate function of circadian and 
homeostatic factors, 




• Optimized environmental factors/ external zeitgebers in order to 
enhance external control of circadian rhythm. 
3.2.2 Normal sleep 
The Oxford dictionary defines sleep as a condition of body and mind, which 
typically occurs several hours every night, in which the nervous system is 
inactive, the eyes closed, the postural muscles relaxed, and consciousness is 
practically suspended. In simple terms, it is a reversible state of perceptual 
disengagement with the environment. 
Normal human sleep includes two states: rapid eye movement (REM) sleep 
and non-REM sleep. These two states alternate during sleep and both can be 
identified on EEG recordings due to their distinctive EEG features (see 2.1.2 
for details). Normal sleep starts with NREM state, followed by the first REM 
sleep state, usually occurring 80 to 100 minutes after sleep onset. Thereafter, 
NREM & REM sleep cycles repeat themselves roughly every 90 minutes. 
During a night’s sleep, healthy adults go through 4 to 6 cycles. Slow-wave 
sleep predominates in the first third of the night and REM sleep predominates 
in the last half of the night. 
 
Figure 3-9: Alternating sleep stages during night sleep. REM sleep is shown with red 
lines. 




Identification of sleep onset is not straight forward as very often EEG patterns 
are not associated with a healthy subjects’ own reports. For example, while 
polysomnography and behavioural changes suggest onset of sleep, subjects 
report that they were awake (Kryger et al., 2011). At the sleep onset, the 
electromyography (EMG) shows gradual loss of muscle tone, 
electrooculogram (EOG) shows slow, asynchronous eye movements; and the 
EEG shows clear rhythmic alpha activity mainly located on the occipital region 
or EEG features of stage 1 sleep which is characterized by low-voltage, mixed 
frequency EEG pattern. Even the observation of stage 2 sleep on PSG may 
not be perceived as sleep by subjects (Agnew and Webb, 1972). This 
mismatch between the self-reports and PSG feature may be explained by the 
fact that humans most often drift in and out of arousal at the beginning of sleep. 
Sleep stage distribution may be influenced by age, quality of sleep during 
previous night, circadian rhythm disorders, environmental temperature, 
ingestion of medications, alcohol and drugs and sleep disorders such as 
narcolepsy, sleep apnoea and other medical conditions, which lead to increase 
of sleep fragmentation. 
3.2.3 REM sleep and dreaming 
Dreaming has been described as (Kryger et al., 2011);  
“a universal human experience occurring during sleep in which fictive events 
follow one another in an organized, story-like manner and into which are woven 
hallucinatory, primarily visual, images that are largely congruent with an 
ongoing confabulated plot.” 
Although some dreaming occurs in NREM sleep, the majority of dreaming 
takes place during REM sleep when intensive gamma frequency (30 to 80 Hz) 
and fast brain oscillations are recorded (Gross and Gotman, 1999). During 
REM sleep a significant increase of neural activity was shown in subcortical 
regions of the brain as well as visual processing areas of the cortex 
accompanied by relative deactivation of lateral prefrontal cortex (Maquet and 




Phillips, 1998, Maquet et al., 2005). It was also shown that, REM sleep 
dreaming exhibits default mode network processing but with some 
disconnection between network subsystems (deactivation of 
dorsomedial/posterior structures and activation of ventromedial/ prefrontal 
structures) and therefore, a good access to self-referential, emotional, 
cognitive memories but with a limited access to autobiographical memories 
occur during dreaming (Buckner et al., 2008). 
While many studies using positron emission tomography and functional MRI 
imaging, consider the associations with dreaming and neural activity in various 
parts of the brain, the question of “why we dream?” continues to attract 
attention in the area of sleep research. REM sleep serves to help offline 
consolidation of memories and learning in certain domains during certain 
timelines of sleep (Stickgold et al., 2001, Wamsley et al., 2010, Stickgold et 
al., 2000, Gais et al., 2000). In humans, the first half of the sleep is dominated 
by NREM, and the second half by REM sleep. This enables design of research 
studies, where timing of different cognitive processes can be examined. For 
example, it was shown that while improvement of a visual discrimination skills 
and declarative memory correlates with early night sleep, procedural memory 
consolidation mainly happens during late sleep (Gais et al., 2000, Plihal and 
Born, 1997). Furthermore, it was suggested that dreaming is a state, where 
highly complex analysis and recasting of emotional events occur and there 
might be a positive association between REM sleep and the selective 
consolidation of central, negative aspects of complex scenes which helps 








3.3 HOW MUCH SLEEP DO WE NEED? 
Total sleep time (TST) varies between five and ten hours in healthy young 
adults (300 to 600 minutes). According to a report of an expert panel seven to 
nine hours of sleep is recommended for adults aged 25 to 64 years and seven 
to eight hours of sleep recommended for older adults (≥ 65 years) (Hirshkowitz 
et al., 2015).  
The 2007 AASM Manual for the Scoring of Sleep and Associated Events 
defines arousals as sudden change of EEG frequency that lasts between 3 
and 15 seconds following at least 10 seconds of stable sleep. This is 
accompanied by increase in muscle tone. Wakefulness should not occupy 
more than 5% of sleep (Hirshkowitz et al., 1992). Hence, a healthy adult with 
good sleep is expected to have sleep efficiency of 95%, with swift sleep onset 
(less than 15 minutes) and have few and brief nocturnal awakenings only 
(Hirshkowitz, 2004). 
3.3.1 Sleep deprivation 
3.3.1.1 Acute sleep deprivation 
Sleep deprivation may be due to total sleep loss or increased sleep 
fragmentation. Several studies showed that acute sleep deprivation result in 
apparent changes in mood, alertness, and performance (Goel et al., 2013, Lo 
et al., 2012, Babson et al., 2010, Pires et al., 2016). Acute sleep deprivation 
result in production of a recovery sleep, which shows increased slow wave 
sleep state followed by increased REM activity (Borbely et al., 1981, 
Nakazawa et al., 1978). 
3.3.1.2 Chronic sleep deprivation 
Chronic sleep deprivation can be due to sleep disorders as well as work and 
life-style conditions. Regardless of the reason for chronic sleep deprivation, it 
results in reduction of daytime functioning, cognitive performance, safe 
operating of machinery/ driving (Reynolds and Banks, 2010). It also negatively 
effects mood and physiological functions. In the recent years, there have been 




great interests in the disturbance of immune, cardio-vascular, endocrine and 
metabolic functioning due to chronic sleep deprivation. For example, chronic 
sleep deprivation lead to decreased glucose tolerance, elevation of evening 
cortisol levels which then lead to development of diabetes and obesity (Spiegel 
et al., 2000, Spiegel et al., 2003, Spiegel et al., 1999, Van Cauter et al., 2007, 
Knutson and Van Cauter, 2008); reduction of immune function due to changes 
in natural killer cell activity, cellular adhesion molecule expression, 
lymphokine- activated killer cell activity, interleukin-6 and soluble tumour 
necrosis factor activity (Redwine et al., 2004, Redwine et al., 2000, Shearer et 
al., 2001, Irwin et al., 1996); and increase of cardiovascular events and 
morbidity (Kohansieh and Makaryus, 2015, Mullington et al., 2009, Tobaldini 
et al., 2017, Tobaldini et al., 2014). 
3.4 EFFECT OF SLEEP ON LEARNING, MEMORY AND 
BRAIN PLASTICITY 
In the recent years there have been several studies published suggesting that 
sleep plays an important role in learning, memory consolidation and brain 
plasticity. This is particularly important in patients with prolonged disorders of 
consciousness. If their circadian rhythm and sleep- wake patterns are severely 
deranged, would it be ever possible to make a recovery of their brain 
functions? 
Memory consolidation is defined as a time-dependent process, which converts 
labile memory traces into more permanent and enhanced forms over hours, 
days, or even years (McGaugh, 1966). This process is facilitated by brain 
plasticity which can be simply defined as ability of the brain to modify its own 
structure and function following changes within the body or in the external 
environment (2012) and sleep takes part in this process. Furthermore, different 
stages of sleep have distinct memory related functions. Therefore, ability to 
maintain normal sleep structure, where different sleep stages are adequately 
achieved, is imperative. For example, REM sleep is necessary for synaptic re-
modelling, which is essential for learning and cognition; NREM Stage 2 sleep 




takes part in synaptic plasticity and targeted bidirectional plasticity in the 
neocortex; NREM Stage 3 &4 (slow wave-dependent activity) would serve to 
strengthen memory circuits and therefore consolidation of memories. In 
addition, while motor skills learning happens in NREM, visual learning happens 
mostly in slow wave sleep and REM (Stickgold and Walker, 2007, Walker and 
Stickgold, 2006). (see Table 3-1: Summary of different memory and learning 
events in distinctive sleep stages.) 
Table 3-1: Summary of different memory and learning events in distinctive sleep stages. 
DECLARATIVE MEMORY CONSOLIDATION 
Semantic memory REM and Stage 2 sleep (Brualla et al., 1998, 
Bastuji et al., 1995, Bastuji et al., 2002, 
Daltrozzo et al., 2012, Perrin et al., 1999) 
Episodic memory Slow wave sleep, spindle activity (Plihal and 
Born, 1999, Plihal and Born, 1997, Fogel and 
Smith, 2006, Clemens et al., 2005) 
NONDECLERATIVE MEMORY CONSOLIDATION 
Perceptual learning Both REM and slow wave sleep (Karni and Sagi, 
1991, Atienza et al., 2004, Gottselig et al., 2004) 
Motor learning Stage 2 sleep (Walker et al., 2002, Walker et al., 
2003, Backhaus and Junghanns, 2006) 
Priming REM sleep (Wagner et al., 2003) 
  
 




3.5 SLEEP AND AGING 
Although only minor differences were found between healthy young adult men 
and women, sleep parameters differ significantly with aging. In a review paper 
published in 2017 (Mander et al., 2017), changes in sleep with aging 
summarized as below:       
Macro sleep changes: 
• Advanced sleep timing (earlier bed times and rise times), 
• Longer sleep-onset latency, 
• Shorter overall sleep duration, 
• Increased sleep fragmentation, 
• Higher likelihood of being woken by external stimuli, 
• Reduced amount of deep/ slow wave sleep, 
• Increased time spent in Stages 1 and 2, 
• Shorter and fewer NREM-REM sleep cycles, 
• Increased time spent awake during the night, 
• Increased daytime naps. 
Micro sleep changes: 
• Reduced slow wave activity 
• Reduction in amplitude and density of slow wave activity especially over 
the frontal lobe topography, 
• Reduction in spectral power in the frequency of sleep spindles due to 
decline of sleep spindles density especially over frontal EEG 
derivations. 
Sleep Quality Recommendations published by National Sleep Foundation 
(USA) give values for sleep continuity measures, sleep architecture measures 
and naps as indicators of good sleep quality among healthy individuals across 
the life span (Ohayon et al., 2017). Table 3-2 gives the summary of the 
recommendations defined as appropriate and uncertain (where there was a 




disagreement between the experts) for the sleep measures of adults and older 
adults: 
Table 3-2: Summary of National Sleep Foundation’s recommendations for good sleep 
quality. The values in brackets represent the ranges where there was a disagreement 
amongst the experts. 
Sleep Continuity Measures 
 ADULTS (26-64 years) OLDER ADULTS (≥65 years) 
Sleep Latency 0-30 mins (31-45 mins) 0-30 mins (31-60 mins) 
Awakenings > 5 mins 1 (1-3) 2 (2-3) 
Wake after sleep 
onset 
0-20 mins (21-40 mins) 0-30 mins (31- 60 mins) 
Sleep efficiency >85% (75-84%) >85% (75-84%) 
Sleep Architecture Measures 
 ADULTS (26-64 years) OLDER ADULTS (≥65 years) 
REM Activity 21-30% (<10- 20% and 31-
40%) 
(<10- 40%) 
N1 Sleep <5% (6-20%) (0-25%) 
N2 Sleep (up to 80%) (up to 80%) 
N3 Sleep 16-20% (6-15% and >26%) (≥26%) 
Naps 
Number of naps (0-3) (0-3) 
Nap duration (mins) (0-100) (0-100) 
 
Circadian rhythm changes with aging play an important role in the age-related 
sleep changes. In a recently published review paper, it was suggested that 
progressive yellowing and thickening of the lens may reduce sensitivity to light. 
In addition, reduction of arginine vasopressin and vasoactive intestinal 
polypeptide expression and fewer GABAergic synapses may decrease 
signalling within the SCN, leading to a decrease in the overall amplitude of its 
firing rhythm. As a result, a weaker SCN output signal may in turn reduce the 
strength of downstream oscillators in central and peripheral tissues, including 
the cortex, pineal gland, liver, kidney, thyroid, and spleen. Therefore, providing 
other zeitgebers such as scheduled meals, which act on the circadian system 




via extra-SCN pathways, may help entrain an aging circadian system (Hood 
and Amir, 2017). 
 
3.6     ASSESSMENT OF SLEEP 
Three main techniques to assess sleep will be discussed here with their 
advantages and disadvantages. 








An actigraph is a small watch-like device that is worn by the individual to 
measure movement (gross motor activity) throughout the day using an 
accelerometer. It aims to assess sleep habits objectively. Interpretation of 
actigraphy results requires assumption of sleep period where there is lack of 
motion and there is overestimating sleep duration on patients who do not / 
cannot move when they are awake. Moreover, comparisons made between 
actigraphy and polysomnography have shown that actigraphy was highly 
correlated with PSG for differentiating sleep from wake in healthy people but 
not necessarily in assessment of sleep onset latencies and wake time after 
sleep onset.  This leads to reduced reliability of actigraphy method for detecting 
Figure 3-10: Examples of actigraphy devices                                                                 
(source: http://actigraphcorp.com/solutions/sleep-assessment/) 




sleep as sleep become more disturbed  (Jean-Louis et al., 2001, Jean-Louis 
et al., 1997b, Jean-Louis et al., 1997a, Ancoli-Israel et al., 2003, Pollak et al., 
2001). The advantage of actigraphy over polysomnography is that, actigraphy 
can record for long periods; it is a relatively cheap equipment in comparison to 
polysomnography and can provide accurate information of sleep/ wake status 
in healthy people. 
Actigraphy has also been compared to direct observations of sleep and to 
sleep logs. It was found that both self-completed sleep logs and actigraphy 
yielded similar data for sleep timing, sleep duration, sleep onset and sleep 
offset but not for sleep latency, number and duration of awakenings or number 
of naps (Lockley et al., 1999). Nursing observations of sleep in psychiatric 
patients as well as the research staffs’ observations of nursing home residents 
showed that direct observations and actigraphy results were similar when 
assessing sleep wake status (Ancoli-Israel et al., 1997, Krahn et al., 1997). 
Although the role and validity of actigraphy is well documented in sleep/ wake 
scoring in healthy population; using actigraphy has its own challenges in 
specific populations such as people with tetraplegia. A study published by 
Spivak et al. (Spivak et al., 2007) showed that comparable results to controls 
were obtained with placing actigraph on the forehead of patients with C4 
tetraplegia. However, patients with disorders of consciousness are usually 
tetraplegic and have very poor head control. When in bed or in their wheelchair 
they require several positioning and postural management equipment such as 
head straps, pillows, splints and other support apparatus to keep them in 
comfortable and in a safe posture. These equipment at the same time may 
limit spontaneous movements. Actigraphy recording would likely to contain 
some levels of exogenous activity due to re-positioning in bed, hoisting, 
moving limbs during personal care and therapies. Moreover, patients with 
disorders of consciousness often have spontaneous movements, which may 
not necessarily be indicative of synchronized cerebral waking. 




3.6.2 Sleep logs 
Individuals who have sufficient cognitive, communicative and physical abilities 
can complete sleep logs. In healthcare institutions, it can also be completed 
by the nursing/ care staff by direct observation of patient and identifying sleep/ 
awake status using external behavioural signs such as eyes open/ close, 
change in respiration and body positioning, snoring etc. However, like 
actigraphy this method carries risk of overestimating sleep (i.e. when eyes are 
closed despite being awake) and is less specific when considering sleep 
parameters such as sleep latency, sleep onset, sleep offset data. 
3.6.3 Polysomnography 
Polysomnography is the most reliable measure of sleep as it provides detailed 
information on sleep measures including sleep stages. However, it is relatively 
expensive, as it requires an EEG system as well as input from trained 
professionals on setting up the recording and for evaluating the data obtained. 
It may be uncomfortable for the patient and may restrict physical management 
(positioning, hoisting) and care of the individual. Additional information can be 
gained with video recording during PSG as well as through monitoring 
physiological parameters such as respiration, blood oxygenation, 
electromyography and electrocardiographic data, alongside of EEG. 
3.7 SLEEP AND MEDICATIONS 
People with PDOC often suffer from several other premorbid medical 
conditions such as heart disease, asthma, diabetes and high blood pressure. 
Following the brain injury, they also are prescribed medications to treat 
neurological complications of brain injury such as spasticity, dysautonomia, 
seizures and involuntary movements. Most of these medications act on the 
central nervous system and have influence on important neurotransmitter 
systems that take part in regulation of arousal and sleep. Some medications 
also influence melatonin levels, hence have an effect on circadian rhythm 
regulation. Therefore, it is important to be aware of these neurotransmitter 
systems as well as the medications which influence sleep and wakefulness 




when interpreting sleep studies and circadian rhythms (Bourne and Mills, 
2004, Papagiannidou et al., 2014, Landolt, 2008, Snel and Lorist, 2011, Drake 
et al., 2006). 
Several medications can affect sleep parameters and when interpreting 
polysomnography reports this should be considered. Based on the changes 
observed in different sleep stages they can be simply grouped as; 
• Medications that can suppress REM Sleep: tricyclic antidepressants, 
MAO inhibitors, amphetamines, barbiturates, alcohol.  
• Medications that can affect stage 2 spindle activity: benzodiazepines 
• Medications that can suppress stage 3 & 4 Sleep: benzodiazepines, 
tricyclic antidepressants or barbiturates. 
The neurotransmitter systems that take part in regulation of arousal and sleep 
are; 
• for maintaining wakefulness: include norepinephrine, serotonin, 
acetylcholine, dopamine, excitatory amino acids, hypocretins and 
histamine;  
• play a role in NREM sleep: include adenosine, Gamma amino butyric 
acid (GABA) and prostaglandins; 
• play a role in REM sleep: include acetylcholine, serotonin, 
norepinephrine and hypocretin (latter three by inhibiting cholinergic and 
cholinoceptive neurons which are implicated in initiation of REM sleep) 
(Monti et al., 2008). 
This section focuses on medications which may have been prescribed to 
people with PDOC and therefore, indirectly may have an effect on measures 
and intervention outcomes used in this research project.  




3.7.1 Medications with hypnotic effects 
3.7.1.1 Medications that modulate GABA-A receptor and sleep 
The GABA-A receptor is the most wide-spread receptor mechanism of 
inhibitory synapses in the central nervous system and they are densely located 
in the hypothalamus (Kryger et al., 2011). Benzodiazepines bind to 
benzodiazepine receptors which are a modulatory site on the GABA-A 
receptor and increase the GABA inhibitory effect by increasing the time that 
chloride channels are open (Johnston, 2005). The “Z” drugs such as 
Zopiclone, Zolpidem and Zaleplon are non-benzodiazepine medications that 
bind to various subtypes of GABA-A receptors. The most often used non-
benzodiazepine medication which is prescribed to treat insomnia in the UK is 
Zopiclone. Zopiclone is preferred due to its short half-life and less sedative 
effects during the day. Zolpidem may be prescribed in cases with PDOC as 
several case reports in literature suggesting it may help with improvement of 
consciousness in the short and long-term. 
GABA-A receptor agonists lead to promotion of NREM sleep (particularly 
increased stage 2 sleep with boosted spindle activity but suppressed stage 3 
and 4 sleep) and inhibition of REM sleep (Mendelson, 2001) which translates 
as decreased sleep latency, decreased awakenings, increased stage 2 sleep, 
decreased stage 3 and 4 sleep, increased REM latency and reduction and 
fragmentation of REM sleep. 
3.7.1.2 Antidepressants and sleep 
Almost all antidepressants affect functioning of noradrenergic or serotoninergic 
systems, or both. Tricyclic antidepressant medications (doxepin, amitriptyline, 
trimipramine) interact with serotonin, norepinephrine, acetylcholine and 
histamine receptors and probably due to the combined effects of these 
neurotransmitter systems, they influence sleep. This translates to sleep 
studies as a reduction of sleep latency, increased sleep continuity, reduced 
REM amount and no significant changes in stages 3/ 4. Other antidepressants 
such as trazadone and mirtazapine also influence sleep by reducing the sleep 




latency and increasing sleep continuity. While trazadone increases stage 3 
and stage 4; mirtazapine has no significant effect on slow wave sleep or REM 
sleep (Montgomery et al., 1983, Ruigt et al., 1990, Winokur et al., 2000). 
Serotonin receptor antagonist antidepressants are non-sedating drugs but 
have been shown to effect sleep. For example, citalopram led to decrease of 
REM and a significant lengthening of REM latency and stage 2 sleep, with no 
changes in sleep continuity (van Bemmel et al., 1993). Similarly, it was shown 
that Fluoxetine reduced the total sleep time and the duration of REM sleep and 
increased awake activity and stage 1 sleep during the night (Nicholson and 
Pascoe, 1988). 
3.7.1.3 First generation antihistaminic medications 
Although these medications are rarely used for their sedative effects in brain 
injured patients, they may be prescribed for treatment of other conditions such 
as allergic conditions. Their H1 antagonist effects cause sedation and changes 
in polysomnography studies such as reduction of sleep latency and REM 
sleep, no change or increase in sleep continuity and slow wave sleep amount 
(Kryger et al., 2011). 
3.7.1.4 Gabapentin and Pregabalin 
These two medications are often prescribed for brain injured patients for 
treatment of neuropathic pain, allodynia, spasticity and as an adjunct 
anticonvulsant medication. Although they are structural analogues of GABA, 
their main effect occurs due to their selective binding to the alpha2 delta subunit 
of N-type voltage-gated calcium channels and possibly due to their effects on 
N-methyl-D-aspartate (NMDA) receptors (Gajraj, 2007, Rose and Kam, 2002). 
Studies indicate that both drugs lead to reduced sleep latency, increased sleep 
efficiency, and significant increase in slow wave sleep amount  (Foldvary-
Schaefer et al., 2002, Hindmarch et al., 2005, Kubota et al., 2001, Roth et al., 
2014). 




3.7.1.5 Antipsychotic medications 
Although rarely, these drugs can be used in brain injured patients for variety of 
indications such as insomnia, psychotic symptoms following brain injury or on 
the background of pre-existing psychiatric illness. Olanzapine and quetiapine 
are most commonly used medications for the patients with psychotic illness. 
Both medications have antagonist effects on serotonin, alpha-1 adrenergic, 
dopamine D2 receptors. They were shown to decrease sleep latency, increase 
sleep time, and efficiency, and increase stage 2, 3 and 4 amounts (Kryger et 
al., 2011, Salin-Pascual et al., 1999). 
3.7.1.6 Medications with wake-promoting effects 
Central nervous system stimulants may be prescribed for brain injured patients 
to combat daytime sleepiness which often is a problematic situation as it 
negatively effects the rehabilitation and social interaction. For the disorders of 
consciousness patients’ daytime sleepiness may further complicate the clinical 
assessment of awareness and may contribute to well-recognized misdiagnosis 
rates as high as 43% (Andrews et al., 1996, Majerus et al., 2005). 
3.7.1.6.1 Amphetamines and Amphetamine-like compounds 
Amphetamine has a simple chemical structure which is very similar to 
endogenous catecholamines and contains three structural components: an 
aromatic nucleus, a terminal amine and an isopropyl side chain. By modifying 
these components several therapeutic (methylphenidate for treatment of 
attention-deficit hyperactivity disorder, modafinil for narcolepsy) and 
recreational drugs (Ecstasy and Love) have been produced over the years. 
Methylphenidate is an amphetamine-like compound and is thought to block the 
reuptake of norepinephrine and dopamine into the presynaptic neuron and 
increase the release of these monoamines into the extra-neuronal space. It 
has attracted some attention recently. Published studies indicate that it may 
have a role in increasing motor and cognitive function after stroke and 
traumatic brain injury (Johansson et al., 2015, Johansson et al., 2017, Lokk et 
al., 2011, Tardy et al., 2006). However, side effects (increase in blood 




pressure, gastro-intestinal disturbance, restlessness, agitation, sweating) and 
contraindications of this medication limits its use in clinical practice (Dymowski 
et al., 2017). 
3.7.1.6.2 Dopaminergic agonists and L-dopa (dopamine precursor)  
These medications are used in treatment of Parkinson’s disease and 
Parkinsonism which may be a clinical feature in brain injured patients. 
Dopamine is a stimulatory transmitter and has an important role in the 
wakefulness, behaviour regulation, mood, language, cognition and motor 
control. It works on the basal ganglia-thalamus network which is connected to 
the supplementary and primary motor areas. It also plays role in modulation of 
dorsolateral prefrontal cortex and limbic structures which support cognition and 
emotion. L-dopa may have been prescribed to PDOC patients as it was shown 
that some patients with brain injury may respond well to treatment with L-dopa 
especially if they have concomitant symptoms of Parkinsonism and neuro-
radiological findings of high intensity lesions in the dopaminergic pathway on 
T2-weighted MRI scans (Matsuda et al., 2005). 
3.7.1.6.3 Modafinil 
Modafinil is used for treatment of narcolepsy in the UK. It has been approved 
for treatment of shift-work circadian disorder and treatment of residual 
sleepiness in obstructive sleep apnoea syndrome. Clinicians may use (off- 
licence) Modafinil to treat daytime sleepiness secondary to brain injury. Its 
mechanism of action is still debated but thought to be due to DAT (Dopamine 
Transporter) inhibition. Animal studies showed that Modafinil decreases REM 
and NREM sleep without rebound hyper-somnolence (Edgar and Seidel, 
1997). 
3.7.1.6.4 Caffeine 
Caffeine probably is the most popular central nervous system stimulant in the 
world as it is present in coffee, tea, cola drinks, chocolate and cocoa. It 
increases mental alertness, speed of thought processing and wakefulness. It 
is a Xanthine derivative and its mechanism of action involves nonspecific 




adenosine antagonism. Adenosine is an endogenous sleep promoting agent 
with neuronal inhibitory effects (Basheer et al., 2000, Porkka-Heiskanen, 1999, 
Porkka-Heiskanen et al., 2002). 
The list of medications that are commonly used in brain injured patients and 
their effects on sleep and/or melatonin levels are shown in table 3.3. 
Table 3-3: Medications that effect sleep and circadian rhythmicity (TST=Total Sleep 
Time, SE=Sleep Efficiency, REM= Rapid Eye Movement, SWS= Slow Wave Sleep, SSRI= 
Selective serotonin re-uptake inhibitor) 
Medication Effect on Sleep or Melatonin 
Benzodiazepines ↓REM, ↓SWS 
Opioids ↓REM, ↓SWS 
Clonidine ↓REM 
NSAIDs ↓TST, ↓SE, ↓Melatonin levels 
Beta-blockers ↓REM, ↓Melatonin production 
Calcium Channel Blockers ↓Melatonin levels 
Amiodarone Nightmares 
Corticosteroids ↓REM, ↓SWS, reduced melatonin secretion 
Tricyclic antidepressants ↓REM, ↑TST 
SSRIs ↓REM, ↓TST, ↓SE 
Typical antipsychotics ↑TST, ↓REM, ↑SWS 
Atypical antipsychotics ↑TST, ↓REM, ↑SWS 
Phenytoin ↑Sleep fragmentation 
Phenobarbital, Carbamazepine ↓REM, ↑TST 
Gabapentin ↑TST, ↑REM, ↑SWS 
Pregabalin ↑SWS, ↓REM 
Levetiracetam ↑SWS, ↓REM, ↑TST 
Cimetidine ↑melatonin concentration 
Fluvoxamine ↑melatonin concentration 
Oestrogens ↑melatonin concentration 
Caffeine ↓SWS, ↓Melatonin levels 
 




3.8 CIRCADIAN RHYTHM SLEEP DISORDERS 
Circadian rhythm sleep disorders are caused by misalignment between the 
endogenous circadian timing system and the external 24-h environment 
(Bjorvatn and Pallesen, 2009). There are six types of circadian sleep disorders. 
The delayed sleep phase type, the advanced sleep phase type, the non-24-
hour sleep/wake syndrome and the irregular sleep/wake rhythm are due to 
primary abnormality of individual’s circadian system. Shift work sleep disorder 
and jet lag disorder on the other hand are due to conflict of surrounding 
environment with the individual’s intrinsic circadian timing (Smith et al., 2008). 
The key characteristics, diagnostic evaluation and therapeutic options for 

























Clinical features Diagnostic evaluation Therapeutic options 
Delayed sleep 
phase disorder 
Delayed in bed and wake times; bedtime 
between 2 and 6am, wake time between 
10am and 1pm.  
Symptoms: Morning sleepiness and evening 
insomnia 
Sleep log or actigraphy 
DLMO and core body temperature 
minimum to verify delayed endogenous 
phase 
Bright light (2000- 10000 lux) in the morning 
Melatonin 0.3-3 mg 5 hours before habitual bedtime 
Chronotherapy: progressively delay bedtimes by 3 hours 




Advanced bed and wake times; bedtime 
between 6pm and 9pm, wake time between 
2am and 5am.  
Symptoms: early morning awakenings, early 
evening sleepiness 
Sleep log or actigraphy 
DLMO and core body temperature 
minimum to verify advanced endogenous 
phase 
Bright light (2000- 10000 lux) before habitual bedtime 
Chronotherapy: progressively advance bedtimes by 3 





A progressive delay in bed and wake times 
Symptoms: sleepiness or insomnia which may 
wax and wane with time 
Generally seen in blind individuals 
Sleep log or actigraphy for at least 1 week 
to verify a progressive delay in bed and 
wake times 
Melatonin 10 mg 1 hour before desired bed time, 0.5mg 
maintenance dose 




Presence of at least 3 irregular sleep bouts 
throughout the 24-hour day 
Total sleep time over 24 hours is age-
appropriate 
Generally seen in individuals with underlying 
neurological disease 
Sleep log or actigraphy 
Bright light: 2 hours of 3000-5000 lux in the morning; 
increased bright light exposure during the day 
Create a favourable night-time sleep environment: reduce 
noise, reduce light, improve continence care 
Structured physical and social activity 
Sleep hygiene 







Shift work sleep 
disorder 
Work schedule is at odds with the individual’s 
endogenous sleep/ wake cycle 
Symptoms: sleepiness during the work shift, 
insomnia during newly desired sleep time 
Sleep log or actigraphy 
PSG to rule out comorbid sleep disorders 
Continuous or intermittent exposure to bright light during 3-
6 hours of the work shift, avoidance of light in the 2 hours 
prior to end of the shift 
Melatonin 3 mg before desired bed time 
Behavioural strategies: favourable sleep environment, 
sleep hygiene, therapeutic napping 
Stimulants (caffeine or modafinil) at the beginning of the 
shift 
Treat comorbid sleep disorders if present 
Jet lag disorder 
Self-limited disorder associated with jet travel 
across two time zones 
Symptoms vary based on direction of travel 
and number of zones crossed 
Further diagnostic evaluation generally 
not indicated 
Strategic exposure to bright light 
Melatonin 2-5 mg for the initial 4 days after arrival 
Behavioural strategies 











3.9       ENTRAINMENT OF CIRCADIAN RHYTHM 
3.9.1 Light  
Light is the most important Zeitgeber and is known to synchronize the SCN to 
a 24-hour rhythm (entrainment). The effect of light on circadian rhythms follows 
phase-response curve and according the phase response curve light can have 
two opposite effects of the circadian rhythm depending on the time of exposure 
(Khalsa et al., 2003). 
While bright light exposure in the early evening results in sleep phase delay, 
exposure after 3.00-5.00 am advances the next sleep phase. The sleep 
phases can be shifted by up to 1-2 hour per day by light exposure, according 
to its timing (Shneerson). The extent of the phase shift also depends on the 
dose and duration of the light exposure. 
Even low intensity light as little as 100 lux, can alter the circadian rhythm but 
exposure to bright light for 10-20 min is required in order to have a significant 
impact. Portable light units which produce about 10 000 lux bright light are 
usually used for 30 to 45 minutes per day to improve the circadian rhythm and 
treat sleep disorders.  
Although it is not necessary to stare at the light continuously, during the 
treatment patients are required to gaze towards the light source. Therefore, 
any change in the head position may cause reduction of the therapeutic effect. 
This can be especially problematic in patients with disorders of consciousness 
as they often have poor head control and positioning of the head and/ or light 
unit is dependent on the staff’s engagement in the process. Moreover, they are 
likely to be lying in bed while light treatment is given due to short sitting 
tolerances and may not be in a close proximity of the light source due to size 
of the bed and equipment around them. Nevertheless, even light of less 
intensity and duration will likely be beneficial.  
Treatment with the light boxes is safe and probably damage to the retina is the 
most serious potential side effect. However, there has been no scientific 




publication reporting damage to the eyes once light treatment is administered 
using approved light boxes according to the standard procedures.  
3.9.2 Melatonin 
Melatonin is synthesized from tryptophan in the pineal gland upon request from 
the biological clock under the direct control of SCN. Melatonin is produced only 
at night time and its production is inhibited by light exposure.  
Due to the close temporal relationship between the SCN and melatonin 
production, melatonin often used as phase-marker of human circadian rhythm 
(Lockley and Foster). Moreover, when mild sedative effect of synthetic 
melatonin coupled with its ability to shift the timing of the clock, its usefulness 
become apparent in treatment of sleep disorders associated with circadian 
rhythm disruption.  
In some countries melatonin is sold as an over-the-counter medication as a 
sleep and circadian rhythm enhancing medication. It has a time to maximum 
concentration of approximately 30 minutes and elimination half-life of 
approximately 60 minutes (DeMuro et al., 2000). With this information in mind, 
it would have been reasonable to expect melatonin to act as a short-acting 
hypnotic, mainly effective to treat sleep onset difficulties. However, a strict 
dose-response relationship does not appear to be present for melatonin and 
its maximum effect may not coincide with its maximum serum concentration 
levels.  Therefore, dose (1mg to 75mg) and administration timing (30 minutes 
to 3 hours before bedtime) of melatonin vary greatly in published studies. This 
makes the recommendation for dosage and timing of administration difficult. In 
the UK, modified-release melatonin is licenced to use to treat insomnia of 
adults 55 years and over with dose of 2-3 mg to be given 1-2 hours before 
bedtime (British national formulary). On the other hand, the same formulation 
is licenced to treat insomnia and delayed sleep phase disorder in children with 
dose of up to 10 mg to be given before bed time (BNF for children). No 




significant risks or adverse effects have been reported and its abuse potential 
is minimal. 
3.9.3 Caffeine 
Caffeine is a weak psycho-stimulant and in addition to its stimulatory action it 
has circadian effects especially on melatonin synthesis in human. Caffeine can 
be used effectively to modulate our mental state and is found to be beneficial 
in restoring low levels of wakefulness and to counteract deteriorations in task 
performance related to sleep deprivation (Snel and Lorist, 2011). 
It was shown that the subjects who suffer from jet lag achieved 
resynchronization of their circadian rhythm earlier than placebo group subjects 
when given caffeine alongside of melatonin (Beaumont et al., 2004, Pierard et 
al., 2001). 
After oral ingestion of caffeine, 90% of it is absorbed from the gastro-intestinal 
tract into the blood stream, peaking 30-60 minutes after ingestion and diffuses 
throughout the entire body by passing all biological membranes including 
blood-brain barrier. It has a half-life of five to seven hours. It can inhibit 
melatonin production due to its adenosine receptor antagonist (mainly A1 and 
A2A receptors) properties (Ribeiro and Sebastião, 2010).  
Adenosine receptors are found in the brain and involved in the regulation of 
sleep, arousal and cognition. Chronic caffeine use may up-regulate adenosine 
receptors and increase adenosine levels and some adenosine actions in the 
brain. As with other regulators of circadian rhythm timing of caffeine 
consumption is important. For example, if caffeine is consumed late in the day 
it may negatively affect sleep and may cause daytime sleepiness the next day. 
 
 




3.10 CHAPTER SUMMARY 
In chapter 3, I tried to summarize key information about regulation of sleep and 
circadian rhythms in humans, which then evolved into brief review of 
techniques that are used to assess sleep and circadian rhythms, physiological 
changes with aging, effect of medications and finally, disorders of circadian 
rhythms. Although further research is required to further understand the refined 
relationships between learning, memory and plasticity functions of the brain 
and sleep, which plays an important role in these events. It appears that all 
sleep stages are almost equally important and most likely they complement 
each other. Therefore, achievement of good sleep with adequate length, depth 
and quality is important for people with brain injury and during their 
rehabilitation process.  
People with brain injury often suffer from sleep difficulties due to the 
physiological and pathological changes in the brain as well as associated 
processes involved in recovery from brain injury such as medications, reduced 
ability to be physically active and environmental settings such as busy hospital 
wards and rehabilitation units. Although this information is considered when 
discussing a patient’s arousal levels and impact on the low arousal levels on 
assessment process; there are usually no formal processes and procedures 
in place to optimize patient’s sleep-wake cycle as part of their neurological 
rehabilitation and diagnosis. Furthermore, there is limited research on the 
impact this optimization could have on patients’ recovery.  
Now the foundation information about sleep and circadian rhythms in hand; 
the next chapter will focus on what is known on sleep and circadian rhythms 








Chapter 4 CIRCADIAN RHYTHM AND SLEEP IN 
PDOC - REVIEW OF THE 
LITERATURE  
The previous chapter showed that the regulation of sleep is complex. 
Interactions between the homeostatic and endogenous circadian processes, 
habits and behavioural factors as well as the environmental factors influence 
sleep regulation.  Abnormality of one or more of these factors - if not 
normalized effectively and promptly, may lead to dysregulation of sleep and/ 
or circadian rhythm and eventually to sleep disorders. 
In order to have a well-timed and of high quality/ quantity sleep a person needs; 
1. To have intact neural structures and pathways to regulate circadian 
rhythm and sleep regulation, 
2. To be able to keep awake for a substantial amount of time during 
the day in order to reach high quality sleep at night which is 
evidenced by slow wave sleep/ deep sleep activity and REM, 
3. Improved habits and behaviours to facilitate function of circadian 
and homeostatic factors, 
4. Optimized environmental factors/ external zeitgebers to enhance 
external control of circadian rhythm. 
People with PDOC lack all four requirements listed above. They have severely 
damaged neural structures and pathways, have poor arousal levels at day time 
to facilitate high quality sleep at night, have lost all appropriate habits and 
behaviours and are looked after in a hospital based institutional setting where 
environmental factors are far from ideal. For example; they are usually 
prescribed several centrally acting medications to prevent seizures and 
spasticity which may then reduce daytime arousal levels, often fed 
continuously including at night, checked at regular intervals during the night by 




nursing staff which necessitates increasing illumination levels to do so, being 
turned and repositioned regularly in order to prevent pressure sores, and 
constantly being in an environment which is noisier and brighter than an ideal 
sleep environment.  
The aim of this chapter is to review the literature related to sleep and circadian 
rhythms in PDOC, so that the appropriate assessment and treatment methods 
can be identified and used in this PhD research study. 
4.1 LITERATURE SEARCH PROCEDURE 
PubMed, MetaLib and Science Direct search engines were used to find 
published literature. The search was performed using the Medical Subject 
Heading (MeSH) terms “Vegetative state and sleep”, “Minimally conscious 
state and sleep”, “apallic syndrome and sleep”, “unresponsive wakefulness 
and sleep” and finally “disorders of consciousness and sleep” (Figure 4-1: 
Literature review process). Due to wide range of terminology used to describe 
the condition it may not have been possible to capture all the literature 
published. However, by using the most commonly used terminology, it can be 
confidently said that majority of the literature on the subject have been 
identified. Papers that are not in English language, on non-human subjects 
and exclusively for paediatric patient group were excluded. Abstracts of the all 
articles were read and irrelevant papers were excluded. References of the 
papers were also studied to capture any additional papers that did not come 
up during initial search. 







Figure 4-1: Literature review process 




The literature was then reviewed in chronological order to understand the 
development of body of knowledge on this subject in line with the 
developments in overall understanding of disorders of consciousness itself. 
For example, minimally conscious state was only defined in 2002 which 
probably then steered the research towards diagnostic differentiation between 
vegetative and minimally conscious states. Similarly, the research and 
developments in neuro-imaging and neuro-physiology for disorders of 
consciousness might have added an additional dimension to assessment of 
sleep and circadian rhythms in DOC. An additional subgrouping was 
performed, to review the papers with a focus on review of literature, treatment, 
circadian rhythm and neuro-physiological assessment of sleep. (Table 4-1: 
Papers published prior to 2002 and after 2002, sub-grouped according to topic) 









EEG/ PSG 10 9 19 
Circadian parameters 3 5 8 
Review Paper 0 4 4 
Focus on Treatment 0 3 3 
Total 13 21 34 
 




4.2 SLEEP AND CIRCADIAN RHYTHMS IN DOC- 
PRIOR TO DEFINITION OF MCS IN 2002 
4.2.1 EEG/ PSG studies  
Examination of polysomnography recordings may yield more reliable results in 
assessing sleep-wake patterns of the patients with disorders of 
consciousness. Moreover, detailed analysis of EEG patterns may give 
information on the sleep stage as well as the electrical activity/ spectral 
changes over long periods of time. However, obtaining good quality 
polysomnography recordings is very challenging and recordings are often of 
poor quality due to artefacts. The very early studies concentrated on exploring 
the association between broad EEG/ PSG features and the severity of brain 
injury in DOC population.  
For example, in an early study which investigated the sleep EEG patterns as 
a marker of prognosis in post-traumatic coma, it was found that organized 
sleep EEG patterns were associated with a better prognosis in 16 patients 
(Bergamasco et al., 1968) whereas, patients with biphasic (consisting slow and 
fast phases only) and monophasic (slowing or flattening of background EEG 
activity) night sleep EEG recordings all died.  
Later, it was shown that the presence of EEG patterns similar to those of sleep 
was associated with a favourable outcome (Bricolo 1979 & 1983). Moreover, 
REM sleep percentage increases were seen with recovery of cognitive 
functions on brain injured patients (Harada et al. 1976, Ron et al. 1980). 
Matsuo et al. (Matsuo, 1985) described three cases of apallic syndrome due 
to anoxic brain injury. In all cases diffuse EEG attenuation of severe degree 
was demonstrated. Differences between aroused and quiescence were 
observed on PSGs without characteristic differential features of NREM sleep 
stage I-IV. 




From the 1990s onwards, however, more detailed examination of sleep EEGs 
were performed which paid attention to sleep staging, spindling activity and 
REM sleep. 
Gordon and Oksenberg investigated the presence of spontaneous nystagmus 
in 6 VS (secondary to traumatic brain injury (TBI), aged 20-53, time since brain 
injury onset 3-96 months) patients across the sleep wake cycle using 24 hours 
PSGs (Gordon and Oksenberg, 1993). Although in this study, authors focused 
on the nystagmus which was present in awake, Stage 1 and REM stages (but 
not in Stage 2 and slow wave sleep); it was reported that all patients had REM 
sleep between 11.7 and 44.1 mins during the 24-hour PSG recording.  
In 1994, D’Aleo et al. investigated sleep in the initial stages and in the last 
remission stages of vegetative state (D'Aleo et al., 1994b, D'Aleo et al., 1994a). 
In a study that involved 30 patients with vegetative state (20 TBI, 10 hypoxic 
brain injury, aged 16-41). Sleep EEGs of 25 patients were examined with an 
emphasis on the spindling activity. It was found that only 11 (44%) of the 
patients had spindling activity: 8/15 (53.3%) traumatic versus 3/10 (30%) of 
the hypoxic patients. While sleep staging was not achieved in this study, the 
following observations made with comparison to the control group: The 
patients had higher percentage of non-REM sleep, greater fragmentation of 
sleep, higher percentage of wakefulness after re-awakenings, slower EEG 
frequencies and greater oscillations of cardiac and respiratory frequencies 
during REM. According to the old staging of the vegetative state none of the 
patients in stage 0 or 1 showed any evidence of spindling. (Stage 1 of this 
staging score corresponds to vegetative state whereas stages higher than 1 
may fulfil the current criteria for MCS (von Wild et al., 2012)).  
In another study the relationships between spindles and clinical outcomes of 
patients in post-anoxic stupor or coma were examined based on the 20 
minutes EEG recordings. It was found that the absence of spindles or EEG 
reactivity was associated with poor outcome (Hulihan and Syna, 1994). 




Sleep abnormalities in traumatic apallic syndrome were investigated by 
Giubilei et al. (Giubilei et al., 1995). 10 patients with traumatic apallic syndrome 
(awake without being aware), aged 15 to 55, range 47 to 180 days from head 
injury were investigated with computerized tomography (CT) scans, 12-hour 
PSG recordings and Glasgow Outcome Scale (GOS) on admission and at six 
months follow up.  In this study 9 out of 10 patients had sleep patterns. There 
was no significant difference in sleep architecture between patients and 
controls, except increase in time spent awake after sleep onset and higher 
number of awakenings. One patient who did not show any evidence of sleep 
pattern had the lowest Barthel Index total score, remained in VS and died 
before the 6-month follow up. It is worth noting that in this study four of the 
patients were classified as with severe disability on GOS; three of them with 
Barthel Index total score of 35 and one of them with Barthel Index total score 
of 60. Therefore, it is very likely that at least these four patients were in MCS 
or higher rather than in VS.  
In another study nine male patients with vegetative state (aged 17-40, 8 TBI, 
1 non-TBI) were investigated using 24-hour PSG and penile circumferential 
change measurements to examine relations between sleep related erections 
and REM sleep (Oksenberg et al. Sleep Vol 23, No. 7, 2000). In this study, it 
was found that while 95% of the sleep related erections were associated with 
REM sleep, 64.6% of the REMs were associated with sleep related erections. 
No statistically significant difference was found between REM or sleep related 
erections between the recovered and non-recovered patients. Although, this 
study was unable to suggest that sleep related erections could be used as an 
indirect measurement of REM sleep; it provided some important clues with 
respect to disruption of sleep-wake cycles in vegetative states as REM sleep 
with or without sleep related erections were found both nocturnal and diurnal 
periods.  
Again, Oksenberg and his colleagues further investigated the phasic activities 
of REM sleep in 11 vegetative state patients (aged 17-53, 10 males, 1 female, 




TBI). It was found that nocturnal REM sleep time was significantly lower in 
patients than in control group. Mean duration of REM sleep periods was also 
lower in the patient group than in controls over 24-hour period. The patients 
also had significantly lower density of rapid eye movements, chin twitches and 
leg muscle twitches. These were unrelated to recovery of patients. The authors 
suggested that the decrease in the densities of REM and muscle twitches 
during REM sleep may be related to possible damage to the cholinergic 
mechanisms of the pedunculopontine tegmentum.  
Isono et al.(Isono et al., 2002) investigated 12 patients with EEG, evoked 
potentials, MRI and 24-hour PSG studies. The patients included in the study 
aged between 10 and 69, 3 to 18 months post-brain injury (anoxic brain injury 
in three, diffuse axonal injury (DAI) in four and cerebro-vascular disease in 
five). Four of the patients were found to have no sleep-wake cycles (eyes 
usually closed and opened briefly after stimulation). The presence of brain 
stem lesions was the common finding of these four patients with no sleep-wake 
cycles. The remaining eight patients showed obvious sleep-wake cycles 
indicated by sleeping several hours at night and brief sleep episodes during 
the day. REM sleep and spindles were not seen any of the patients with sleep-
wake cycles. Although this study was performed prior to definition of diagnostic 
criteria for MCS, it was noted by the authors that there were no differences 
between the clinical conditions of the patients with and with-out sleep wake 
cycles. It was also noted that none of the 12 patients included in the study 
show any evidence of awareness (therefore, may all have been in vegetative 
state).  
With an aim to find an association between sleep patterns and prognosis, 
Valente et al. investigated 24 patients (post-traumatic, aged 16 to 74 years, 7-
15 days after brain injury) with 24-hour PSG and according to the type of sleep 
pattern found they were classified into 5 groups from simplest monophasic 
EEG to more complex alternating REM/ NREM sleep patterns (Valente et al., 
2002). It was found that the clinical outcome was significantly associated with 




the PSG pattern. Better outcomes were related to better PSG patterns. 
Moreover, outcome showed a significant inverse correlation with age. 
Interestingly, no association was found between GCS on admission or with 
severity of lesions shown by CT brain scans. It was concluded that PSG 
pattern was a reliable prognostic marker of functional recovery in sub-acute 
stages of coma secondary to head injury. Presence of rudimentary sleep 
patterns were a good prognostic marker for survival but not for functional 
recovery. Presence of alternating REM/ NREM sleep patterns were associated 
with favourable outcomes (good recovery or moderate disability).  
4.2.2 Circadian rhythm studies 
Emergence from coma to vegetative and minimally conscious states are 
characterized by return of the simultaneous eye opening and exhibition of 
sleep wake cycles but this does not necessarily indicate preservation of 
circadian rhythmicity. Moreover, observation of naturally occurring circadian 
rhythms can be used in investigating the integrity of brain functioning in 
severely brain injured patients.  
Early studies concentrated on assessment of circadian rhythms by using 
endocrinological markers such as cortisol, prolactin and growth hormone as 
well as physiological markers such as heart rate and blood pressure. 
Normal circadian variation of mostly studied hormones are summarized in 









Table 4-2: Circadian variation of endocrine hormones 
Cortisol:  Highest in the morning, lowest before retiring 
Growth Hormone: Marked peak in the first part of sleep (just after midnight) 
Prolactin:  Highest levels at night, peak at or just after waking 
Melatonin: Higher at night (30-70 times higher than daytime 
concentrations), usually peak between 2 and 4 am. 
 
In healthy subjects, blood pressure and heart rate show a circadian rhythmicity 
with higher values during daytime and lower values during the night time 
(RICHARDSON et al., 1964, Millar-Craig et al., 1978). While this is regulated 
by the autonomic nervous system, both physiological parameters are under 
the influence of many intrinsic and extrinsic factors such as posture, pain, 
spasms, medications and coexistent illnesses.  
In a 1981 study (Ratge et al., 1981) 6 patients with apallic syndrome and four 
healthy volunteers were investigated over a period of 48 hours with 2-hourly 
plasma and urine catecholamine (norepinephrine, epinephrine and dopamine) 
levels. Existence of circadian rhythmicity was determined upon analysis of 
variance for paired data between the sampling times. There was no circadian 
rhythmicity of dopamine in both groups. Five out of six apallic patients had no 
recognizable rhythmicity of epinephrine and norepinephrine levels neither in 
plasma nor urine. The authors also measured plasma prolactin and cortisol 
levels and urinary cortisol excretions and published another paper of the same 
study. In this paper, they reported that all apallic patients the circadian rhythm 
of prolactin was abolished. In 2 patients a rhythm of cortisol was still detectable 
(Ratge et al., 1982). 
24-hour profiles of growth hormone, prolactin and cortisol were studied on 11 
patients with vegetative state (aged 16-57 years, 40-219 days after brain 




injury, 9 TBI, 2 hypoxic)(Vogel et al., 1990). In comparison to age and sex-
matched controls patients in VS fewer growth hormone peaks, higher baseline 
levels of prolactin and cortisol, diminished nocturnal increase of growth 
hormone and prolactin levels. Cortisol on the other hand, showed preserved 
circadian rhythm. Six of these patients were also examined with sleep EEGs. 
None of the patients had REM sleep and only one had atypical sleep spindles.  
In an earlier study by Fukudome et al. (Fukudome et al., 1996) studied the 
circadian variations of body temperature, blood pressure, heart rate as well as 
urinary excretions of hormones (epinephrine, norepinephrine, 17-
hydroxycorticosteroids), water and sodium  on 16 patients with VS (aged 26-
91 years, mixed aetiology, 9 of whom with cerebrovascular accident (CVA), 
33.7 months post brain injury). It was found that circadian variations of blood 
pressure and heart rate were diminished. On the other hand, circadian rhythms 
for body temperature and urinary excretion of catecholamines, corticosteroids, 
water and sodium were preserved.  
 








Table 4-3: Summary of Literature before 2002 (prior to definition of MCS) 









Age  N= Sex Methods used Main Findings 
Bergamasco 
et al. / 1968 






N/S Trauma 3-66  18 N/S Serial Polygraphic 
recordings  
(1h daytime, 7h night-
time) 
Presence of sleep patterns were 
associated with good prognosis. 










3 2F,1M Overnight sleep EEG Differences between aroused and 












TBI 20-53 6 (5M, 
1F) 
24h EEG recordings Spontaneous nystagmus was 
present in awake, stage 1 and REM 
stages only. All patients had REM 
sleep (11.7 min- 44.1 min). 
D’aleo et al./ 
1994 
Sleep EEG 
features with an 
emphasis on 
VS 48 days to 









44% of the patients had spindling 
activity. This was more common in 
patients with TBI than in patients 
with hypoxic brain injury. No 










subjects in full stage of VS (apallic 
syndrome had spindles). In 
comparison to controls patients had 
less REM, more fragmented sleep 







spindle activity  







20 min EEG The absence of spindle activity was 














TBI 15-55 10 3F,7M CT brain, 12-hour 
PSG, Glasgow 
outcome scale on 
admission and at 6 
months  
Only one patient did not have a 
sleep/wake patterns who remained 
in VS and died before the 6-month 
follow up. Two patients had good 
recovery, and all others reached 
level of severe or moderate 
disability at 6 months. 
Oksenberg 








17-40 9 9M 24-hour PSG, Penile 
circumference 
measurements 
95% of sleep related erections were 
associated with REM sleep. There 
was no significant difference 








between REM or sleep related 









TBI 17-73 11 (10M, 
1F) 
24-hour PSG  Nocturnal REM sleep time was 
significantly lower in patients than in 
control group. Patients also had 
lower density of REM, chin twitches 
and leg muscle twitches. REM 
activity and characteristics were not 
related to recovery of patients. 







VS 3-18m Anoxia(3), 
DAI(4), 
CVA(5) 
10-69 12 4F, 
8M 
EEG, EPs, MRI, 24-
hour PSG 
8 of the patients (3 anoxia, 2 DAI, 
had sleep/wake cycles but no REM 
sleep or spindles. There were no 
differences between the clinical 
conditions of the patients with or 












The presence of organized sleep 






















Age  N= Sex Methods used Main Findings 







N/S N/S 14-83  6  N/S Dopamine, adrenalin 
and noradrenalin 
levels (2 hourly blood 
and urine samples for 
48h) 
No dopamine rhythmicity 
1/6 patient had catecholamine 
rhythmicity 
Vogel et al./ 
1990 







16-57 11 2F, 
9M 
PSG on 6 patients 
Blood samples for 
hormone levels every 
20 mins 
All patients had abnormal 
organization of sleep stages, none 
of the patients had REM, only 1 
patient had spindles 



















29-91 16 9F, 
7M 
24-hour blood 
pressure and heart 





Circadian rhythms of blood 
pressure and heart rate were 
diminished. Body temperature and 
endocrine circadian rhythms were 
preserved. 








Anoxia (1) catheters (every one 
minute) (n=12) 












4.2.3 Key messages from literature prior to 2002 
1. Sleep/ wake cycles and sleep EEG patterns are abnormal in patients 
with DOC. 
2. REM and Spindles are more common in TBI than in brain injury 
secondary to non-traumatic aetiology. 
3. The more organized the sleep EEG patterns the better the diagnosis. 
4. Absence of spindles and EEG reactivity are associated with poor 
prognosis. 
5. Presence of alternating REM/ NREM sleep patterns are associated with 
good recovery. 
6. Blood pressure and heart rate circadian rhythms are diminished and / 
or unreliable in DOC. 
7. Catecholamines, dopamine, prolactin and growth hormone rhythmicity 
are diminished. 
8. Cortisol and body temperature rhythmicity is usually present. 
4.3 SLEEP AND CIRCADIAN RHYTHMS IN DOC- 
AFTER DEFINITION OF MCS IN 2002 
4.3.1 EEG/PSG studies 
Electrophysiological correlates of behavioural changes in vigilance in VS and 
MCS were investigated by Landsness et al.(Landsness et al., 2011). Sleep 
studies were performed on 11 patients (6 MCS and 5 VS) using 256-electrode 
high density EEG for 12 hours between 8pm and 8am. Behavioural sleep 
patterns, stages 2 & 3 and periods of REM sleep were observed in the 5/6 
MCS patients. Spindles were observed in all MCS patients. On the other hand, 
in all VS patients behavioural transition to sleep was not accompanied by EEG 
changes. No stage 2 &3 or REM sleep were observed in VS patients. No 




spindles were observed in VS patients in this study. It was suggested that 
electrophysiological sleep features could be a reliable indicator of level of 
consciousness in PDOC and can help to differentiate VS from MCS. With 
respect to failing to show EEG correlates of behavioural changes in vigilance 
in VS the authors suggested two possibilities: insufficient modulation of cortico-
thalamic activity by a deficient ascending reticular activating system such as 
in pontine damage and failure in cortico-thalamic function to transmit signals 
from the ascending reticular activating system. The latter can also explain the 
severe impairment of consciousness in VS. It was further argued that as REM 
sleep generating mechanisms are located in the dorsal pontine tegmentum, 
brain-stem generated features of REM sleep may be present in some VS 
patients. A comparison of slow-wave activity between wake and sleep was 
performed which provided an additional quantitative assessment of EEG 
changes in relation to changes in vigilance.  
Cologan et al. (Cologan et al., 2013) studied 24-hour PSG on 10 vegetative 
and 10 minimally conscious state patients in the subacute stages of their 
illness (1 to 12 months after brain injury). EEG relative spectrum, EMG, EOG 
and heart rate parameters were used to define rest periods which then aided 
to classify patients in three groups: cycled, uncycled and ultradian where at 
least two periodic rest-wake patterns were found. In addition to assessment of 











Table 4-4: Sleep staging criteria used by Cologan et al. 
Waking stage: High frequency (>10 Hz) desynchronized EEG, high muscular 
tone on EMG, eye blinks in EOG 
Stage 1: Slower and synchronized EEG, low muscle tone, the absence of 
eye blinks, and occurrence of slow eye movements 
Stage 2: Presence of sleep spindles 
SWS: high amplitude (75-140 µV) synchronized EEG in the δ band (20% in 
stage 3 or 50% in stage 4), low muscular tone, absence of eye blinks and 
movements. 
REM: synchronized EEG on θ band, muscular atonia, presence of REM 
phasic events and muscular twitches. 
 
PSG sleep cycle was found in 3/10 VS patients and in 5/10 MCS patients. An 
ultradian pattern was present in one VS and two MCS patients. The authors 
noted that the standard temporal progression of sleep stages (wake→ stage 
1→Stage 2 → SWS →REM Sleep →awakening) was not seen in only two 
patients. In this study sleep staging was performed by 3 different examiners 
and most discrepancies were observed in scoring SWS and REM Sleep 
especially in MCS patients. It was argued that this was due to having unclear 
boundaries in SWS in some patients, presence of episodes resembling REM 
Sleep in brain injured patients and of course due to differences in experiences 
of the scorers. The scoring conflicts were resolved by reaching a common 
agreement.  Spindles, SWS and REM Sleep were more prevalent in MCS 
patients than in VS patients but none of these parameters could be statistically 
compared due to small number of patients. The persistence of REM sleep was 
correlated with MCS patients (10/10 MCS patients had REMS in comparison 
to 3/10 VS patients). Sleep spindles were present more in patients who 
clinically improved within 6 months indicating the restoration of thalamo-
cortical connectivity during recovery of consciousness in these patients. The 
authors suggested that VS patients with REM sleep should be further 




investigated with active paradigms to test the persistence of minimally 
conscious state.  
PSG studies, stimulus related evoked potentials and clinical features of PDOC 
patients were examined by de Biase et al. with the aim of increasing diagnostic 
accuracy in PDOC (de Biase et al., 2014). In this study 32 patients with 
prolonged disorders of consciousness (27 VS and 5 MCS) were investigated 
using clinical evaluation tools (CRS-Revised, Glasgow Coma Scale (GCS) and 
Disability Rating Scale (DRS)) and neuro-physiological evaluation tools which 
included 24-hour polysomnography, somatosensory evoked potentials 
(SEPs), brainstem auditory evoked potentials (BAEPs) and visual evoked 
potentials (VEPs) with the aim of identifying possible correlations between 
clinical evaluation and neurophysiological variables. The patients included in 
the study were aged between 26 and 71 years. The causes of the PDOC were 
traumatic brain injury (n=10), hypoxic/anoxic brain injury (n=15) and 
haemorrhagic stroke (n=7). The time since brain injury ranged between 3 
months and 12 years). REM sleep and simultaneous presence of all sleep 
elements (sleep-wake cycle, sleep spindles, K-complexes) were more frequent 
in MCS than in VS. REM sleep was present in all MCS patients and only on 4 
VS patients (two of them had REM only once and only for few epochs). Only 
7.4% of VS patients showed simultaneous presence of all the examined sleep 
elements. While the simultaneous presence of REM sleep and sleep spindles 
together were more adequately correlated with CRS-R scores, there were no 
significant associations between evoked potentials and CRS-R scores. The 
authors argued that PSG recordings may help clinicians to differentiate 
between VS and MCS patients. As REM sleep is associated with dreaming 
and information reprocessing during sleep; it was suggested that presence of 
REM sleep in VS patients could be used as an indicator to investigate these 
patients further with functional neuro-imaging techniques to detect covert signs 
of consciousness.  




Again in 2014, Kang et al. suggested a simple score to predict outcome for 
Unresponsive Wakefulness Syndrome (UWS)/ VS (Kang et al., 2014). A 
clinical prospective study was conducted to identify prognostic markers for 
recovery of awareness and to develop a simple bedside score to achieve more 
reliable outcome prediction for unresponsive wakefulness syndrome. 56 
patients aged 10 to 73 year old, 3 to 12 weeks post brain injury, were included 
in the study where they were investigated with CRS-R, serum neuron specific 
enolase levels and bedside neurophysiological tests which included 24-hour 
video-EEG and somatosensory evoked potentials. Pupillary light reflexes, 
corneal reflexes, motor responses to painful stimulation and main patient 
characteristics (age, sex, time from brain injury and type of brain injury) were 
examined. Presence of EEG reactivity, sleep spindles and cortical N20 
responses were considered. The neurological outcomes were no recovery of 
awareness (GOS 1 and 2) and recovery of awareness (GOS 3,4,5 and 
additional category for patients in MCS). Type of brain injury, motor response 
to pain, EEG reactivity, sleep spindles and N20 differed significantly between 
the recovered and not recovered patients. Interestingly although all these 
variables had high specificity for recovery awareness; only sleep spindles 
showed a high sensitivity (70.8%). A scoring tool called TMSEN (type of BI- 
Motor response- sleep spindles- EEG reactivity- N20) was developed to be 
used in outcome prediction for UWS. While a score of 3 or more translates into 
80.77% probability of recovery within one year (positive predictive value), 
score of 0 to 2 translates into 90% negative predictive value. The TMSEN 









Table 4-5: TMSEN Score as developed by Kang et al.  
Relative factor Categories Points 




Motor response to pain Flexor 
Extensor or absent 
1 
0 












Total  5 
 
Rossi Sebastiano et al. investigated the value of multiple neurophysiological 
tests which included EEG, 18-hour polysomnography, auditory event related 
potentials and multi-modal evoked potentials in classifying DOC in patients 
with chronic VS and MCS (Rossi Sebastiano et al., 2015). In this study 142 
patients (aged 50.9±14.1 and after 38.8±34.6 months after acute brain injury) 
were included. 85 of the patients in VS and 57 were in MCS as diagnosed with 
CRS-R. EEGs were evaluated using the Synek scale. See Table 4-6: Synek 
Scale- EEG patterns for coma prognostication in adults (Synek, 1988). Sleep 
was evaluated on 18-hour long EEG recordings and was scored using an 
arbitrary scale developed by the authors rather than standardized sleep 
staging criteria published by AASM. The multimodal evoked potential 
responses were scored arbitrarily (absent, abnormal, normal), as the MMN/ 
P300 responses (absent, present). It was found that combined multimodal EPs 
and sleep EEG scores provided the most valuable information as sleep 
patterns were robust indicator of DOC severity regardless of the aetiology and 
EPs informed the clinicians on patients’ susceptibility to specific stimuli to tailor 




customised rehabilitation programmes. Although, standard spectral EEG 
analysis outcomes were significantly related to DOC classes and CRS-R 
scores they did not make a significant additional contribution to DOC 
classification. 
Table 4-6: Synek Scale- EEG patterns for coma prognostication in adults 
Grade EEG Characteristics Prognostication 
Grade 1 Predominantly regular alpha activity, some 
scattered theta activity 
Favourable 
Grade 2 Dominant theta activity with some alpha 
and delta 




Grade 3 Dominant diffuse delta activity, mostly seen 
in coma. Several subgrades defined based 
on rhythmicity of delta activity, presence of 
sleep patterns and amplitude of delta. 
Depends to 
subgrade. 
Grade 4 Burst-suppression pattern. Four 
subgrades: alpha pattern coma, 
epileptiform, theta pattern coma, low-
output EEG. 
Poor 
Grade 5 Absence of EEG activity Brain death 
 
Generation of slow wave activity (SWA) requires activity of cortico-thalamo-
cortical loops as well as preservation of cortical plasticity which then enables 
sleep-related restorative, learning and memory functions. Pisani et al. 
hypothesized that modulation of SWA using repetitive transcranial magnetic 
stimulation (rTMS) may help to differentiate MCS and VS (Pisani et al., 
2015).Ten patients (4 MCS, aged 26 to 72, five TBI and five anoxic brain injury, 
4 male, 4-23 months post-ictus) were included in the study. The patients 
underwent 24h PSG recordings which was followed by a real or sham 5Hz-




rTMS and a second PSG recording. Presence of sleep-wake cycles and 
standard temporal progression of sleep stages (wakefulness/ NREM/ REM/ 
awakening) were only seen on the MCS patients. Furthermore, only MCS 
patients had showed significant after-effect following real rTMS but not 
following sham rTMS. None of the VS patients had any significant after-effect 
following either the real or sham rTMS. This provided further evidence that 
assessment of sleep- wake cycles and sleep stages may help to diagnose 
disorders of consciousness and that being able to elicit responses to rTMS 
may provide additional supporting evidence for inconclusive cases.  
Arico et al. explored combining sleep studies and pain evaluation to increase 
diagnostic accuracy in DOC (Aricò et al., 2016). 14 patients with DOC (6 MCS, 
8 VS, aged 31 to 72, 7 TBI and 7 non-TBI) were studied with CRS-R 
assessments, 24-hour PSG and laser evoked potentials. Clinical and 
neurophysiological data were compared in the two groups by means of un-
paired t-tests (p<0.05). A Fisher’s test was carried out for correlation analysis.  
It was shown that patients in MCS showed a more structured sleep than those 
in VS. This was independent of DOC aetiology. Patients in VS showed more 
delayed N2P2 LEP (laser evoked potentials) component latency and reduced 
amplitudes than MCS. It was suggested that presence of clear LEP 
components and more structured PSG may indicate a more organized 
thalamo-cortical system. 
Bedini et al. investigated the contribution of Per3 genotype on sleep quantity 
and consciousness recovery level in patients with disorders of consciousness 
(Bedini et al., 2015). The Per3 gene has been recognized to have a role in 
circadian rhythmicity generation (Dijk and Archer, 2010) and has different 
genotypes (5/5, 4/5 and 4/4 genotypes) which are related to different sleep 
phenotypes and sleep-wake disorders. For example, EEG alpha activity in 
REM sleep, theta/alpha activity during wakefulness and slow wave activity in 
NREM sleep are elevated in Per3 5/5 which is present in 10% of the 
population. In this study 48 patients with DOC (44 VS and 27 MCS, 26 TBI/45 




vascular, aged 17-81 years, 2-22 years post brain injury) were investigated 
with PSG (2pm to 9am the following day) and Per3 genotyping. The median 
total CRS-revised score in Per3 5/5 group was significantly higher than 4/4 
genotype suggesting Per3 5/5 genotype may be associated with a better 
outcome. Analysis of the 48 PSGs revealed that all patients had stage 2 sleep, 
41% had Slow Wave Sleep and 22 % had REM sleep. The only significant 
difference between the VS and MCS patients was in NREM 2 + SWS duration 
(p=.047). Although statistical significance was not achieved, SWS and total 
sleep time in Per3 5/5 patients was higher than Per3 4/4 and 4/5 patients. The 
authors speculated that the higher total sleep time in Per3 5/5 patients may be 
associated with a protective role of this genotype in preserving a better sleep 
homeostasis. Furthermore, SWS could be related to better functional 
outcomes by leading to preservation of main cerebral connections, memory 
consolidation and learning.   
In a recently published work (Arnaldi et al., 2016) it was shown that better 
clinical outcomes were associated with the presence of sleep integrity, a better 
baseline clinical status and younger age. In this study 31 patients with DOC 
(18 males, age 18 to 81 years, 1-6 months post-anoxic/ haemorrhagic brain 
injury and 1-12 months post-TBI) were investigated with 24-hour PSG studies. 
Sleep integrity was defined  using the scoring structure index (SSI) established 
by Valente et al. (Valente et al., 2002). Three patients had no sleep pattern 
(SSI=1), 12 had sporadic NREM markers only (SSI=2), three had sporadic 
REMs (SSI=3) and nine patients had identifiable sleep stages (SSI=4). The 
patients were then monitored with CRS-R assessments for 30 months. 
Association with better baseline clinical status and younger age was well-
known. However, the predictor value of presence of sleep integrity was 
stronger than the other two factors tested. It was suggested that sleep 
investigations should be included as part of routine evaluation of patients in 
the sub-acute stages of DOC.  




4.3.2 Circadian rhythm studies 
People with brain injuries often suffer from dysautonomia (Baguley et al., 1999, 
Baguley et al., 2009) which can render assessments of rhythmicity for blood 
pressure and heart rate challenging. Nevertheless, circadian blood pressure 
and heart rate changes in patients in a persistent VS after TBI was investigated 
(Pattoneri et al., 2005). In this study 10 patients with VS (TBI, aged 19-39, 27.3 
±5.6 days after trauma) and 10 healthy controls underwent ambulatory heart 
rate and blood pressure monitoring for 24 hours. The patients presented with 
symptoms of dysautonomia. It was found that patients had higher 24-hour 
mean values of blood pressure and heart rate than the controls. There was no 
physiological nocturnal dip in the patients. Day-night differences of blood 
pressure and heart rate were significantly lower in patients. These results 
suggested that dysautonomia after TBI is associated with alteration of 
circadian blood pressure (BP) and heart rate (HR) pattern.  
Bekinschtein (Bekinschtein et al., 2009b) investigated the circadian 
temperature rhythms on five patients with vegetative state (two traumatic brain 
injury, two anoxic brain injury, one stroke) using iButton sensors which 
measured skin temperatures every 15 minutes over 13-16 days continuously. 
In addition, the degree of cortical and subcortical atrophy was assessed using 
a 5 point visual scale where atrophy levels are graded between no atrophy to 
highly severe atrophy (Galton et al., 2001). Two patients with traumatic brain 
injury had well-formed circadian temperature rhythms and had more reflexive 
behaviours and relatively low cortical and sub-cortical atrophy, whereas the 
three patients from anoxic-hypoxic origin demonstrated no cycles or rhythmic 
behaviour. In discussing the reason for the difference between traumatic and 
non-traumatic patients, authors pointed that anoxic and ischaemic brain 
injuries lead to diffuse, cortical, basal ganglia and hippocampal damage 
particularly affecting the medical and inner parts of the brain where the 
biological rhythms are regulated. Finally, it was suggested that circadian 
rhythms may be used as a measure of physiological state and/or prognosis as 




hypothalamic and midbrain functions can be deduced from circadian 
parameters.   
Guan et al.(Guan et al., 2011) investigated the infradian (circaseptan) and 
circadian rhythms of blood pressure and heart rate on 26 patients (15 males 
and 11 females, age 43.7-/+ 6.3) in persistent vegetative state secondary to 
traumatic brain injury. Heart rate and blood pressure were recorded hourly for 
10 days. Time since the brain injury or specifics of the monitoring equipment 
used were not reported. Cosinor analysis of the data suggested that both 
infradian and circadian rhythms were present in VS patients. However, 
infradian rhythm had greater amplitude than the circadian rhythm.  
Cruse et al. investigated the circadian sleep-wake cycles by using actigraphy 
in 55 patients with disorders of consciousness (Cruse et al., 2013). The 
actigraphs were applied to the limb with the highest range of movement over 
four days and cosinor analyses were performed to assess circadian 
rhythmicity. This study has shown that significant proportion of patients with 
disorders of consciousness did not exhibit statistically reliable sleep-wake 
rhythms. In addition, findings of this study suggested that the circadian sleep-
wake cycles of patients with MCS were significantly statistically more reliable 
than those of VS patients. Interestingly this study also indicated that patients 
with disorders of consciousness were most active in the late afternoon which 
may have been related to being institutionalized. (While activity peaks of 
healthy individuals occur earlier in the day between approximately 13.30 pm 
and 16.00 pm this is delayed in institutionalized patients due to abnormal 
fluctuations of light as well as low light levels) (Shochat et al., 2000, Ancoli-
Israel et al., 2002). However, due to practical limitations of actigraphy in this 
particular patient population, the findings of the above study need to be 
interpreted with caution as the results were not supported with use of another 
measure such as sleep/ wake logs and/or polysomnography. 




Nocturnal melatonin regulation in vegetative state (6 patients, 2 female, 6 to 
18 months after TBI) was assessed by Guaraldi (Guaraldi et al., 2014). He 
demonstrated that VS patients did not have physiological elevation of 
nocturnal melatonin levels. When exposed to light the control subjects had 
significant suppression of melatonin levels. On the other hand, all VS patients 
lacked such physiological response. The importance of circadian rhythm 
assessment was re-iterated, and it was suggested that melatonin 
supplementation may provide benefit to VS patients. 
4.3.3 Review Papers 
Bekinschtein et al. reviewed the factors underlying wakefulness and their 
interactions with each other in 2009 (Bekinschtein et al., 2009a).  It was 
recommended that; at least four days of recording of continuous temperature 
and motor activity with actigraphy, three days (and nights) blood sampling 
every 6 hours to assess cortisol and melatonin day-night differences and 24-
hour EEG should be performed in order to gather adequate information on 
circadian rhythmicity which can aid to plan behavioural assessments 
accordingly. Importance of performing behavioural assessments when patient 
is systemically healthy and homeostatically stable. 
Cologan et al. (Cologan et al., 2010) published a review paper in 2010 where 
they focused on the importance of evaluation of the biological rhythms in DOC, 
methodological issues around sleep staging in DOC and finally on the 
available data on sleep according to different states of consciousness namely 
in brain death, coma, vegetative state, in recovery from coma and in locked-in 
syndrome. Sleep in minimally conscious states was not discussed on this 
paper, as at the time of the preparing this paper the authors were not able to 
find any published data on sleep of patients with MCS.   
De Salvo et al. reviewed the role of neurophysiological testing for clinical 
differentiation and outcome evaluation in VS and MCS patients (De Salvo et 
al., 2012). The challenges of interpreting sleep studies in DOC as well as role 




of sleep studies in differentiating MCS from VS and its role on prognostication 
have been highlighted.  
Blume et al. reviewed the literature neuroimaging methods and sleep on a 
paper published in 2015 (Blume et al., 2015). It was highlighted that in DOC 
some rhythms may recover while some do not. For example, previously it was 
shown that circadian rhythm of body temperature and urinary excretion of 
hormones may be observed in VS patients. On the other hand, studies failed 
to observe preservation of blood pressure and heart rate circadian rhythms. 
Authors suggested that interventions targeting restoration of circadian 
rhythmicity may be a promising tool to support assessment and rehabilitation 
process in DOC. Furthermore, upon review of the PSG literature the authors 
recommended to use of PSG for reliable and valid assessment of sleep in DOC 
patients. Bright light therapy was suggested as in intervention to restore the 
circadian rhythmicity and normalize sleep as well as to stimulate patients right 
before assessments of consciousness.  
4.3.4 Publications with a Focus on Treatment 
In a paper published by Sará et al. two different mechanisms were identified 
that may explain why, in some patients, an improvement of consciousness 
following intra-thecal baclofen pump implantation occur. The authors 
hypothesized that intrathecal baclofen might have helped the clinical 
improvement by increasing stabilization and coherence of the circadian 
rhythms, through the activation of postsynaptic GABA-B receptors, by 
enhancing metabotropic glutamate receptors 1 and mediated excitatory 
transmission.  It was further suggested that effects of baclofen on serotonin 
release may be linked to its action on alertness (Sara et al., 2009). The authors 
concluded that the strategic use of drugs aimed at modulating the arousal-
circadian dynamics might orient neural plasticity and therefore, may result in 
clinical improvement.  




De Weer et al. examined four patients with disorders of consciousness (2 TBI, 
2 anoxic brain injury, aged 19-61, 3 MCS and 1 coma). Only two of the patients 
with MCS following TBI were able to exhibit increased motor activity on their 
actimetric measurements and their arousal levels when they were expose to 
light irradiation (De Weer et al., 2011). Hence, bright light may be used to re-
establish circadian rhythms in disorders of consciousness by increasing day 
time arousal and promoting sleep at night.  
Blume et al. investigated the presence of circadian temperature rhythms 
across 6 to 7 days using external skin temperature sensors as well as the 
relationship between CRS-R scores and circadian rhythmicity in 18 patients 
with DOC (Blume et al., 2017). In this study all patients had preserved 
circadian rhythmicity of skin temperature and the integrity of circadian 
variations were correlated with CRS-S scores, especially the arousal subscale 
scores. Eight of the patients were then given bright light treatment for one three 
times a day. It was found that the bright light treatment led to not only 
improvement of circadian rhythmicity but also improvement of CRS-R scored 
in three patients.  
 








Table 4-7: Summary of Literature after 2002 (after definition of MCS) 
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4.3.5 Key messages from literature after 2002 
1. Body temperature measurements and actigraphic recordings may aid 
to assess circadian rhythmicity in DOC. 
2. Melatonin circadian regulation is impaired in VS. 
3. Light therapy and melatonin supplementation may be used to restore 
circadian rhythmicity. 
4. Strategic use of drugs may be required to modulate arousal- circadian 
dynamics. 
5. Presence of spindles indicate favourable prognosis. 
6. Spindles and REM are much more common in MCS therefore may help 
to differentiate VS and MCS. 
7. VS patients with REM may need to be investigated further to detect 
covert signs of consciousness. 
8. Battery of neurophysiological tools which include PSG can be used for 
diagnostic accuracy, predicting recovery as well as identifying patients 
who may need customised rehabilitation programmes. 
9. Novel investigations such as genotyping and rTMS may play role in 
further assessment of sleep and circadian rhythms in DOC patients.  
 
4.4 CONCLUSION 
This literature review illustrates the temporal progress of research on the area 
of sleep and circadian rhythms in DOC. In addition to the clinical assessment 
tools and neuro-physiological/ neuro-imaging techniques, it is reasonable to 
conclude that   sleep and circadian rhythm studies will become part of battery 
of tools that will be used to differentiate VS and MCS but also to predict 
prognosis.   Most importantly, optimizing the circadian rhythmicity may help to 
generate electrophysiological features of normal sleep such as REM and sleep 
spindles which in turn help to aid increasing brain functions and recovery.  
Based on evidence extracted from the literature reviewed the following   flow 
chart may be used to help design clinical assessment and treatment protocols. 













Chapter 5 : BACKGROUND WORK 
The previous chapters of this thesis showed that PDOC is a complex 
pathological and, sleep is a complex physiological condition. Research studies 
indicated that sleep in PDOC is often deranged, but there has been no 
systematic attempt to treat it. Furthermore, most research studies were 
performed in a variety of clinical settings where clinical practices and 
environmental factors differ. For example, a patient who is in an intensive care 
setting soon after brain injury will have different contributory factors to his 
condition than another patient who is in chronic stage of his illness and resident 
in a nursing home setting. 
It is clear from the previous chapter that a study which looks at the impact of 
normalizing circadian rhythm in patients with PDOC. However, before that we 
needed to know the answers to the following questions: 
1. Is late recovery of awareness possible in PDOC patients? 
2. What are their sleep wake patterns like? 
3. What are the characteristics of environmental factors in our study 
setting? 
The aim of this chapter is to summarize the three pieces of foundation work, 
which were performed to answer above questions.  
5.1 EXPLORING LATE RECOVERY OF AWARENESS 
IN PDOC- A CROSS-SECTIONAL COHORT STUDY 
(Yelden et al., 2017a) 
According to the Royal College of Physicians Guidelines on Prolonged 
Disorders of Consciousness, the likelihood of significant functional 
improvement diminishes over time and cause of brain injury is a strong 
determinant of outcome for both VS and MCS (Royal College of Physicians of 
London).  




The objective of this work was to detect any improvement of awareness in 
prolonged disorders of consciousness in chronic stages. If present, such 
improvement may indicate a potential for naturally occurring neuro-plasticity, 
which can be potentially accelerated by treatment and/or therapy. 
Thirty-four patients with prolonged disorders of consciousness (16 male and 
18 female; aged 21 to 73) who were residents in the specialist nursing home 
section of the Royal Hospital for Neuro-disability (RHN) were included in the 
study. 
The causes of brain injury were: anoxic brain injury in 15; severe subarachnoid 
haemorrhage (SAH) (The World Federation of Neurosurgeons, classification 
Grade IV and V) in 11; traumatic brain injury (TBI) in six; and massive 
ischaemic stroke in two participants.  
All patients were initially diagnosed with SMART assessment while they were 
inpatients in the specialist neurological rehabilitation unit of the hospital and 
eventually were transferred to specialist nursing home for long term care. 27 
(79%) of the patients had a diagnosis of vegetative state on initial SMART 
assessment, and the remaining seven (21%) had diagnosis of minimally 
conscious state. Time from brain injury to initial diagnosis varied between five 
and 38 months.  
Time from brain injury to re-assessment was between 2 and 16 years. The 
main outcome measure for re-assessment was recovery of awareness, which 
was measured using CRS-R. 
The results showed that although all patients remained severely disabled, 32% 
of the patients showed improvement of awareness of themselves or their 
environment (See Table 5-1, Table 5-2). Most of the late recovery of 
awareness occurred in patients with SAH (5/11, 45.5%). The age of patients 
within the late recovery group (Mean=45, SD=11.4) and non-recovery group 
(Mean+43.5, SD=15.5) was not statistically different (p=0.76).  




Only one patient, who suffered from severe SAH and was previously in 
minimally conscious state, had progressed to the level of functional verbal 
communication and object use. The remaining six patients with MCS failed to 
improve.  
 
Table 5-1: Demographic and clinical features of patients according to cause of brain 














Mean Age (SD) 38.5(10.9) 49.2(12.5) 53.6(9.2) 58(21.2) 49.2(12.4) 
Mean Months BI to 
SMART (SD) 




VS 4 15 8 0 27 
MCS 2 0 3 2 7 
MCS+ 0 0 0 0 0 
Years BI to CRS-R 
(mean±SD) 
4.9±2.1 6.9±3.9 4.9±3.0 7.0±1.4 5.9±3.4 
CRS-R Outcome 
(MCS+/MCS/ VS) 
0/4/2 0/3/12 1/8/2 0/1/1 1/16/17 
Improvement 33% (2/6)  20% 
(3/15) 
 46% (6/13) 32% 
(11/34) 












Time BI to 
SMART 
(months) 
Time SMART to 
CRS-R (years) 
Auditory function Visual function Motor function Oromotor/ 
Verbal function 




M/ VS/ SAH 












F/ VS/ SAH 
8 2 Consistent movement to 
command 
Visual pursuit Flexion withdrawal Oral reflexive 
movement 




F/ VS/ TBI 
15 3 Reproducible movement 
to command 
Visual pursuit Flexion withdrawal Oral reflexive 
movement 
None Attention 12 
Patient 4 
F/ VS/ TBI 
12 2 Localization to sound Visual pursuit Abnormal posturing Vocalization/oral 
movement 
None Attention 11 
Patient 5 
M/ VS/ Anoxia 




Object manipulation Oral reflexive 
movement 
None Attention 15 
Patient 6 
F/ VS/ SAH 




None Attention 13 
Patient 7 
F/ VS/ Anoxia 
38 4 Reproducible movement 
to command 
None Flexion withdrawal Vocalization/ 
oral movement 
None Attention 10 
Patient 8 
M/ MCS/ Infarct 
7 5 Consistent movement to 
command 








M/ VS/ Anoxia 
10 2 Auditory startle 
 
Fixation Flexion withdrawal Oral reflexive 
movement 




F/ VS/ SAH 
12 2 Reproducible movement 
to command 







F/ VS/ SAH 
10 2 Reproducible movement 
to command 
Object recognition Object manipulation Vocalization/ 
oral movement 
None Attention 17 
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5.1.1 Contribution to thesis 
First, this study showed that late improvements in awareness were not 
exceptional even in non-traumatic PDOC cases. Second, while it highlighted 
the importance of long term follow up of patients with disorders of 
consciousness, regardless of the aetiology, age and time passed since the 
brain injury; it also indicated that despite having profound brain injury and being 
in vegetative or minimally conscious state for such a long time, neuro-plasticity 
and axonal regrowth can still occur.  
Currently most interventional research studies are performed in the more 
acute/ subacute stages of PDOC. Finally, these patients also have an 
additional advantage of being medically stable and being on established 
medication and feeding regimes. Hence, any changes in the clinical status 
during an interventional study are least likely to be due to other clinical factors 
such as resolution of an infection, seizures, dysautonomia, hydrocephalus or, 
changes made to the medication regimes. Therefore, patients who are in 
chronic stages of their illness may also be included in studies that are designed 
to explore effect of intervention on consciousness and/ or awareness. 
5.2 OBSERVATION OF SLEEP-WAKE PATTERNS OF 
PATIENTS WITH PDOC 
The aim of this work was to investigate the sleep patterns and arousal levels 
of patients with disorders of consciousness. Five patients with DOC were 
observed for 40 days during their inpatient stay in a specialist rehabilitation unit 
while undergoing assessment and rehabilitation. Clinical assessments 
(SMART, WHIM, Music Therapy Assessment Tool for awareness in DOC 
(MATADOC)) indicated that all 5 patients were in vegetative state.  
Presence of the sleep state was identified using the physical signs of this 
condition, which include lack of movement, reduced postural muscle tone, 
closed eyes, and more regular and relaxed breathing, usually accompanied 
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with an increase in upper airway noise. Presence of awakening was simply 
identified by opening eyes. 
Based on these criteria, sleep/ wake status was recorded every 4 hours; during 
therapy/ assessment sessions; and during physical nursing care. No changes 
were made to delivery of care or therapy/ assessment sessions.  
On average patients had 223 four-hourly observations. Between 8am and 
8pm, the patients were awake during 60% of the observations.  Midnight and 
4 am observations revealed that the patients were awake 30% of the time. 
Arousal levels were higher in the afternoon and evening hours. 
Arousal levels were recorded during 74 therapy/ assessment sessions in total. 
While in 35% of the sessions patients were awake throughout the session, in 
25% of sessions they were asleep most of the session or throughout the 
session. In the remaining 40% of sessions patients were awake more than half 
of the therapy session duration.  
Arousal levels were recorded during 137 nursing care episodes. In 55% of 
nursing sessions patients were awake. In 8% of the nursing sessions they were 
asleep most of the session or throughout the session despite being exposed 
to high levels of stimuli provides during nursing care which involved re-
positioning in bed, hoist transfers and personal care. 
5.2.1 Contribution to the thesis 
As a result of this simple observational study, it was concluded that sleep/ 
wake patterns of patients with prolonged disorders of consciousness were very 
abnormal possibly indicating presence of circadian sleep disorder.  
Disturbed night-time sleep is likely to have a negative impact on rehabilitation 
and recovery of PDOC patients. Moreover, low arousal levels observed during 
assessment sessions, may contribute to misdiagnosis and missing subtle but 
conscious behaviours which can be used for rehabilitation. Improvement of 
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sleep-wake cycle is essential in PDOC, so the patients can be assessed, 
diagnosed and rehabilitated appropriately. 
5.3 ENVIRONMENTAL CHARACTERISTICS OF 
PATIENT ROOMS AND SLEEP ENVIRONMENT 
(Yelden et al., 2015) 
Fatigue, lethargy, day time reduced arousal level and low mood are common 
problems that are encountered in hospital and residential care settings. Most 
of the time, these problems are attributed to physical or if present, cognitive 
impairment of patients. However, very little attention is paid to sleep patterns. 
It has been previously demonstrated that sleep fragmentation caused by 
relatively brief interruptions, leads to measurable changes in daytime 
alertness, cognitive functioning, neuroplasticity, memory, psychological 
functioning and learning (McCoy and Strecker, 2011, Martin et al., 1997, 
Roehrs et al., 1994, Stepanski et al., 1987, Djonlagic et al., 2012). Daytime 
sleepiness and fatigue have been shown to be related to difficulties in sleeping 
(Goodchild et al., 2010). The commonest preventable causes of sleep 
disturbance in healthcare settings are background noise and light. Sudden 
increase in their levels cause interrupted sleep. Environments that are too hot 
or cold may also be disturbing.  
The World Health Organization (WHO) and The Society of Light and Lighting 
published standards for ward-based hospital environments to minimise sleep 
disturbance.  
According to the WHO Guidelines for Community Noise (Berglund et al., 
1999), the noise levels in hospital rooms should be 35 dB or less. The 
recommended maximum intensity for individual events at the patient’s bedside 
is 45 dB. Temperature and humidity should be maintained between 20-22 C° 
and 30-60 % respectively (World Health Organization. Regional Office for 
South-East Asia., 2002). The Society of Light and Lighting states that night 
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and observation illuminance in patient rooms should be below 5 lux and should 
not exceed 10 lux (2002). 
Night time environmental characteristics of patient rooms, namely light, noise, 
temperature and humidity levels need to be optimised not only to provide 
comfortable accommodation but to improve sleep quality and consequently to 
minimize the problems that may be faced due to poor sleep. 
Having established that the patients with prolonged disorders of 
consciousness have abnormal sleep wake patterns; there was a need to 
understand influence of environmental factors on their sleep-wake status. How 
much of this disturbance is due to extrinsic factors rather than intrinsic 
circadian sleep disorders? 
This study aimed to obtain background information on light, noise, temperature 
and humidity levels of patient rooms which can affect the circadian rhythms 
and sleep-wake pattern of patients with DOC at the Royal Hospital for neuro-
disability. As sleep hygiene is one of the most important treatment methods for 
circadian sleep disorders; understanding the environmental characteristics of 
sleep environment and, if not ideal, trying to optimize the sleep environment 
as part of planned interventional study was essential.  
To examine the sleep environment of patients with DOC, measurements of 
environmental characteristics were recorded on three non-consecutive nights 
by data loggers in a 12-bedded ward. The obtained measurements were 
compared with the recommendations of the WHO and the Society of Light and 
Lighting. 
Recordings were within recommended levels for light and humidity overnight. 
Light intensity levels were reasonably maintained within the recommended 
levels between 11pm and 7am. Mean temperature levels were higher than 
recommended. Average noise levels were above the recommended levels. 
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There were abrupt increases of light and noise levels which were high enough 
to cause sleep fragmentation. 
Mean sound levels in all occupied rooms were consistently in excess of the 35 
dB and therefore, not within the recommendations made by the WHO for 
healthy sleep environment in healthcare settings. Moreover, there were abrupt 
increases of sound levels as high as 84 dB which is equivalent to sound of an 
alarm clock at 2 ft distance. Hence, the 45-dB threshold of recommended 
maximum intensity for individual events at the patient’s bedside was exceeded. 
5.3.1 Contribution to the thesis 
This study indicated that activities of the night staff significantly contributed to 
the increased noise levels in patient rooms as it is unlikely that the patients 
with disorders of consciousness would be the source of noise. Following this 
work, an internal review of the ward equipment and fixtures & fittings were 
performed by the estates maintenance department. Series of educational 
events were delivered for nursing and care staff on importance of avoiding 
sudden increases in light and noise levels at night, as well as on importance 
of sleep for our patients. 
5.4 BACKGROUND WORK: CONCLUSIONS 
1. Patients with PDOC who are in chronic stages of their illness may also 
be included in our interventional study which will be designed to explore effect 
of intervention on their consciousness and/ or awareness levels as their brains 
continue to have level of neuro-plasticity which was indicated presence of 
natural improvement of their consciousness over years/ decades. Moreover, 
these patients are usually medically stable and on established medication 
regimes.  
2. Our simple observational study on sleep-wake states of patients with 
disorders of consciousness showed that their sleep/ wake patterns were very 
abnormal possibly indicating presence of circadian sleep disorder. However, 
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visual assessment of the subject is not enough for the characterisation of sleep 
stages. Physiologically, the electroencephalogram (EEG), the electromyogram 
(EMG) and the electrooculogram (EOG) provide a higher level of quantification 
in the description of the different sleep stages. Incorporation of detailed 
assessment methods examining the sleep stages and circadian rhythms are 
vital in design of our interventional study.  
3. Our work on environmental factors in patients’ rooms indicated that 
there was a need to provide education and training of night staff to raise 
awareness on importance of sleep and environmental factors and 
development of strategies to reduce noise levels at night with the objective of 
providing better sleep environment and reduce possible complications of 
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Chapter 6 METHODS DEVELOPMENT 
The main aim of this research project is to optimize sleep of people with PDOC 
using simple interventions and to assess effect of these on their consciousness 
levels. The introductory chapters showed that many techniques are available 
to assess sleep, circadian rhythm and levels of consciousness but in this 
particular patient population not all techniques are sensitive and practical. 
When designing an interventional study, which includes patients who cannot 
consent to research, are vulnerable in many ways and who require care for all 
their needs, the researchers need to choose techniques which are easy to 
perform, informative, repeatable, and least harmful to the patients.  
Due to the clinical characteristics of patients in vegetative and minimally 
conscious states it was clear from the beginning that adjustment of standard 
techniques that are normally used for assessing circadian rhythm and 
obtaining neurophysiological data was needed.  The presence of involuntary 
movements, an inability follow commands, an inability to express discomfort 
and pain were the biggest concerns. Therefore, several techniques were 
trialled in order to find out the most practical, comfortable and efficient ways of 
collecting data. This chapter will the describe the development of the methods 
used in this study, including the ethical issues, study design and development 
of data collections methods. 
6.1 ETHICAL CONSIDERATIONS 
This study involved individuals who do not have the capacity to consent for 
themselves. We followed the criteria for involving people who lack capacity to 
consent to participate in a research study, as laid down in the Mental Capacity 
Act (Health, 2005). We liaised with the ward managers/ nursing staff to identify 
a suitable consultee (someone who has known the patient when s/he had 
capacity and is willing to be consulted on what the patient’s wishes and feelings 
would be towards participating in the project). The consultees were provided 
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with written information and any questions raised by them were answered. 
Signed assent was obtained.  
This study conforms to the World Medical Association Declaration of Helsinki 
and ethical approval was obtained from National Research Ethics Service.  
(Research Ethics Committee ref: 11/LO/1233, Site Specific Assessment ref: 
11/LO/2052) 
6.2 STUDY DESIGN 
This research study aims to find answers to following questions: 
1. Do the patients in vegetative state and minimally conscious state 
maintain any circadian rhythm? If so, is it normal? 
2. If their circadian rhythm is abnormal, can we optimize it by using simple 
and inexpensive clinical interventions namely blue light, melatonin and 
caffeine? 
3. Could these interventions lead to improvement of consciousness/ brain 
functions measured using either clinical assessment tools and/ or 
neurophysiological investigations? 
To be able to answer the questions above, randomized controlled trial (RCT) 
and cross-over trial study designs were considered. 
RCTs are considered the gold standard for a clinical trial but they require two 
groups of patients who are assigned to treatment and control subgroups. 
Blinding is recommended when performing RCTs. RCTs are most suitable for 
the diseases with high number of patients and treatments which can easily be 
concealed for blinding. Number of patients who can be enrolled in a RCT trial 
and ways of blinding the interventions were considered. The number of people 
with DOC due acquired brain injury and medically stable in our hospital was 
too small to enable a robust RCT design. In addition to this limitation, some 
difficulties with blinding were identified. These were the use of placebo drugs 
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for people who lack capacity to consent, and difficulty of administering sham 
blue light treatment. 
 
Figure 6-1: Randomized controlled trial design illustration 
 
In cross-over trials there are usually two groups in parallel. The subjects who 
are first assigned to the treatment group and, after a brief interval of wash-out, 
are moved into the placebo /alternative treatment group and vice versa. The 
alternative treatment can be the usual practice. The subjects act as their own 
control at the end of the study.  
 
Figure 6-2: Cross-over study design 
 
Due to the difficulties given for a RCT trial, cross-over design was explored in 
length. As normalization of circadian rhythmicity was not previously studied in 
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this patient group, treatment- wash out- alternative treatment design was 
rejected. The main reason for this was, uncertainty over the duration of effect 
once circadian rhythm is optimized. Therefore, the study was designed in a 
way that the participants still act as their own controls by utilizing a design 
which allowed us to look at individual participants and the group: Investigations 
performed twice to examine any fluctuations at baseline- treatment- repeat 
investigations.  
 
Figure 6-3: PhD study design 
 
6.3 ASSESSMENT OF CIRCADIAN RHYTHM 
Circadian rhythmicity can be demonstrated by assessing endocrine markers 
and physiological changes. In practice, the most widely used endocrine 
markers are cortisol and melatonin; and most commonly used physiological 
marker is core body temperature. Therefore, these measurements were 
considered predominantly to assess circadian rhythmicity and explored in 
detail to choose best method of data collection for our research participants. 
6.3.1 Endocrine markers of circadian rhythm 
Cortisol is a corticosteroid hormone that is produced in the adrenal cortex. 
Cortisol shows a circadian rhythmicity through multi-synaptic suprachiasmatic 
nucleus-adrenal pathway (Buijs et al., 1999). Its levels can be measured in 
serum and saliva; however, several factors influence the secretion of cortisol 
such as physical and psychological stress and diet. Although cortisol 
measurement was considered as a method to assess circadian rhythm, due to 
the influencing factors it was identified as a less sensitive indicator of circadian 
rhythm in our patient population as people with PDOC are immobile, artificially 
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fed and suffer from many other physio-pathological processes such as 
dysautonomia, pain and discomfort due to immobility and increased muscle 
tone. 
Melatonin levels can be measured in plasma or saliva, and levels of its 
metabolite, 6-sulfatoxymelatonin, in the urine. Although melatonin levels can 
be influenced by posture, exercise, caffeine and certain drugs such as non-
steroid anti-inflammatory drugs (NSAIDs) and beta blockers, its rhythmicity 
remains reasonable preserved. Therefore, it was identified as a choice of 
endocrine marker for this study. 
Patients with DOC may have had a urinary catheter inserted in the acute 
phases of their illness, however, they are usually without the urinary catheter 
in the chronic phase and urinary and faecal incontinence is managed with 
using incontinence pads. Therefore, collection of urine for melatonin 
measurement was not practical. Insertion of a urinary catheter carries risk of 
urinary tract infection as well as discomfort. Similarly, plasma collection for 
melatonin measurement was impractical, as it required the invasive procedure 
of venous cannula insertion. Hence, it was concluded that saliva collection 
procedure was the most sensitive, practical and risk-free way of measuring 
melatonin levels as a marker of circadian rhythm in the patients with DOC.  
Salivary flow rate is influenced by many factors such as hydration state and 
body positioning. Saliva samples can be efficiently collected when person is 
sitting upright with the head slightly tilted forward and the eyes open. Time of 
the day (peak values in the afternoon), subject’s medical status and 
medications can also influence saliva production. In addition to these factors, 
patients with DOC often sleep mouth open, often have a sucking reflex and 
clench their teeth tightly if any object is placed in the oral cavity. 
Saliva can be collected by using four main methods: draining, spitting, 
suctioning and swab (Navazesh, 1993). Occasionally draining may be possible 
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in the patients with DOC. This requires the patients to have hyper-salivation 
which may lead to spontaneous drooling in a sitting position. However, this is 
not possible in all patients and highly dependent on the position of the patient. 
Spitting entails active effort and involvement of the patient, hence was not 
possible to use in this study. Suction necessitates insertion of a test tube into 
the mouth floor, which may be hazardous in DOC patients due to not being 
able to co-operate, sucking reflexes and clenching teeth. The swabbing 
method requires use of pre-weighted gauze, cotton wool or sponge.  
Owing to the difficulties listed above it was imperative to choose a collection 
swab which was safe to use, absorbent enough and also free from pre-
treatment with chemicals which could interfere with melatonin assays in the 
laboratory. Therefore, advice from the scientists who perform the assays, 
dental practitioners, nursing staff and speech and language therapists was 
sought. Several types of collection swabs were initially trialled on healthy 
subjects and then on patients for absorbency and suitability with laboratory 
processing.  
Oral swabs with foam head are commonly used for the   oral 
care of patients in the hospitals. These swabs were not 
suitable in our patient group due to the possibility of 
detachment of the sponge head from the stick during use.  
Large cotton bud swabs were safe and easy to use in our 
patients. However, when sent to laboratory for melatonin 
testing, the results were unsatisfactory due to the interference 
of an unknown chemical with the melatonin essay.  
Salimetrics paediatric oral swabs (Salimetrics, USA) are long 
enough to allow one end of the swab to be held while it is in 
the mouth and it is made of a durable polymer, which 
withstands chewing. The volume of the sample recovered is 








Figure 6-4: Oral 
foam swabs 
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melatonin essays. When tested for melatonin in the laboratory there was no 
chemical interference. Hence, these swabs were chosen to be used for saliva 
melatonin measurements in our study. 
Having decided on what to measure and how to collect the samples, we 
needed to decide when and how often to collect samples. 
In practice, measurement of dim-light melatonin onset (DLMO) is commonly 
used, as 24-hour melatonin sample collection is time-consuming and also 
inconvenient for the subject. DLMO reflects the phase of the circadian rhythm 
only if the individual’s phase is approximately normal and measured over more 
than one cycle (Hofstra and de Weerd, 2008). However, due to the severity of 
brain injury sustained people with DOC are likely to have free running circadian 
rhythms and therefore, abnormal phase and peak times. Hence, frequent 
measurements of melatonin levels throughout a 24-hour period were a 
necessity in order to assess peak times and even longer periods of sample 
collection to assess rhythmicity. Hence, it was decided that in our study, 
samples should be collected every 4 hours, for two days.  
6.3.2 Physiological markers of circadian rhythm 
Circadian pacemaker in the suprachiasmatic nucleus not only generates and 
maintains circadian rhythms of sleep/wake cycle and secretion of hormones; 
but also, many physiological features such as blood pressure and body 
temperature. Measurement of the temperature circadian rhythm is commonly 
used, usually by means of measuring core body temperature (CBT). CBT 
rhythm is characterized by nocturnal decline reaching its minimum at 
approximately 5am and reaching its maximum during the afternoon around 
5pm. This rhythm reflects the combined effects of the body clock, sleep, and 
physical and mental activity and can be described by a cosine curve. The 
regulation of body temperature rhythms is provided by the circadian 
pacemakers and thermoregulatory system located within the hypothalamus 
and influenced by several external factors such as activity levels, external 
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temperatures and perspiration levels (Refinetti and Menaker, 1992, Weinert 
and Waterhouse, 2007). It was also shown that melatonin has suppressing 
effects on core body temperature (Deacon et al., 1994, Deacon and Arendt, 
1995). 
CBT can be measured by a variety of methods (e.g. intravascular, tympanic, 
bladder, rectal, oesophageal). These methods are invasive, some may cause 
discomfort or even wake the patient up during data collection procedure, and 
consequently negatively influence the circadian rhythms. Most importantly, as 
patients with DOC are unable to express pain and discomfort it was necessary 
to find a method which measured changes in body temperature reliably, did 
not discomfort, did not interfere with personal care or the feeding regime of 
patients.  
Proximal skin temperatures measured at the thorax, breast, abdomen, and 
thigh have been found to follow the same circadian rhythm as rectal 
temperature (Krauchi and Wirz-Justice, 1994). Bogh et al. studied the 
circadian rhythms of temperature measurements from axilla, chest wall and 
rectum  and showed that chest wall and axillary sites gave similar results to 
rectal measurements but these were both more variable and up to 8 hour later 
than those for rectal temperature especially in physically active subjects (Bogh 
et al., 1994). It was also shown that conditions with and without sleep had 
different effects on the core, proximal and distal body temperatures (Kräuchi, 
2002, Kräuchi et al., 2000). Interestingly it was shown that distal and proximal 
skin temperature increased in parallel after lights out while the core body 
temperatures fell.  
Collecting continuous body temperature measurements require either wired or 
wireless connection to a recording device or use of battery powered loggers 
that store data in a memory unit for later download. Use of a wired recording 
device was not practical for our patients as they were often repositioned in bed, 
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hoisted to/ from wheelchair and taken out of the ward during the day for 
participation social activities. 
The iButton (Maxim Integrated, USA) has been found to be a reliable and valid 
measure of body temperature and its application to human skin was shown to 
be comfortable and tolerable with no significant adverse reactions. Moreover, 
the iButton is an inexpensive, wireless data logger that can be used to obtain 
a valid measurement of human skin temperature. It was suggested as a 
practical alternative to traditional measures of circadian rhythms in sleep/wake 
research (Hasselberg et al., 2013). It has been used previously to examine 
circadian rhythms in PDOC patients (Bekinschtein et al., 2009b). 
DS1921H high resolution thermochrone ibuttons (Maxim Integrated, USA) 
measure temperature in 1/8°C increments between +15 and +46 Celsius, at 
user-programmable intervals from 1 to 255 minutes. Due to its ease of use and 
reliability ibuttons were chosen as method of recording body temperature as 





Figure 6-7: DS1921H high resolution thermochrone ibuttons  
6.4 ASSESSMENT OF SLEEP 
Polysomnography is the only tool that can reliably be used for assessment of 
sleep structure in patients with DOC, but both acquisition and analysis of EEG 
data is challenging in this patient group. First of all, recording of good quality 
EEG signals is difficult due to spontaneous movements, excessive sweating, 
drooling, interference from other electrical devices such as feeding pumps and 
complex care which require frequent re-positioning of patients to prevent 
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pressure sores and hoisting for transfers. These may contribute to 
displacement of electrodes, skin irritation as well as occurrence of artefacts. It 
is ideal to have long polysomnography recordings for example over 48 to 72 
hours, but when this was trialled on two patients, we were able to identify some 
complications related to this technique, as there was evidence of skin irritation 
and interference with the patient’s personal care which could potentially lead 
to distress of the patient, carers and relatives. Therefore, 24-hour recording of 
polysomnography was judged to be an appropriate and safe method of 
performing sleep studies in our patient group.  
Analysis of polysomnography recordings are based on sleep stage scoring 
which is based on an epoch by epoch approach. Identification of wakefulness, 
sleep stages 1 & 2, slow wave sleep (stage3/4) and REM is well defined in 
healthy individuals. Although there are established criteria to report 
polysomnography in healthy subjects, this is not straightforward in DOC. The 
EEGs recorded in patients with DOC are heterogeneous in appearance, often 
because of the varied neuroanatomical abnormalities seen in this patient group 
due to injuries suffered. The visual inspection of the baseline EEG recordings 
in these patients tends to show differing proportions of theta and delta activity, 
impoverished-low amplitude and/or devoid of distinguishing features which is 
especially a feature of recordings taken from patients in vegetative state. 
Therefore, it was necessary to document the subjects’ baseline EEG whilst 
awake, before the start of the polysomnography recording. In this way, we 
would be able to compare the initial awake background activity with any overall 
change in EEG background, which was taken as in indicator for change in state 
(sleep onset/sleep). Following this, it was necessary to adapt sleep staging 
criteria as sleep does not always match the standard scoring criteria for this 
patient group (Cologan et al., 2010, Cologan et al., 2013).  
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6.5 BEDSIDE ASSESSMENT OF CONSCIOUSNESS  
In the introduction chapter of this thesis, three different bedside assessment 
tools were described: SMART, WHIM and CRS-R. 
WHIM was identified as a useful tool in tracking recovery of patients and it was 
shown to have good inter-rater and test-retest reliability after a training was 
given to the assessors. However, the stimuli given to assess responses of 
patients are not well-prescribed.  
The SMART and CRS-R both apply similar stimuli and specify the method of 
application. CRS-R is an easily performed and reliable assessment tool (Seel 
et al., 2010). CRS-R includes all the modalities of the SMART assessment with 
the exclusion of the gustatory and olfactory sensory stimulation techniques. 
Both, assessments tools use well-described detailed instructions to give stimuli 
as well as to score responses observed. While a single SMART assessment 
takes approximately one hour to complete, a single CRS-R assessment takes 
about 20 mins. SMART also requires training of assessors through a training 
and certification program, while CRS-R requires training through video.  
For this research project, CRS-R was chosen as the bedside tool to assess 
consciousness levels. In addition to the advantages given above, the 
researchers who performed the data collection were already trained and 
experienced in using it.  
6.6 NEUROPHYSIOLOGICAL ASSESSMENT OF 
CONSCIOUSNESS 
As shown in the introduction chapter of this thesis, event related potentials can 
give information on assessing brain responses to specific stimuli such as 
auditory tones, words or pictures. They can be used in their familiar 
environment and at the bedside of patients, eliminating transportation to a 
different facility. For this research study, all ERP methods were considered. 
Active paradigms were considered to be too complex for our patient group, as 
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they require following instructions and active involvement of the patient- such 
as counting deviant stimuli amongst many standards. The paradigms which 
use visual stimuli were discarded as observation of participants indicated that 
most patients would not be able to keep their eyes open for the duration of 
testing or able to focus their eyes on the screen. There was also possibility of 
some patients suffering from cortical blindness especially following hypoxic 
brain injury.  
Therefore, auditory passive ERP paradigms were chosen as a method of 
assessing consciousness neuro-physiologically. Although, deafness after a 
brain injury is rare, it is possible after traumatic brain injury or due to other 
medical conditions such as ear infections, ear wax and degeneration. 
Therefore, auditory evoked potential testing was planned to exclude any 
hearing impairment and false-negative ERP results. A simple oddball 
paradigm to measure mismatch negativity and a more complex paradigm to 
measure brain responses to a meaningful and significant stimulus- subjects 
own name, were developed. Using EEG caps during ERP experiments was 
identified as the easiest and quickest way of recording EEG responses.  
6.7 DEVELOPMENT OF INTERVENTION TECHNIQUE 
We aimed to optimize circadian rhythm of patients with disorders of 
consciousness by improving sleep of patients; by achieving light- dark cycle in 
their usual environments; by using pharmacological agents to improve 
circadian rhythmicity and finally by using pharmacological agents to increase 
daytime arousal.  
6.7.1 Improving sleep environment of patients 
As identified in the background work on environmental factors in patients’ 
rooms, each participant’s room was assessed prior to the interventional study 
in order to improve sleep environment of patients. Nine of the patients who 
participated in the study were residents in single rooms. One patient was a 
resident in a room where two other patients with disorders of consciousness 
              Optimizing Circadian Rhythm and Characterizing Brain Function in DOC




were also residents. The rooms were not in a close proximity to the nurses’ 
work station. Moreover, nursing staff were informed that the patients were 
participating in a research study aiming to examine the sleep-wake patterns.  
Based on the information gathered in the background work; they were asked 
to keep the interruptions to minimum, and to avoid switching the main lights on 
unless it was necessary to do so. A short training session was provided on use 
of night observation lights and reduction of noise. 
6.7.2 Optimisation of light-dark cycle  
We aimed to achieve optimization of light-dark cycle by;  
A) ensuring the disturbance at night is kept to a minimum as explained 
above,    
B) ensuring the lights were off, and windows and doors fully obscured at 
night, if safe to do so,  
C) Using light therapy boxes in the mornings. 
 
Blue light therapy is the only treatment that is able rapidly to shift the biological 
clock. Blue-light therapy can be used in treatment of sleep disorders, circadian 
rhythm disorders, dementia and seasonal affective disorders. Light treatment 
can be provided with light therapy lamps are specifically manufactured to 
provide blue light.  
Bright light administration start time was agreed as 8am which is the time of 
shift changeover between night and day nursing staff to prevent night staff’s 
exposure to bright light.  
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We also considered use of eye shields at night to minimize light exposure at 
night. However, as the illumination levels in the patients’ rooms were within the 
recommended levels, eye shields were not used. Other factors that influenced 
our decision were a wish to avoid additional work load of donning and doffing 
of patient eye shields in the evening and morning by nursing staff and a wish 
to avoid risk of unintentional but prolonged use of eye shields in the morning 
hours which could negatively affect exposure to bright day light and blue light 
therapy in the mornings.  
 
6.7.3 Pharmacological agents 
6.7.3.1 Melatonin 
Melatonin is licenced for treatment of sleep onset insomnia and delayed phase 
syndrome for adults over 55 years of age in the UK. The recommended clinical 
dose for this indication is 2 mg modified-release tablets once daily 1-2 hours 
before bed time for up to 13 weeks.   It should be avoided in patients with 
autoimmune disease, hepatic impairment, pregnancy and breast feeding. A 
liquid preparation for paediatric use is also available for off licence and 
research purposes.  
In the early research of 1970s and 1980s it was shown that up to 300 mg of 
melatonin daily was administered without any toxicity in humans. Therefore, it 
was concluded that melatonin can be used in clinical trials with safety. Most 
Figure 6-8:  Philips Energy Light Lamp 
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trials however, shown that much smaller doses of melatonin can induce phase 
shifts in humans.  
Melatonin is usually given 1-2 hours before usual bedtime around between 8 
and 10pm. The patients with DOC usually have poor sitting tolerance and they 
are usually in bed before 6pm in the afternoon. Evening dose of their 
prescribed medications usually given between 6 and 8 pm and they may have 
visitors until 8pm. The main lights in their rooms are turned off after 8pm. 
Therefore, in order to synchronize environmental cues, light-dark cycle of their 
environment and sleep-wake cycle, melatonin administration time was set as 
6pm in the evenings.  
Acute administration of melatonin acutely lowers the body temperature- in 
contrast to acute elevation of body temperature with bright light. Therefore, 
combination treatment with bright light and melatonin would be more effective 
in the management of circadian rhythm disorders.  
6.7.3.2 Caffeine 
Caffeine, the third and final interventional component used in this study, is a 
weak psycho-stimulant. In addition to this it has circadian effects, especially on 
melatonin synthesis in humans, inhibiting melatonin production due to its 
adenosine receptor antagonist properties (Ribeiro and Sebastião, 2010, Shilo 
et al., 2002, Wright et al., 1997). Caffeine increases levels of wakefulness and 
counteracts deteriorations in task performance related to sleep deprivation 
(Snel and Lorist, 2011). It has been shown that subjects who suffer from jet lag 
achieve resynchronization of their circadian rhythm earlier than placebo group 
controls when given caffeine to restore wakefulness and melatonin to 
encourage sleep (Pierard et al., 2001, Beaumont et al., 2004). However, as 
with other regulators of circadian rhythm the timing of caffeine administration 
is important. For example, if caffeine is consumed late in the day it will 
negatively affect night sleep resulting in daytime sleepiness the next day. 
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Caffeine was chosen for its stimulant properties as well as its effect on 
melatonin secretion. It has no significant side effects. The timing of caffeine 
administration was set to be in the early hours of day in order to maximize its 
effect during the day but prevent its possible carry over effect to night time. As 
the research participants were not used to consuming caffeinated products 
since their brain injury, a prescription schedule which provided gradual 
increase of caffeine given was designed.  
6.8 CHAPTER SUMMARY 
Methods development chapter of this thesis shows that designing an 
interventional study is challenging, as the researchers need to carefully 
consider number of ethical and methodological issues. There are only few 
studies which examined effect of intervention in PDOC patients, especially 
when given over a period of weeks rather than days. In addition to this, as the 
literature review chapter previously indicated, there are limited number of 
literature examined the circadian rhythms in PDOC at baseline. Only one study 
examined the effect of light treatment in six PDOC patients for one week 
(Blume et al., 2017). Although, it was found that bright light treatment could 
boost circadian rhythmicity in some PDOC patients whether their sleep is also 
improved or not, is unknown. Therefore, we needed to design a study which 
investigated the effect of interventions (optimization of sleep environment, blue 
light, caffeine and melatonin treatment) on sleep and circadian rhythms which 
was given over weeks. In addition to this, we designed a robust methodology 
which examined possible fluctuations of sleep and circadian rhythms at the 
baseline in order to reduce possibility of false positive results. Furthermore, we 
wanted to test if the circadian rhythm changes after intervention maintained or 
not. The following chapter provides detailed information on methods used in 
this PhD research study.  
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Chapter 7 METHODS 
The main aim of this research project is to investigate effect of light, melatonin 
and caffeine treatment on circadian rhythm and sleep of patients with PDOC. 
However, in the first instance, we needed to know how their circadian rhythm 
and sleep were at their baseline. Therefore, this study was performed in 2 
stages - baseline assessment of sleep and circadian rhythm followed by the 
interventional study, as outlined in Table 7.1.  
There has been no formal calculation of sample size. For this study we 
estimated that only one or two participants at a time can be studied due to the 
complex nature and timeline of the study which required participants to be 
enrolled in the study for 12 to 14 weeks. This meant that a maximum of 10 
participants could be included in the study per year. Therefore, we estimated 
that over two years of data collection, a sample size of 20 would be reasonable 
and achievable. We recruited 17 patients with PDOC in the baseline studies 
using convenience sampling. Twelve of these 17 patients then were enrolled 
in the interventional study. Ten of the 12 patients were able to complete the 
interventional study.  
For the patients who were participated in the baseline stage only, the study 
duration was one week. For the 10 patients who completed the interventional 
study, the study duration was 13 weeks. 
Table 7-1: Study time points 
Week 1 Week 5 Week 6-9 Week 10 Week 11 Week 13 








24 Hour saliva 
collection for 
melatonin 
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The baseline investigations included BAEP, 30-minute EEG, CRS-R, 24-hour 
PSG and 48-hour saliva melatonin levels for all patients (n=17). We also aimed 
to collect body temperature measurements data as a supplementary circadian 
rhythm marker.  
The patients who proceeded for the interventions also received ERP studies 
using auditory oddball experiments for mismatch negativity responses and 
subject’s own name paradigms. All tests with the exclusion of BAEP and 30-
minute EEG were repeated 4 weeks later to see if there was any significant 
fluctuation of sleep, circadian rhythm, bedside clinical assessments, mismatch 
negativity and subject’s own names responses on neurophysiological tests. 
The same set of tests were repeated once more, during the last week of 
interventions, to evaluate the effect of interventions given on sleep, circadian 
rhythm and consciousness levels. Once the interventions stopped, further 
saliva melatonin measurements were performed 3 days later and 3 weeks 
later, to see if the effect of interventions on circadian rhythm was maintained. 
This chapter aims to give detailed information on the methods used in this 
research.   
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Figure 7-1: Study protocol 
7.1 BASELINE METHODS 
7.1.1 Setting and patients 
This study was conducted in rehabilitation and long-term care units of Royal 
Hospital for Neuro-disability (RHN), Putney, London. The rehabilitation unit 
admits patients with PDOC for a period of 3 to 6 months to provide specialist 
diagnostic assessments, disability management and rehabilitation. The long-
term care units of the hospital provide specialist nursing care for people with 
profound brain injuries. 
Patients are usually admitted to hospital’s neuro-rehabilitation unit from acute 
healthcare settings. During this admission, the patients may not be in a 
medically stable condition. They often require treatment for spasticity, 
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involuntary movements, dysautonomia and seizures; specialist investigations 
such as EEG, computerized tomography and/or magnetic resonance imaging 
of brain; and even surgical procedures such as cranioplasty and ventriculo-
peritoneal shunt insertion for treatment of hydrocephalus. Their feeding 
regimen is being optimized and if possible decannulation of tracheostomy is 
attempted using weaning protocols. Only once medical stability is achieved, 
patients undergo assessments of consciousness and the diagnosis is 
confirmed. The clinical care, assessments and rehabilitation are provided by 
multi-disciplinary teams led by consultant doctors in rehabilitation medicine. 
Following assessment and disability management at the neuro-rehabilitation 
unit, patients are usually discharged to specialist long term care settings which 
include specialist nursing home section of the RHN. The majority of patients in 
the specialist nursing home of RHN had been discharged from its neuro-
rehabilitation unit. While they are residents in the specialist nursing home their 
medical stability is maintained by specialist nursing care, medical care 
provided by general practitioners with input from neuro-rehabilitation 
consultants as well as, neurology, neuro-surgery and other specialists as 
required.  
In the specialist nursing home, the patients are given regular sensory stimuli 
which are provided in sensory rooms and are exposed to art and music therapy 
sessions as well as to regular social events. They are provided with 
maintenance level therapy input to maintain good posture and to prevent 
secondary complications such as development of contractures and pressure 
sores. Specialist nursing care of the patients with disorders of consciousness 
entails management of artificial feeding and hydration via enteric tubes; 
management of tracheostomies if present; postural management with use of 
specialist support equipment, regular re-positioning as well as bladder and 
bowels management. Patients are subject to further assessments if a change 
in their consciousness state is suspected.  
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The inclusion criteria were:  
- patients with diagnosis of VS or MCS made by expert clinicians using 
validated assessment tools with robust psychometrics such as SMART 
and CRS-R; 
- being medically stable,  
- predicted to remain in RHN for the duration of the study;  
- intact brain stem-auditory evoked potentials in at least one ear.  
Exclusion criteria for the study were:  
- uncertain diagnosis or diagnosis made without the use of validated 
assessment tools;  
- PDOC secondary to progressive neurological condition;  
- medical instability;  
- oral hypersensitivity; 
- very large skull defects;  
- BAEP indicating hearing impairment in both ears;  
- excessive involuntary movements or agitation;  
- due to be discharged from RHN and thus not likely to complete study 
- Baseline EEG showing frequent/ ongoing seizure activity of brain.  
In order to identify potential candidates for the study, case notes of all the 
patients with disorder of consciousness were screened for diagnostic 
information and predicted length of stay at the RHN. Following this, a second 
stage face to face screening was performed to identify patients with medical 
instability, oral hypersensitivity, excessive involuntary movements and large 
skull defects. Patients who fit the above criteria underwent BAEP and EEG. 
A total of 17 patients (7 female, aged 30-73) with PDOC (5 VS/ UWS, 12 MCS) 
were included in the baseline studies which aimed to investigate the state of 
circadian rhythms and sleep patterns in these patients. Eight of the 17 patients 
had suffered from anoxic brain injury. Other aetiological causes for the brain 
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injury included trauma (n=3), cerebrovascular accident (CVA) (n=3), mixed 
pathology (n=2) and vasculitis (n=1).  
12 of the 17 patients who were residents in the long-term care unit, and 
therefore likely to remain at RHN for the duration of the study, were included 
in the interventional study. Out of 12, one of the residents died due to newly 
diagnosed malignancy and another was excluded due to excessive movement 
artefacts observed on baseline EEG/ PSG data, which rendered neuro-
physiological tests unsatisfactory. 
Time since the brain injury varied between 6 months and 9 years. At the time 
of study all patients were medically stable and established medication regimes. 
Seven out of 17 patients were being fed during the day, and the remaining 
during evening/night hours. All patients required turning/ repositioning every 4-
6 hours to prevent pressure sores. Five of the patients were in a shared room 
where two or three other patients with PDOC also stayed. The remaining 12 
patients were in single rooms.  
7.1.2 Investigations to examine clinical status of patients  
Electronic and paper based clinical files were reviewed for all patients. 
Demographic variables (age and sex), cause of brain injury (e.g. traumatic, 
anoxic, subarachnoid haemorrhage, ischaemic stroke), time from brain injury 
to diagnostic assessment at the neuro-rehabilitation unit and the outcomes of 
the initial diagnostic assessments were recorded on Excel (Microsoft Office 
365, 2016). Significant clinical episodes, results of brain imaging studies, 
medications, feeding regime were documented.  
7.1.2.1  Coma Recovery Scale- Revised assessments 
All patients who were included in the study were re-assessed using CRS-R at 
the beginning of each investigations week by two clinicians who were 
experienced in clinical assessments of patients with disorders of 
consciousness for confirmation of diagnosis.  
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The re-assessments were undertaken in a quiet, well lit room while patients 
were in the sitting position. CRS-R was chosen as the method of assessment 
as it is a quick and reliable assessment tool for screening purposes. CRS-R 
includes all the modalities of the SMART assessment with the exclusion of the 
gustatory and olfactory sensory stimulation techniques.  
One of the investigators was not involved in the initial review of case notes and 
was blinded to the initial diagnosis of the patients. CRS-R scoring sheets were 
completed upon consensus of both clinicians on patients’ responses during 
the assessment. In a few occasions, where there was disagreement between 
the assessors on the responses elicited, the CRS-R scores were recorded for 
the lower assessment. For example, if one of the clinicians did not agree on 
the presence of a consistent movement to command, this was scored as “not 
present”.  
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Figure 7-2: Coma Recovery Scale-Revised Scoring Sheet 
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7.1.2.2 Brainstem auditory evoked potentials 
Brainstem Auditory Evoked Potentials (BAEP) are useful in assessing 
peripheral auditory nerve, auditory portion of cranial nerve VIII (CN VIII) and 
auditory pathways in the brainstem as they provide closely correlated 
information between specific auditory waveforms and structures in the brain 
stem (Daube and Rubin, 2009). They occur within the first 10 milliseconds of 
stimulus. Patients with severe brain injuries and PDOC may have had an 
additional injury to auditory pathways which might have been missed or not 
assessed at the acute stages of their illness. Therefore, prior to using any 
auditory event related potential investigations to detect signs of conscious 
information processing or any changes in the brain activities in reaction to 
given stimuli (simple tones, names etc.), it is important to make sure that 
auditory pathways are functionally intact at least on one side. Also, any hearing 
impairment may lead to false negative outcomes in clinical assessments as all 
structured assessment clinical tools use auditory stimuli to elicit responses. 
Therefore, we performed BAEP testing for our research participants at the start 
of study.  
To correctly interpret our BAEP results, and later on auditory stimuli ERP 
investigations results, a brief summary of how auditory pathways are 
structured and the BAEP waves are generated will be given here.  
The auditory system begins with the peripheral auditory apparatus, where the 
pressure changes from vibrations generated by sound waves are sensed by 
hair cells in the organ of corti (Blum and Rutkove, 2007). The hair cells then 
communicate with bipolar neurons of cochlea which then project to the 
pontomedullary junction via the auditory portion of CN VIII. Wave 1 of the 
BAEP is generated by the distal action potential of the CN VIII and seen as a 
negative potential at the ipsilateral ear electrode which appears about 1.5 
milliseconds after the stimulus. To reliably assess the central auditory 
conduction wave 1 needs to be present but will only be present ipsilaterally. 
The axons of cochlear nerve then enter the medulla and project to dorsal and 
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ventral cochlear nuclei where the Wave II of the BAEP is generated. After this 
point, the input from cochlear nuclei is transmitted to ipsilateral superior olivary 
nucleus where Wave III is produced, but also to the contralateral superior 
olivary complex. Therefore, superior olivary nuclei receive auditory inputs from 
both sides. Signals then projects proximally to lateral lemniscus (Wave IV), 
inferior colliculus (Wave V) and finally to medical geniculate nuclei of thalami 
and superior temporal gyri (Waves VI and VII).  
 
Figure 7-3: BAEP pathways 
 
Clinically absolute latency values and inter-wave intervals need to be 
evaluated and the normal values for these parameters are given in table 7-2. 
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Table 7-2: Brainstem auditory evoked potentials normal values (Chiappa, 1982, 
Chiappa, 1983, Misulis et al., 2007) 
                                            Male Female 
Wave I    2.10 ms  2.10 ms 
I-III 2.55 ms 2.40 ms 
III-V   2.35 ms 2.20 ms 
I-V     4.60 ms 4.45 ms 
V/I AMP    0.5 0.5 
I-V inter-ear    0.5 ms 0.5 ms 
The most common BAEP abnormality in patients with disorders of central 
nervous system is prolongation of I-V interpeak latency. Absence of all 
waveforms, decreased V/I amplitude ratio and preservation of wave-I with 
poorly formed II-V waves are also seen in central nervous system disorders 
(Daube and Rubin, 2009).  
It is important to note that the inputs from the both ears project to the central 
structures through superior olivary nucleus where the ipsi- and contra-lateral 
signals cross-over. Therefore, the pathways above superior olivary nuclei carry 
signals from both ears to lateral lemniscus, inferior colliculus, medial 
geniculate nucleus and finally to primary auditory cortex. Primary auditory 
cortex is in the transverse temporal gyri of Heschl in the superior temporal 
gyrus, where Brodmann Area 41 (primary area where auditory input received) 
and Area 42 (auditory association area) are located (see figure 7-4). Then, 
further connections are made to the secondary auditory areas to interpret 
auditory stimuli.  
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Another important information to note is that lateralization exists in the brain 
cortex. However, this does not mean that only one hemisphere participates in 
processing, but one side plays a more significant role than the other. For 
example, processing of speech mainly occurs in the left hemisphere and 
processing of musical and environmental stimuli in the right hemisphere as 
with other emotionally significant auditory stimuli.   
The BAEP was measured from each subject using Dantec KeyPoint 
EMG/NCS/EP system incorporating a 4-channel amplifier (Natus Medical Inc, 
USA). Stimuli were delivered monoaural stimulation of each ear via 
headphones. The stimulus frequency was 10Hz using alternating polarity 
clicks (condensation/ rarefaction). The hearing threshold could not be 
ascertained in our research participants as they were unable to communicate, 
so the assumption of sensory hearing level was determined at 10dB. The 
stimulus intensity was 80dB. The click stimulation was square wave pulse of 
duration 100µs. The epoch duration was 10msec. To obtain the BAEP 1500 
epochs were averaged. 
Peak latency measurements of I, III and V, amplitude measurements of waves 
I and V, and inter-peak interval calculations of I-III and III-V were performed.  
 
Figure 7-4: Brodmann areas 41 & 42 
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7.1.2.3 Baseline EEG 
Baseline EEG investigations were performed to assess electro-physiological 
features of brain and to exclude non-clinical status epilepticus.  
7.1.2.3.1 EEG data acquisition 
The EEG was recorded through the application of single use Ag/AgCl 
electrodes (Unimed Electrodes Ltd, UK) applied to the scalp in accordance 
with the 10-20 system of electrode placement (Klem et al., 1999). EEG 
electrodes applied were F4, F3, C4, C3, T4, T3, P4, P3, O2, O1, Fz, Cz, Pz, 
A2 and A1. EOG was recorded from electrodes positioned over the right and 
left outer canthi. Submental EMG was recorded from three electrodes applied 
(i) midline, 1cm above the inferior edge of the mandible, (ii) 2cm below the 
inferior edge of the mandible and 2cm to the right of the midline, (iii) 2cm below 
the inferior edge of the mandible and 2cm to the left of midline. Bipolar surface 
EMG was measured from a pair of electrodes applied to the right and left 
tibialis anterior muscles using a belly-tendon montage (Perotto, 1994). 
Figure 7-5: Dantec KeyPoint 4 Workstation 
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All electrode impedances were kept to below 5kΩ. Acquisition of the EEG 
signals was conducted with an EEG system incorporating a 50-channel 
amplifier, Desktop PC and integrated Digital Signal Processing board, with 
Neuroworks Acquisition Software (Natus Neuroworks version 7.1) installed 
onto a windows XP operating system (XLTEK, Optima Medical, Guilford, 
Surrey, UK).  The EEG signals were online acquired with the common average 
reference montage (Goldman, 1950), band pass filtered between 0.5-70Hz, 















Figure 7-7: EEG Electrode placement based on 10-20 system 
Figure 7-6: Xltek EEG Acquisition System 
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7.1.2.3.2 Artefact rejection 
Visual inspection of the EEG data was conducted using profile reader 
software. Any sections of recording contaminated by EMG (e.g. spontaneous 
movements, facial grimacing, yawning), ECG and eye blink artefacts, 
particularly affecting the electrodes of interest were identified. Sections of 
contaminated recording deemed irrecoverable were excluded. Recordings of 
suitable quality were exported in European Data Format (EDF) for further 
processing for artefact rejection, using independent component analysis (ICA) 
algorithms within the EEGLab toolbox (Delorme and Makeig, 2004). ICA 
algorithms enable the isolation of artificially generated EEG sources with the 
assumption that the EEG sources of non-cerebral origin will not be reliably 
phase locked. The automated version of the informax ICA algorithms, runica, 
was used as a MATLAB function from within the EEGLab toolbox. The 
decomposed ICA EEG data were visualised within EEGLab, and the sources 
representing artefactual contaminants of EMG and mains interference were 
excluded.   
7.1.2.3.3 Reporting and classification of EEG 
EEGs were reported by a Senior Clinical Neuro-physiologist (LJ) based on the 
recommendations of American Clinical Neurophysiology Society guidelines 
(Tatum et al., 2016). EEG reports included description of dominant and non-
dominant background electrocerebral activity including characteristics of 
waveforms, reactivity to external stimuli, degrees of symmetry, rhythmicity, 
amplitude, location, and any epileptiform discharges. Any significant/ 
unexpected abnormalities such as epileptiform activities were reported to the 
main researcher (KY) immediately who then liaised with the patient’s usual 
clinicians to initiate treatment and/ or dose adjustment of anti-epileptic 
medications. 
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Figure 7-8: Typical resting state EEG of patients with PDOC:  Characterized by diffuse 
polymorphic delta activity at 1.0-2.5Hz between 10-20µV (low amplitude record). 
 
7.1.2.4 Polysomnography/ Sleep studies 
24-hour polysomnography recordings were obtained from 15 out of 17 patients 
who participated in the baseline studies by the Senior Clinical Neuro-
physiologist (LJ). Recordings were started around midday, following 30- 
minute baseline EEG recording. Electrodes were taken out after a 24-hour 
PSG recording the next day. Patients were checked over for any skin reaction 
at each electrode site. 
7.1.2.4.1 PSG data acquisition 
PSG data was recorded using the standard physiologic parameters of 
Electroencephalography (EEG), Electrooculography (EOG), 
Electromyography (EMG) and Electrocardiography (ECG). Respiratory 
parameters of chest and abdominal movements were also recorded. 
The PSG EEG data was acquired via Ag/AgCl electrodes (Unimed electrodes 
Ltd, UK) applied in accordance with the 10-20 system of electrode placement. 
The electrode positions utilised were F4, F3, C4, C3, T4, T3, P4, P3, O2, O1, 
Fz, Cz, Pz, A2 and A1.  
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Figure 7-9: PSG Scalp electrode placement 
Measurement of EOG was achieved by applying electrodes over the right (1cm 
above) and left (1cm below) outer canthi (AASM, 2007). Submental surface 
EMG was also measured the same as described for the EEG recordings. 
Surface EMG taken from the right and left tibialis anterior in a belly-tendon 
montage. A lead I ECG was also applied. All electrode impedances were kept 
below 5kΩ. Respiratory effort was measured using inductive Plethysmography 
Effort Sensor (Sleep Sense SLP Inc, USA) by positioning the effort belt around 
the chest at the level of the zyphoid process.  
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Figure 7-10: PSG Electrode Placement 
The instrumentation used consisted of a Video-EEG monitoring system 
(XLTEK, Optima Medical, Guilford, UK) in conjunction the Trex HD ambulatory 
EEG headbox (XLTEK, Optima Medical, Guilford, UK) which incorporated 






Figure 7-11: Xltek Trex HD Ambulatory System Headbox 
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The sampling rate for acquisition of all signals was 256Hz.  Filter settings for 
the online acquisition of the EEG and ECG signals was 0.5-30Hz, sensitivity 
was 70uV/cm. The filter settings employed for EMG signals was 10-100Hz.  
Sensitivity settings for submental EMG was 20uV/cm and 100uV/cm for EMG 
taken from tibialis anterior. Respiratory effort filter settings and sensitivity 
settings were 0.5-30Hz and 0.5mV respectively. 
During the PSG recording nursing staff were asked to fill in activity log where 
any event which may have attributed to awakenings and/ or artefacts were 
recorded. Examples of such activities include, re-positioning in bed, giving 
medications, routine checks. 
Raw PSG data was loaded to computer using Xltek data transfer cable and 
made available for data analysis and reporting by our neuro-physiologist (LJ). 
7.1.2.4.2 Analysis of PSG data 
Sleep staging was done using visual inspection method adopted from AASM 
2007. We reviewed 8 channels of EEG over 30sec epochs, 3 channels of 
EMG, one channel ECG and one channel of EOG. Information obtained via 
nursing activity monitoring sheet were entered on PSG data. This helped us to 
identify influence of external events which are not in control of subjects on EEG 
data and sleep events. Sections of recording contaminated by EMG (e.g. 
spontaneous movements, facial grimacing, yawning), ECG and eye blink 
artefacts, particularly affecting the electrodes of interest were identified. 
Sections of contaminated recording deemed irrecoverable were excluded.  
Once the broad EEG patterns identified, detailed visual inspection and micro-
structure assessment of sleep recording were used to identify sleep stages 
independently by two experienced neurophysiologists who were blinded to the 
stage of the study that the patients were in at the time of the reporting.  
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The following criteria was established for sleep stage scoring in DOC patients 
based on the characteristics of baseline EEG features and criteria used in 
previously published work (Cologan, 2013).  
Table 7-3: Sleep staging criteria developed for DOC patients 
Sleep 
Stages 
EEG Characteristics in Normal 
individuals 
EEG characteristics in DOC 
patients 
Stage 1 Beginning of sleep, slow eye 
movements and overall 
muscle relaxation 
Absence of eye blinks as well 
as markers of other sleep 
stages 
Stage 2 Presence of spindles (12-15 
Hz, 10-50 μV, 0.5-2 s) and κ-
complexes 
Presence of “slow” spindles 
can be seen in the 6-9 Hz 
frequency range 
Stage 3/4 High amplitude (>75 μV) and 
slow frequency (0.5-2 Hz) 
activity dominating ≥20% of 
the 30-s epoch 
Proportion of delta activity 
>20% of ongoing record with 
higher amplitudes, lack of 
muscle artefacts and eye 
blinks, -/+ rolling of eyes 
REM Muscular atonia, lack of 
spindles and slow wave sleep, 
presence of rapid eye 
movements, predominant 
theta rhythm 
Muscular atonia, lack of 
spindles and presence of rapid 
eye movements 
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Figure 7-12: Stage 1 sleep. Characterized by absence of eye blinks as well as markers 
of other sleep stages 
Figure 7-13: Slow spindles seen in PSG of a patient in minimally conscious state 
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Figure 7-14: REM: Identified by muscular atonia, lack of spindles and presence of roving 
rapid eye movements 
 
7.1.2.4.3 Evaluation of sleep using sleep parameters 
The following sleep parameters were computed in order to be used for 
evaluating sleep both quantitatively and qualitatively (Pressman, 2000):  
1. Study Duration: This represents the total recording time which the 
amount of time that the recording equipment remains activated. This is 
the time between the “First Lights off Time” and “Last Lights on time” as 
recorded by the neuro-physiologist. 
2. Total Sleep Time: Total Sleep Time is the total amount of sleep time 
scored during the study. This is computed by adding Sleep Stage 1 + 
Stage 2 + Stage 3&4 + REM sleep. Low total sleep time is usually 
indicative of nonrestorative sleep and may contribute to daytime 
sleepiness. 
3. Sleep Efficiency: Sleep efficiency represents the percentage of total 
sleep time actually spent in sleep. This is typically computed by (Total 
sleep time/ Time in bed) X 100. It gives an overall sense of how the 
patient slept but makes no distinction between frequent, brief periods of 
awakenings from long periods of awakenings. Therefore, it needs to be 
evaluated with other sleep parameters in order to get a better picture of 
sleep quality.  
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4. Total wake time: This is the amount of wake time during the study. It is 
computed from the total of all epochs scored as wake using the sleep 
scoring criteria employed.  
5. Sleep latency: This is the time in minutes from lights out to sleep stage 
1.  
6. Number of awakenings/ arousals: These are the events scored during 
any stage of sleep if there is an abrupt shift of EEG frequency including 
alpha, theta, and/or frequencies > 16 Hz (but not spindles) that lasts at 
least 3 seconds, with at least 10 seconds of stable sleep preceding the 
change. 
Table 7-4: Example of sleep parameters computed for one of the participants 
Sleep Statistics 
Study Date:  aa/bb/cccc Study Duration:  1717.2 
Study ID:  XXX First Lights Off Time:  12:06:52 PM 
Time in Bed:  1644.8 Last Lights On Time:  03:31:41 PM 
Total Sleep Time:  69.5 Sleep Efficiency:  4.2% 
Sleep Onset: 10:08:54 PM Total Awakenings:  7 Index: 6.0 
Sleep Latency:  602.0 REM Onset:  Not detected 
REM Latency: N/A Final Wake Onset: 04:56:54 AM 
Final Wake Latency: 408.0  AHI: N/A 
PLM Index: 0.0 Minimum OSat: <1% 
Average OSat: Not measured WASO: 338.5 
Number of Epochs: 3331 Unscored Epochs: - 
Sleep efficiency, time spent and % sleep time in identified sleep stages (stages 
1, 2, 3/ 4, REM) were also reported. 
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Table 7-5: Sample sleep stage distribution for one of the research participants. 
Stages Time % Sleep Time %  
Time in Bed 
% Sleep Period 
Time 
WAKE 1576.0 - 95.8% 82.9% 
Stage 1 67.0 96.4% 4.1% 16.4% 
Stage 2 2.5 3.6% 0.2% 0.6% 
Stage 3 0.0 0.0% 0.0% 0.0% 
Stage 4 0.0 0.0% 0.0% 0.0% 
REM 0.0 0.0% 0.0% 0.0% 
MT (movement 
time) 
0.0 0.0% 0.0% 0.0% 
UNS 0.0 - 0.0% 0.0% 
NREM (1+2+3+4) 69.5 100.0% 4.2% 17.0% 
 
7.1.3 Assessment of circadian rhythm 
7.1.3.1 Melatonin as a marker of circadian rhythmicity 
Saliva melatonin samples were collected using Salimetrics paediatric oral 
swabs (Salimetrics, USA) over 48 hours during. The samples were collected 
every 4 hours with a shift of 2 hours on collection times in the second half. 
 
 
After collection, the samples were frozen and later shipped for melatonin levels 
measurement using radioimmunoassay analysis at the laboratories of 
Stockgrand Ltd. The assay characteristics were as follows: limit of detection = 
Figure 7-15: Saliva melatonin collection protocol.  
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0.9 pg/ml, quality controls low = 3.6 pg/ml +/- 0.4 CV = 10.7%; medium = 26.1 
pg/ml +/- 2.3 CV = 8.9%; High = 54.6 pg/ml +/- 4.9 CV = 9.0%. 
7.1.3.2 Body temperature as a measure of circadian rhythmicity 
Ibuttons were previously used to obtain continuous skin temperature 
measurements from patients in vegetative state (Bekinschtein et al., 2009b). 
In our study, we have attached DS1921H High resolution Thermochrone 
ibuttons (Maxim Integrated, USA) to chest wall using hypafix surgical tape for 
72 hours. Ibuttons were set to record temperature every 30 seconds.  
7.2 INTERVENTIONAL STUDY 
7.2.1 Study design 
For the 10 patients who proceeded to the interventional study, EEG, BAEP, 
CRS-R, PSG, saliva melatonin and body temperature measurements were 
already performed at baseline. In addition to this, event related potential 
studies were performed using MMN and Subject’s Own Name (SON) 
paradigms within the same week. All investigations were repeated four weeks 
later in order to detect any fluctuation that may occur without any intervention. 
This was followed by five-week period of interventions which were consisted 
of melatonin in the evening, blue light treatment and caffeine in the morning. 
On the fifth week of intervention period all investigations were repeated once 
more to detect and improvement of consciousness/ brain functions.  
During the intervention, 8am and 8pm saliva samples were collected to confirm 
presence of high and low saliva melatonin levels. A 24-hour saliva collection 
were performed 3 days after cessation of intervention to find out whether the 
circadian rhythm of melatonin secretion was entrained and once again two to 
three weeks after to see if this was maintained or not. Total number of saliva 
melatonin samples collected from each patient was 38 (12 at baseline-1, 12 at 
baseline-2, 2 during interventions, 6 three days after the interventions and 6 
three weeks after the interventions). See Figure 7-16: Saliva collection time 
points throughout the study. 
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Figure 7-16: Saliva collection time points throughout the study 
 
7.2.2 EEG, BAEP, CRS-R, PSG, Melatonin and Body 
Temperature Measurements 
These investigations were performed as explained in the section 7.1. 
7.2.3 Event related potentials (MMN and SON paradigms) 
7.2.3.1 Data acquisition  
All experiments were performed while patients were sitting in their own 
wheelchair in a quiet room. EEG activity was recorded using 64-channel EEG 
amplifier (ANT-Neuro, Netherlands) and shielded Waveguard EEG cap. To 
optimize signal quality, the impedance at electrodes was kept below 5 kΩ. 
Sampling rate was 1024 Hz and two of the electrodes were used to record 
electro-oculogram (EOG).  
Two experiments were used to obtain event related potential component 
mismatch negativity: standard frequency oddball paradigm and ‘subject’s own 
name’ paradigm. Patients were provided with 5-10 minutes rest time between 
the experiments.  
During the MMN paradigm the patients were presented with 1000 repetitions 
of two types of pure tone delivered binaurally through headphones at an 
intensity of 70dB. The standard tone was set at 1000Hz (80%) and the oddball 
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or deviant at 1200Hz (20%). The duration for each stimulus was 60ms (rise 
time 10ms) with an inter-stimulus interval of 500ms.  
In the subject’s own name paradigm, three different types of stimuli were 
used:1) subject’s own name; 2) four examples of other peoples’ names; and, 
3) four examples of time reversed names. Other names were chosen from a 
pool of spoken names that were not deemed significant to patients by their 
relatives. Some of the other name stimuli were time reversed to create 
unintelligible stimuli which preserve their acoustic complexity and some voice 
identity. The names were recorded by a native English speaker male person 
unknown to them and edited for quality and length (range 400-800ms), time-
reversed and amplified using Praat software version 5.3.23 (Boersma, 2012).  
Inter-stimulus interval was 1200ms. The stimuli were delivered binaurally via 
headphones.  
7.2.3.2 Pre-processing of data on SPM 12 
ERP data pre-processing was performed offline using Statistical Parametric 
Mapping (SPM12, Institute of Neurology, UCL) software. The following steps 
took place in the pre-processing of EEG data as outlined in the SPM 12 manual 
(published by Functional Imaging Laboratory Group, UCL, 2013); 
1. Conversion of EEG Data 
This is the first step of the analysis where native machine-dependant 
format EEG data is converted to a MATLAB based, common SPM 
format. The conversion of native EEG data produces two SPM files: 
*mat file which contains data structure and *dat file which contains the 
EEG data. 
2. Preparation of the data and batch inputs 
This step involves review of the trials, selecting subset channels (EEG, 
EOG) which produces ‘channelselection.mat file. 
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Trial definition was performed by specifying the time window (in ms) to 
be cut around triggers and the number of conditions. The conditions are 
then labelled such as “standard” or “rare”.  
Montaging stage allows one to specify custom montages. A simple way 
to specify some common montages is via ‘re-reference’ option. In our 
pre-processing re-referencing was done by selecting all channels. This 
step produces ‘…avref.mat’ file (average referenced file) batch input 
file. Following the montaging spm produces two files 
Mspmeeg_subject.mat and Mspmeeg_subject.dat files. 
3. The next step is to derive the EOG channels by using the previously 
saved ’avref.mat’ file. At this step he HEOG channel is defined as the 
difference of EXG1 and EXG2 and VEOG as the difference of EXG2 
and EXG3. Then, the montaged is saved as ’avref_eog.mat’ file.  
4. Epoching the data (=spm_eeg_epochs) 
Epoching cuts out little chunks of continuous data and saves them as 
single trials. This step involves defining trials by defining the time 
window in peri-stimulus time, specifying the triggers and labelling the 
conditions. Peristimulus time window of -100ms to 400ms was used for 
our data. This step produces a trialdef.mat batch input file. 
5. Filtering the data  
Continuous or epoched data can be filtered, over time with a low-, high-, 
stop-, or bandpass- filter. High-pass filter removes ultra-low frequencies 
close to DC, and a low-pass filter removes the high frequencies. SPM 
uses Butterworth filter to do this. In our pre-processing we used ‘high-
pass’ with 0.5 as cut-off frequency and ‘low-pass’ with 20 cut-off 
frequency. The resulting filtered data is saved as 
fMspmeeg_subject_mat and fMspmeeg_subject_dat files. 
6. Baseline correction 
This step subtracts the baseline from channel data where baseline 
period is set e.g. [-100 to 0 ms] 
7. Down-sampling (spm_eeg_downsample) 
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This step is performed when data is acquired at a higher sampling rate 
(in our study this was 1024 Hz) than one needs for making inferences 
about low-frequency components. We chose sampling rate of 200 Hz 
at this stage. This step produces dfMspmeeg_subject.mat and 
dfMspmeeg_subject.dat files. 
8. Filtering 
In our pre-processing we used ‘low-pass’ with 20 cut-off frequency. This 
step produces fdfMspmeeg_subject.mat and fdfMspmeeg_subject.dat 
files. 
9. BERG correction of eye artefacts (In this method an accurate, head 
model-independent estimate of the spatial distribution of eye activity is 
obtained from calibration data containing systematic eye movements 
and blinks. Using the resulting spatial vectors together with the brain 
model, eye activity in EEG and event-related response data are 
estimated in the presence of overlapping brain activity and corrected.) 
(Berg and Scherg, 1994). 
10. Epoching 
Previously produced trial definition file is used to epoch the data. The 
epoched data is then saves to files efdfMspmeeg_subject.mat and 
efdfMspmeeg_subject.dat files. 
11. Artefact detection and rejection 
In our pre-processing we used 80 µV threshold value was used to detect 
and reject artefacts. This step creates aefdfMspmeeg_subject.mat and 
aefdfMspmeeg_subject.dat files. 
12. Averaging (spm_eeg_average) 
Averaging of single trial data is a crucial step to obtain evoked (or 
induced) response. When averaging single trial data, single trials are 
averaged within condition. Robust averaging of data estimates weights, 
lying between 0 and 1, that indicate how artefactual a particular sample 
in a trial is. Later, when averaging to produce evoked responses, each 
sample is weighted by this number. Robust averaging is useful for 
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finding out what parts of the data were down-weighted and adjusting 
parameters if necessary. In our pre-processing, we used robust 
averaging by computing weights by condition as we had unequal 
number of trials for each condition. Following the robust averaging 
maefdfMspmeeg_subject.mat file is saved.  
The 12 steps described above completes the pre-processing stage. 
Following the pre-processing, 3D images were created for each trial, 
containing smoothed recorded potentials in scalp space (two dimensions, X 
and Y in mm) over peri-stimulus time in ms (z dimension). 
7.2.4 Intervention techniques 
Interventions included melatonin treatment in the evenings, blue light and 
caffeine treatments in the mornings in order to optimize circadian rhythmicity. 
 
Figure 7-17: Intervention techniques used in the study 
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7.2.4.1 Melatonin treatment 
Melatonin is normally given 1-2 hours before usual bedtime, between 8 and 
10pm. The patients with PDOC typically have poor sitting tolerance and 
therefore need to be put in bed before 6pm in the afternoon. Evening dose of 
their prescribed medications given between 6 and 8 pm and they may have 
visitors until 8pm. The main lights in their rooms are turned off after 8pm. 
Therefore, in order to synchronize to the environmental cues and light-dark 
cycle of their environment, melatonin administration time was set as 6pm in 
the evenings.  
In our study liquid 3 mg Melatonin (1mg/ml) was given via percutaneous 
enteral gastrostomy (PEG) tube at 6pm each night by nursing staff during their 
medication rounds.  
During the interventions once only 8am and 8pm saliva melatonin 
measurements were performed to confirm presence of raised melatonin levels 
following administration and absorption of melatonin at 6pm; and decreasing 
levels of saliva melatonin at 6am, following its overnight metabolism.  
7.2.4.2 Blue-light therapy 
We used Philips Energy Light lamps (HF3308) to provide blue light treatment 
in the mornings. According to the manufacturer, these lamps mimic natural 
daylight by giving up to 10,000 lux at 20 cm and 2500 lux at 60 cm distance. 
Prior to use in the study the lamps were tested in the laboratories of Health 
Protection Agency and it was reported back that luminance values place no 
restriction on use of lamps for therapy, up to 2 hours per day at distances of 
20 cm or greater. At the bedside of patients, Tecpel 536 light meter/ RS232 
data logger was used to measure illuminance levels in patients’ eye level within 
one-meter distance which yielded illuminance levels between 1500 and 2500 
lux. 
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Lamps were placed in close proximity to patients in their rooms. Average 
distance from patients’ eye level to lamp was 60 cm. It was not possible to 
place the lamps closer than 50 cm due to width of the hospital beds and 
equipment/ furniture around the beds. Lamps were automatically controlled 
using a timer electrical plug in order to maintain consistency of treatment. The 
on time was set to 08:00 and off time to 09:00 every day. Earlier on time was 
avoided to prevent night nursing staffs’ exposure to bright light at the end of 
their shifts. Day nursing staff were instructed to turn the patients towards the 
lamps at 08:00 hours and to make sure patients remained faced towards the 
light during the treatment.  
7.2.4.3 Caffeine 
We aimed to administer caffeine 100 mg twice a day (at 08:00 and 12:00 
hours) as part of our intervention due to its stimulant and circadian rhythm 
effects. However, there is no licenced caffeine in the UK as a single agent. It 
is often added to analgesics to improve their efficacy.  
ProPlus Caffeine tablets (Bayer plc.) are sold over the counter in high street 
shops for temporary relief of tiredness and to maintain mental alertness. It is 
commonly used by students. Each ProPlus tablet contains 50mg of caffeine 
which is equivalent to caffeine content of 100 mls instant coffee or regular tea. 
Maximum recommended caffeine intake per day is 400 mg regardless of the 
source.  
Caffeine was introduced in gradual manner as PDOC patients are not given 
any caffeine containing feed or fluids normally. Initially 50mg Caffeine was 
given at 8am for three days, then increased to 50mg at 8am and midday for 
three days, then 100mg at 8am for three days, and finally 100mg twice a day 
which was the dose given for the rest of the intervention period.  
Pro-plus tablets were crushed and dissolved according to usual nursing 
practice of giving tablets via feeding tube and after administration the tubes 
were flashed with water to avoid tube blockage.  
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7.2.5 Post-intervention investigations 
On the fifth week of the interventions all clinical and neuro-physiological 
investigations (CRS-R, saliva melatonin, body temperature, PSG, ERPs) were 
repeated in order to assess effect of interventions on sleep, behavioural and 
neurophysiological indicators of awareness/ consciousness.  
Three days after the cessation of interventions 4-hourly saliva melatonin 
samples were collected for 24 hours and once again three weeks after. The 
aim of these two further collections was to see if the circadian rhythmicity was 
improved and maintained.  
7.3 STATISTICAL ANALYSIS 
Descriptive statistical tests, means comparisons, ANOVA tests and reliability 
analyses were performed using SPSS software (IBM Corp. Released 2016. 
IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY).  
7.3.1 Analysis of saliva melatonin data 
7.3.1.1 Summary statistics 
Raw melatonin data were normalized to the mean. 
The following were performed prior to applying detailed statistical tests: 
1. Normalized saliva melatonin data was plotted as a function of time  
- to explore whether an obvious rhythmicity could be recognized or not;  
- to make macroscopic/ qualitative analysis of noise;  
- to see if there is cycle-to-cycle variability or not 
2. Examination of maximum (peak) melatonin values to see if maximum 
values reached around 02:00-03:00 h as a response to dark and 
minimum values reached between 14:00-15:00 h 
3. Means comparison between diurnal (08:00-20:00h) and nocturnal 
(20:00-08:00h) values 
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7.3.1.2  Cosinor analysis 
Raw saliva melatonin results were normalized to mean melatonin values and 
further analysed using single cosinor analysis software which was provided by 
Stockgrand UK laboratories. The software is an Excel based program where 
from values of circadian rhythm markers mesor, amplitude, acrophase and % 
rhythms are computed. Amplitude and acrophase 95% confidence limits and 
p-values are calculated. P-values < 0.05 are deemed to be statistically 
significant.  
Cosinor Analysis is based on linear least squares regression model that is 
used to fit a sinusoidal curve to time-series data (Nelson et al., 1979). It 
involves representing the data span by best-fitting cosine function and is 
performed using the formula below (Muñoz-Hoyos et al., 1993): 
Yi= M + A cos (wt + φ) 
 
Y is the mean of the function at time i 
M is the mesor (the mean level of the cosine curve) 
A is the amplitude of the curve 
w is the angular frequency of the curve 
t is the time when point i was measured 
φ is the acrophase (phase angle of the maximum values of the curve/ 
calculated peak time) 
 
Parameters of the rhythm (mesor, amplitude, and acrophase) can be 
calculated from this equation. In other words  cosinor analysis reduces the time 
series to three independent variables per subject: amplitude (level of melatonin 
in the blood at its peak in the 24-h cycle), acrophase (the time the peak occurs), 
and mesor (the mean level over the period)(Gibertini et al., 1999). 
Percentage rhythm is the measure of the relative strength of a rhythm and is 
calculated by making direct comparison between the variability of the data 
points about the fitted curve. (Minors and Waterhouse, 1988) . 
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The percentage rhythm is calculated as:  
Percentage rhythm= 100 X (Total Sum of Squares-Residual Sum of 
Squares)/Total Sum of Squares 
In a perfect fit percentage rhythm is 100%. In a healthy person, this is expected 
to be around 90%. 
T-test statistics were performed for pre- and post-intervention % rhythmicity 
values in order to investigate the effect of interventions on melatonin circadian 
rhythmicity. 
 
Figure 7-18: Definition of rhythm characteristics. The MESOR is a rhythm-adjusted 
mean; the double amplitude (2A) is a measure of the extent of predictable change within 
a cycle; the acrophase is a measure of the timing of overall high values recurring in 
each cycle, expressed in (negative) degrees in relation to a reference time set to 0°, with 
360° equated to the period; and the period is the duration of one cycle. (modified from 
Cornelissen Theoretical Biology and Medical Modelling 2014, 11:16) 
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Figure 7-19: Cosinor analysis results output 
 
7.3.2 Analysis of body temperature data 
Body temperature data obtained via I-Button data loggers was transferred to a 
laptop PC using the connection kit supplied by the manufactured and data was 
initially reviewed on 1-wire software (Maxim Integrated, USA) and then 
analysed on Excel 2013 (Microsoft, USA). Summary statistics and cosinor 
analysis were performed as described above. T-test statistics were performed 
for pre- and post-intervention % rhythmicity values in order to investigate the 
effect of interventions on body temperature circadian rhythmicity. 
7.3.3 Statistical analysis of PSG data 
For the patients who were included in the interventional study General Linear 
Model ANOVA tests were performed to see if the data differed at three time 
points (baseline 1, baseline 2 and post-intervention) and pairwise comparisons 
were made. If the baseline 1 and 2 data were not significant at 0.05 level 
(CI=95%), these were collapsed together and means comparisons were made 
against post-intervention data. 
As the PSGs were reported by two neurophysiologists who were blinded to 
each other, the PSG data obtained two-way mixed intra-class correlations 
(raters are chosen and subjects are random) were performed to assess inter-
rater reliability. If the absolute agreement was at and above acceptable level 
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(>0.7, CI=95%), the data from both raters were collapsed together and t-test 
comparisons were made between pre-intervention and post-intervention 
results.  
7.3.4 Analysis of ERP data 
ERP data analysis was performed offline using Statistical Parametric Mapping 
(SPM12, Institute of Neurology, UCL) software. Following data pre-processing, 
3D images were created for each trial, containing smoothed recorded 
potentials in scalp space (two dimensions, X and Y) over peri-stimulus time (z 
dimension). 
We searched across the whole of scalp space but, limited the analysis to a 
fixed time window of interest 150-500 ms post-stimulus (by applying a small 
volume correction). After this mask was applied to the SPM we report voxels 
that survived a peak level value of p< 0.001 uncorrected.  
Contrasts for each subject were created at the first level that were then taken 
up to the second level design matrix. Second level design matrix contrasts 
were defined to examine statistical differences between the responses before 
and after the intervention using -1 1 contrast for the oddball experiments, and 
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Table 7-6: Contrasts applied for oddball and subject’s own name experiments at the 1st 
level design matrices. (SON= Subject’s own name) 
ERP 
Test 
Timepoints that the 
contrasts applied 
1st level individual design matrix 
for 3 time-points 
Oddball 
Baseline experiments -1 1 -1 1 0 0 
Post-intervention 
experiments 








0 0 0 0 0 0 1 -1 0 
 
In order to extract the MMN values after the intervention, we went to the 
individual subjects’ 1st level design matrix and searched for the peak MMN 
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Chapter 8 RESULTS 
This chapter aims to present the study results. The first section of the chapter 
will give the results of baseline investigations which provided insight into the 
sleep and circadian rhythms of our 17 participants with PDOC. This will be 
followed by the results of the interventional study which 10 patients received 
melatonin, blue light and caffeine with the aim of optimizing sleep and circadian 
rhythmicity.  
8.1 BASELINE RESULTS 
CRS-R, BAEP, EEG, PSG, saliva melatonin and body temperatures were 
performed as baseline investigations. 17 patients were enrolled in baseline 
assessments. Although we aimed to perform all tests for all patients, this was 
not possible due to missed appointments and occasions due to the practical 
difficulties performing the tests on this very severely disabled patient 
population. 
Detailed demographic and clinical information which include outcomes of 
baseline BAEP and EEG investigations are summarized in Table 8-3. 
Medications that act on the central nervous system or known to cause 
drowsiness as a side effect are shown in bold and medications that may reduce 
melatonin levels and/ or production are shown in italic. None of the patients 
suffered from liver disease which may reduce melatonin metabolism.  
8.1.1 Investigations to examine clinical status of patients 
8.1.1.1 Coma Recovery Scale-Revised assessments 
Patients’ initial diagnoses were recorded based on the outcomes of multi-
disciplinary team assessments using standardized clinical assessment tools 
(SMART, WHIM, CRS-R, MATADOC) upon their admission to the Royal 
Hospital for Neuro-disability. All patients who were long term care (LTC) 
residents in the specialist nursing home were re-assessed using CRS-Revised 
and their diagnosis were updated when applicable.  
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All clinical and demographic data are presented in table 8.2. The average 
CRS-R score value for our cohort of patients was 10.2. The number of patients 
with CRS-R≤10 (VS/ UWS and low MCS) was 8.  
Three patients (patient 1, 6 and 8) were found to have had significant 
improvement of their consciousness and change of diagnosis- from VS to 
MCS, since their initial diagnostic assessments, over 3 to 5 years (Table 8.1). 
Table 8-1: Diagnosis change in three patients 





































8.1.1.2 BAEP test results 
We were able to obtain BAEP testing in 13 patients (one study difficult/ 
inconclusive, three not done due to missed appointments). While, seven out of 
13 patients had completely normal results, the remaining six patients had 
some abnormality in their BAEP results. None of the patients had severe 
hearing impairment affecting both sides. 
In all the six patients with abnormality of BAEP, the abnormalities were mainly 
localized to the right ear confirming additional brainstem pathology in addition 
to their known widespread central nervous system disease (see table 8-2). 
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Three of our interventional study participants (patient 2, 4 and 9), had absent 
wave 1 on right side. 
Table 8-2: Observed BAEP abnormalities in six patients 
Patient ID Cause of Brain Injury BAEP Abnormality 
Patient 2 Anoxia Right BAEP absent 
Patient 4 CVA (bleed) Right BAEP absent 
Patient 6 CVA (bleed) Right BAEP wave latencies 
delayed, waves poorly 
formed bilaterally 
Patient 9 Vasculitis Right BAEP absent 
Patient 12 Anoxia Right BAEP absent 
Patient 14 CVA (bleed) Right BAEP wave latencies 
delayed 
 
8.1.1.3 Baseline EEG results 
Baseline EEG outcomes were available on 16 patients. One patient had 
severe involuntary movements which resulted in very poor-quality EEG. All our 
patients who had baseline EEG had abnormal baseline EEG’s: poorly 
responsive, low amplitude EEG with theta and delta waveforms dominance. 
One of our patients had copious amounts of beta activity on her EEG which 
was explained by prescribed benzodiazepine medications.  
Many prognostic classifications of EEGs are based on the dominant waves 
(Synek, 1988, Young et al., 1997, Hockaday et al., 1965). Polymorphic delta 
dominance suggests a disruption of cerebral function. Therefore, it can be 
concluded that the slower the frequency, the more severe the abnormality 
especially when the reactivity/ responsiveness is also diminished. Although, 
such EEGs are expected in PDOC population dominant theta and delta waves 
pose an additional challenge when reporting stages 3/ 4 of the sleep EEGs 
which will be explored further in PSG sections of the thesis.  
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In addition, three patients with anoxic brain injury had frequent sharp waves/ 
spikes with no associated clinical seizure/ myoclonic activity. There has been 
a long-standing discussion whether the patients with sharp waves/ spikes 
require anti-epileptic treatment or not. While some clinicians favour treatment, 
others argue that these waves are due to nonepileptic encephalopathies and 
treatment with anti-convulsant is not indicated and may cause side effects. In 
our study, two patients with sharp waves/ spikes were already on clonazepam 
(patient 3 and 11) and the third patient (patient-2) was on triple anti-epileptics: 
clonazepam, valproate and levetiracetam. Both patient-3 and patient-11 had 
history of troublesome myoclonic jerks and patient-2 had history of myoclonic 
jerks as well as tonic-clonic seizures. As there was no correlation of EEG 
features with clinical presentation, we did not make a recommendation to alter 
these patients’ anti-epileptic treatment regime.  








Table 8-3: Patient demographic and clinical information  
(F=female, M=male, BI= Brain injury, CVA= cerebrovascular accident, TBI= traumatic brain injury, SAH= subarachnoid haemorrhage, VP shunt= ventriculo-
peritoneal shunt, R= right, L= left, AVM= arteriovenous malformation, LTC= Long-term care, BL= baseline, Dx= diagnosis,  Tx=treatment, BAEP= brainstem 
auditory evoked potentials, α= alpha, β= beta, δ= delta, θ= theta) Note: The medications with sedating side effects are written in bold, and the one that 


















BL and Tx 5 years Daytime Co-careldopa, Levetiracetam, 
Lansoprazole 
Extensive white matter low 
attenuation, atrophy, R 
frontal bleed, L occipital 
infarct, VP shunt 
Normal Polymorphic δ at 2-
2.5 Hz at 20-30 µV 
with occasional β 
PT2/ 58/ 
M/ LTC 
Anoxia  MCS / 
8 





changes, loss of grey-
white matter differentiation 
in cortex and basal 
ganglia 
R absent,  
L present 
Polymorphic δ activity 
at 1-2.5 Hz at 10-20 










Normal frequent spike wave 







BL and Tx 4 years 16:00-04:00 Baclofen, Dantrolene, 
Gabapentin, Valproate, 
Lansoprazole 
R temporal AVM, 
intracerebral and subdural 
haemorrhage 
R absent,  
L present 
Asymmetric EEG, R: 
low amplitude 











Normal Dominant δ activity at 
1.5-2.0Hz, up to 





BL and Tx 3 years 18:00-02:00 Amlodipine, doxazocin, 
levetiracetam, oxybutinine, 
simvastatin 
L temporoparietal stroke & 
haemorrhage 
R delayed,  
L Normal 
Asymmetric EEG, 
dominant δ and θ 
activity on the right 












BL and Tx 8 years 16:00-02:00 Bisoprolol, clopidogrel, 
gabapentin, warfarin 
Bilateral ganglia infarcts, 
and infarction in the L 
occipital lobe 














Vasculitis VS/ 6 BL and Tx 2 years 16:00-04:00 Bisoprolol, pregabalin Widespread necrotising 
leucoencephalopathy 
R absent,  
L present 














Extensive diffuse signal 
change in the L temporal 
and occipital lobes and 
parietal cortices consistent 
with ischaemia 
Normal Copious amounts of β 





Anoxia VS/ 5 BL only 6 months 10:00-24:00 Clonazepam, baclofen, 
hyoscine patch, Dantrolene 
Diffuse hyperintense 
signal at bilateral 
periventricular and deep 
white matters, basal 
ganglia and occipital gyri. 
N/A Poorly responsive 
EEG, frequent 
spikes, diffuse 










8 years Daytime Lansoprazole, Tizanidine, 
laxatives 
Global cerebral infarction 
and ischemia 
R absent,  
L normal 





Anoxia VS/ 7 BL only 9 months Daytime Baclofen, Warfarin, 
Dantrolene, Levetiracetam, 
Clonazepam 
Global hypoxic brain injury N/A θ activity at 5-6Hz, 
Occasional δ at 1.0-
2.0Hz, Widespread β 








BL only 9 months 16:00-04:00 Folic acid, Lansoprazole, 
Levetiracetam, Bisoprolol, 
Thiamine, Amlodipine, 





R delayed,  
L absent 
diffuse δ activity at 
1.5-2.0Hz, θ activity 
















posterior δ  

































Normal β activity at 15-16Hz 
over both 
hemispheres. 
Occasional θ and α 
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8.1.2 Polysomnographic study results 
One patient was excluded from PSG studies due to identification of frequent 
seizures on EEG and another due to worsening of involuntary movements. 
Therefore, 15 patients (7 female, 8 male), aged between 30 and 73 years, had 
24-hour polysomnography. Seven of the 15 patients had suffered from anoxic 
brain injury which led to prolonged disorders of consciousness. Other 
aetiological causes for the brain injury included trauma (n=2), haemorrhagic 
stroke (n=4), ischaemic stroke (n=1), and central nervous system inflammatory 
disease/ vasculitis (Steven- Johnson Syndrome) (n=1).  
A healthy adult with good sleep is expected to have sleep efficiency of 95%, to  
have few and brief nocturnal awakenings only (Hirshkowitz, 2004).  
Recommended total sleep time is 7 to 9 hours (Hirshkowitz et al., 2015). In 
adults, approximately 5% of the total sleep time is spent in stage 1, 50% in 
stage 2, 20% in stage 3 and stage 4, and the remaining 20% in REM 
(Pressman, 2000, Silber et al., 2007). 
Basic review of hypnograms revealed that all patients had abnormal sleep 
patterns with one of the following conditions:  
a) increased sleep activity during daytime with wakefulness at night (6/15),  
b) increased sleep activity in both day and night time (2/15),  
c) reduced sleep activity in both day and night time (5/15)  
d) short sleep mostly at night (2/15).  
Total recording time for the PSGs varied between 1247 and 1855 minutes. 
Therefore, Total Sleep Time (TST) and Sleep Efficiency (S.Eff.) values were 
normalized to 24-hour period. TST was reduced in all patients (Range:34-
518mins, Mean:246 mins, SD:146.4) in comparison to recommended 7 to 9 
hours of sleep for adults.  
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Two patients with traumatic brain injury had the least sleep efficiency (<%5) 
with 69.5 and 37.5 mins of sleep during PSG recording of 24 hours. Two 
patients with the most total sleep time and sleep efficiency however, had either 
increased sleep activity during day time and night time or increased sleep 
activity during day time. Both of these patients suffered from anoxic brain injury 
and had diagnosis of vegetative state (See Figure 8.1 for hypnograms of the 
patients with longest TST, and figure 8.2 for graphical representation of total 












Figure 8-1: Hypnograms of two patients with highest sleep time and efficiency 
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Figure 8-2: Graphical representation of total sleep time in relation to CRS-R scores 
 
In our study, baseline sleep efficiency was very low (Mean= 18.1%, SD=8.45) 
and sleep was fragmented in all patients’ PSGs with the number of 
spontaneous awakenings varying between 6 and 56 within a 24-hour period 
(Mean=16.5, SD= 10.8). None of the baseline PSGs contained sleep 3,4 
stages and only 4 out of 15 patients, albeit very short, REM sleep (Table 8.4 







































Table 8-4: PSG findings of patients with PDOC. Total Sleep Time and Sleep Efficiency are normalized to 24-hour period. (Please note; 
in the table below, stage % may not add up to %100 due to movement time and presence of epochs that were not scorable) 
Patient ID Diagnosis PSG Study 
Duration      
(mins) 
Total Sleep 
Time         





Stage 1 (% 
sleep time) 
Stage 2 (% 
sleep time) 
Stage 3 & 4 
(% sleep 
time) 
REM      (% 
sleep time) 
PT-1 MCS 1508 271 19.5 10 67.8 32.2 0 0 
PT-2 MCS 1374 135 10.4 11 60.7 39.3 0 0 
PT-3 VS 1480 518 36.4 21 99 0 0 0 
PT-4 MCS 1691 269 17.3 19 94.8 2.8 0 2.4 
PT-5 MCS 1717 58 3.7 7 96.4 3.6 0 0 
PT-6 MCS 1855 140 11.7 6 100 0 0 0 
PT-7 MCS 1484 288 21.2 22 58.3 39.2 0 0 
PT-8 MCS 1610 34 2.2 11 82.7 17.3 0 0 
PT-9  VS 1645 268 16.3 15 100 0 0 0 
PT-10 MCS 1728 276 19.7 10 14.9 66.5 0 20.5 
PT-11 VS 1423 567 20.2 27 97.1 1.8 0 0 
PT-12 MCS 1483 326 23.1 18 84.8 0 0 14.5 
PT-13 VS 1599 266 28.3 17 85.1 14.9 0 0 
PT-14 MCS 1285 275 23.1 48 90.2 6.5 0 3.3 
PT-15 MCS 1247 151 18.3 5 62.5 37.2 0 0 
MEAN  1541.9 256 18.1 16.47 79.6 17.4 0 2.7 
SD  171.4 146.4 8.75 10.83 23.4 20.6 0 6.2 
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Figure 8-3: Sleep stages observed at group level on 24-hour polysomnography of 15 
patients with PDOC 
 
Figure 8-4: Sleep stages expected to be observed in normal subjects 
 
Only 4 of the 15 patients had REM sleep in our study. Two of these patients 






Sleep stages observed at group level





Sleep stages in Normal Population
Stage 1 Stage 2 Stage 3 REM
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prolonged disorders of consciousness. All of the patients who had REM sleep 
were in minimally conscious state. 11 of the 15 patients had stage-2 sleep 
during time spent asleep. 3 patients had stage 1 sleep only. None of the 
patients showed presence of deep sleep (stage 3&4).  
8.1.3 Circadian rhythm assessment results 
8.1.3.1 Melatonin as a marker of circadian rhythm 
48-hour saliva melatonin results were available for 15 patients. Out of the 180 
samples collected within 48 hours 158 samples yielded results. Review of the 
melatonin plots showed that 6 out of 15 patients (1 VS, 5 MCS) had melatonin 
peak times occurring within the same two-hour window on consecutive 24- 
hour periods indicating that these patients may have a degree of preserved 
circadian rhythmicity. However, two of the patients had melatonin peaks at 
7am and 11am.  
 
Figure 8-5: Peak times in each consecutive 24-hour period for each patient. Peak times 
occurring within the same 2-hour window are circled. 
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Daytime (8am to 8pm) melatonin mean was 84.42 (SD=29.4), and night (8pm 
to 8am) melatonin mean was 106.63 (SD=27.8). Means comparisons of day 
and night normalized melatonin values did not reach statistically significant 
values (p=0.07).  
Cosinor analysis of saliva melatonin results revealed that averaged baseline 
% rhythmicity was low (Mean: 30.87%, Range: 10% - 66.4%, SD: 16.5) in 
comparison to a perfect fit scenario where percentage rhythm is 100% (Minors 
and Waterhouse, 1988). Although % Rhythmicity was higher in the patients 
who were fed during the day than in the patients who were fed at night; the 
difference between the two groups was not statistically significant t(13)=1.27 



























Table 8-5: Baseline sleep and melatonin rhythmicity results in order of Melatonin %Rhythm  




PT7 288 21.2 1, 2 58.3 39.2 0 night 66.4 16:00-02:00 
PT10 276 19.7 1, 2, REM 14.9 66.5 20.5 night 51.9 Daytime 
PT11 567 20.2 1,2 97.1 1.8 0 day &night 49.8 Daytime 
PT8 34 2.2 1, 2 82.7 17.3 0 night 46.5 Daytime 
PT14 275 23.1 1,2, REM 90.2 6.5 3.3 night (early AM) 40.5 16:00-04:00 
PT1 271 19.5 1, 2 67.8 32.2 0 night (early AM) 34.55 Daytime 
PT12 326 23.1 1, REM 84.8 0 14.5 Night 32.9 Daytime 
PT3 518 36.4 1 99 0 0 day &night 28.2 Daytime 
PT9 268 16.3 1 100 0 0 day &night 23.45 16:00-04:00 
PT17 N/A N/A N/A N/A N/A N/A N/A 19 16:00-04:00 
PT4 269 17.3 1,2, REM 94.8 2.8 2.4 day &night 16.8 16:00-04:00 
PT6 140 11.7 1, 2 100 0 0 day 16.55 18:00-02:00 
PT2 135 10.4 1,2 60.7 39.3 0 day &night 13.5 Daytime 
PT5 58 3.7 1, 2 96.4 3.6 0 night 12.9 16:00-02:00 
PT16 N/A N/A N/A N/A N/A N/A N/A 10 16:00-02:00 
PT13 266 28.3 1,2 85.1 14.9 0 Night N/A  
PT15 151 18.3 1,2 62.5 37.2 0 night (early morning) N/A  
PSG= Polysomnography, TST=Total Sleep Time (normalized to 24 hour), S.Eff= Sleep Efficiency (Normalized to 24 hour), REM= Rapid Eye Movement
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Means comparisons were made between 8pm, midnight and 4am values to 
evaluate whether there was a melatonin response dark in patients whose 
melatonin results were available at these time points. The result of the paired 
t-test was statistically significant at group level between 8pm and midnight 
values. (See table 8.6)  
 










































The same test was applied for the patients in vegetative state and minimally 
conscious state subgroups to see if the response to dark differed between two 
diagnostic subgroups. While the patients in VS had no significant increase of 
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18.441 8.247 -26.278 19.518 -.410 4 .703 
 
 












































8.1.3.2 Body Temperature as a marker of circadian rhythmicity 
Complete data sets for temperature measurements for 48 hours were available 
in eight patients yielding total of 768 measurements (measurement with i-
button every 30 minutes). 
Graphical representation of the mean temperature values revealed a similar 
pattern to distal body temperature rhythm of healthy people with increased 
values during night; instead of a similar pattern to core body temperature 
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rhythm of healthy people (Kräuchi, 2002). Please see figure 8.6, 8.7 and 8.8 
for comparison. 
 
Figure 8-6: Body temperature data (moving averaged) for each subject n=8 
 
 






































































































































































































































































































































Mean body temperature values (moving average) in 
PDOC
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Figure 8-8: Body temperature measurements of healthy people (Adopted from Kräuchi, 
Clin Auton Res (2002) 12: 147–149) 
Cosinor analysis of baseline body temperatures (period 23.5 to 24.5 hours) 
revealed low % rhythmicity. Mean % rhythm was 40.47% (Range= 2.1-84.4, 
SE= 5.1). 
8.1.4 Summary of baseline investigations 
• All patients had abnormal baseline EEG with low amplitude record 
characterized by diffuse polymorphic delta activity at 1.0-2.5Hz between 
10-20µV. 
• Our assessments showed that baseline circadian rhythmicity and sleep 
were abnormal in all patients.  
• Cosinor analysis of saliva melatonin results revealed that averaged 
baseline %Melatonin rhythmicity was low (Mean= 31%, Range= 13% - 
66.4%, SD= 18.4). Body temperature %rhythmicity was also low. 
























Time course of core, distal and proximal body 
temperatures in healthy
CBT DBT PBT
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• Quantity and quality of sleep was severely abnormal in patients with 
PDOC. Total sleep time was low (Range 35-523 mins, Mean= 251 mins, 
SD=139.8). Sleep efficiency was low (Mean= 18.1%, Range 3.7%- 
36.4%, SD= 8.45). None of the patients had slow wave sleep and only 
four patients had REM sleep. 
• These results suggest that there is a need to attempt to normalize 
circadian rhythm and sleep of patients with PDOC, which may then lead 
to improvement of awareness/ consciousness levels.  
8.2 INTERVENTIONAL STUDY RESULTS 
This section of the thesis summarizes the results of the 5-weeks intervention 
which aimed to optimize the circadian rhythm and sleep with melatonin at night, 
caffeine and light treatment in the mornings with the aim of optimizing circadian 
rhythm and sleep. We also wanted to explore that whether the interventions 
led to improvement of consciousness/ brain functions measured using either 
clinical assessment tools (CRS-) and/ or neurophysiological investigations (on 
MMN and SON experiments).  
Detailed clinical information on interventional study participants can be found 
in Appendix 1. 
8.2.1 Side Effects and Tolerability of Interventions 
One of the patients (patient 12) who was initially enrolled in the interventional 
study developed behavioural responses which were unusual for her (agitation, 
grimacing during personal care and manual handling suggesting patient might 
had been experiencing pain) whilst she was in the second week of 
interventions. This prompted medical reviews and investigations. She was very 
quickly diagnosed with advanced intra-abdominal malignancy. She was then 
transferred to another healthcare facility near to her family to receive palliative 
care. She died few weeks later.  
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None of the 10 patients who completed the interventional study had any side 
effects. Nursing staff and families of patients reported no difficulty in giving 
care and/or interacting with patients during intervention.  
8.2.2 Effect of intervention on circadian rhythm 
8.2.2.1 Melatonin 
General Linear Model pairwise comparisons between baseline 1 and baseline 
2 conditions were not significant for melatonin rhythms. However, comparisons 
between both baseline measurements and post-intervention measures were 
significant. This indicates that, melatonin circadian rhythms were stable at the 
baseline tests which were performed one month apart from each other without 
any change to patient’s conditions; and, the change following the intervention 
was not due to natural fluctuations in these measures. Hence, the data from 
baseline conditions and post-intervention conditions were collapsed together 
and t-test statistics were performed to find out if the improvements were 
significant.  
Increase in %Melatonin Rhythm following intervention was statistically 
significant (p=0.012) (see table 8.9 and 8.10 for details). Improvement in % 
melatonin rhythm was maintained even three weeks after cessation of 
intervention as general linear model pairwise comparison between 3-days and 
3-weeks after the intervention was not significant (sig=0.888). Plotting of peak 
times revealed that while prior to intervention only 2 patients had melatonin 
peaks in dark, after the intervention 7 patients had their melatonin peaks in 
dark (figure 8.9). 
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Table 8-9: Descriptive statistics of saliva melatonin % rhythmicity results at baseline1 
(BL1), baseline 2 (BL2), post-intervention 1 (PI1) and post-intervention 2 (PI2) time 
points. 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
BL1%rhythm 10 11.20 92.20 37.7000 24.25586 
BL2%rhythm 10 7.40 60.60 24.4500 19.08328 
PI1%rhythm 10 .00 96.80 54.3500 26.98478 
PI2%rhythm 10 2.40 100.00 51.8500 37.29934 
Valid N (listwise) 10     
Figure 8-9: Melatonin peak times before the intervention (circles) and after the 
intervention (stars). 
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Table 8-10: Means comparison (paired samples t-test) results for baseline and post-
intervention saliva melatonin % rhythmicity results 
































8.2.2.2 Body Temperature  
Cosinor analysis of body temperature values showed that the patients with 
PDOC maintained degree of rhythmicity at baseline (period 23.5- 24.5 hours). 
However, the value was low. Baseline body temperatures % rhythmicity mean 
value was 40.47 (Range= 2.1-84.4, SE= 5.1).  
The post-intervention mean body temperature % rhythmicity was lower than 
the baseline (Mean= 36.44, SE= 4.94, Range= 7.1-90.3), however this was not 
statistically significant at the paired samples two-tailed t-test (p=0.57). 
8.2.3 Sleep studies 
General Linear Model pairwise comparisons between baseline 1 and baseline 
2 conditions were not significant for any of the PSG parameters. As the PSG 
studies were independently reported by two different neuro-physiologists who 
were also blinded to patient’s experimental conditions and to each other, intra-
class correlations were performed to see if there was an absolute agreement 
between them. It was found that there was excellent agreement for total sleep 
time (TST), time spent in sleep at night, sleep efficiency and REM stage 
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scorings. Therefore, all baseline and all post-intervention data for these 
parameters were collapsed together and means comparisons were made to 
see if the improvements observed were statistically significant. Although 
improvement of all 4 parameters were observed the improvement following the 
intervention did not reach statistically significant levels (table 8.11). 
 
Table 8-11: 24-hour Polysomnography parameter changes. TST= Total Sleep Time, SE= 
Sleep Efficiency, REM= Rapid Eye Movement 
Sleep parameter Range Mean SD P value 
Baseline Night Sleep  78.4- 204.3 
mins 




23.5-334.3 mins 168 mins 112 
Baseline REM 0-31.9 mins 5.8 mins 11.3 
.145 
Post-Intervention REM 0-76.5 mins 22 mins 33.5 
Baseline TST  71.1-439.7 mins 236.3 mins 119.3 
.420 
Post-Intervention TST  56.3-627.0 mins 286.7 mins 197.2 
Baseline SE 4.5-29.3 15.6 7.8 
.413 
Post-intervention SE 3.6-44.5 19.3 13.9 
 
 
8.2.4 Behavioural assessments 
General Linear Model pairwise comparisons between baseline 1 and baseline 
2 conditions were not significant for behavioural measures. However, 
comparisons between both baseline measurements and post-intervention 
measures were significant. This indicates that, CRS-R scores were stable at 
the baseline tests which were performed one month apart from each other 
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without any change to patient’s conditions; and, the change following the 
intervention was not due to natural fluctuations in these measures. Hence, the 
data from two baseline conditions (two time points) were collapsed together 
and compared with post-intervention (one time point) results to find out if the 
improvements were significant.  
Table 8-12: CRS-R Scores Pre- and Post- intervention for each patient 
Subject 




Patient 1 12.5 15 
Patient 2 8 9 
Patient 3 4 4 
Patient 4 10 10 
Patient 5 13 18 
Patient 6 16.5 16 
Patient 7 12 15 
Patient 8 11.5 14 
Patient 9 6 6 
Patient 10 10.5 11 
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7 patients had improvement of CRS-R scores with intervention. Wilcoxon 
signed ranks test revealed statistically significant improvement of CRS-R 
scores with the intervention; both between CRS-R baseline averaged data and 
post-intervention (p=0.034) and, between baseline-2 and post-intervention 
which represents the change between the two closest time points before and 
after the intervention (p=0.027).  
8.2.5 ERP results 
All the patients who had improvement of clinical scores (7/10) also had 
statistically significant improvement of neurophysiological responses on MMN 
and SON experiments (p=0.001).  
At the group level we identified two peaks where the MMN increased after 
therapy. These were in the right frontal region and left occipital region. In the 
SON experiment we identified two peaks response to stimuli amplitude 
increased with therapy. These were both located at the left parietal region (see 
Figure 8-11: Statistical parametric mapping group t-test results for oddball and 
subject's own name experiments for pre-intervention and post-intervention 
conditions. MMN=mismatch negativity, SON= Subject’s own name). 
Table 8.13 and 8.14 gives beta values (µV) for each subject during each MMN 
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Table 8-13: ERP magnitude beta values for MMN experiments 























pt1 38 61 371 0.8737 -0.6837 1.5574 2.9956 -2.1709 5.1665 2.0657 2.6283 -0.5626 3.362 -0.563 
pt2 -30 61 389 1.2135 -0.1921 1.4056 0.6208 0.5643 0.0565 -3.319 0.7715 -4.0905 0.731 -4.091 
pt3 38 34 398 14.3254 0.1797 14.1457 0.0462 0.0481 -0.0019 1.865 1.5357 0.3293 7.072 0.329 
pt4 17 2 387 3.2224 0.1029 3.1195 0.0745 -0.7573 0.8318 -1.1454 0.2477 -1.3931 1.976 -1.393 
pt5 38 -73 381 0.7162 -0.2974 1.0136 0.9784 -0.5453 1.5237 -1.5769 -0.3195 -1.2574 1.269 -1.257 
pt6 -26 61 395 1.6772 0.16 1.5172 0.1368 -0.1179 0.2547 -2.8165 0.0003 -2.8168 0.886 -2.817 
pt7 43 29 396 0.1661 -1.5561 1.7222 -0.1619 0.7094 -0.8713 -15.8518 -3.3752 -12.4766 0.425 -12.477 
pt8 -9 2 309 0.1973 -0.106 0.3033 -0.5738 -0.2987 -0.2751 -0.7567 0.508 -1.2647 0.014 -1.265 
pt9 -4 13 152 2.2739 0.1611 2.1128 -0.1993 -0.1326 -0.0667 -1.6999 0.5503 -2.2502 1.023 -2.250 















Table 8-14: ERP magnitude beta values for SON experiments 










β TP1_diff TP2-SON-β 
TP2-Other-







pt1 -17 -19 229 -0.7417 -0.7361 3.7361 -1.4064 -1.2684 -0.138 -2.5306 -1.2135 -1.3171 1.799 -1.317 
pt2 4 -36 164 10.0167 0.5585 2.4415 0.7839 0.4182 0.3657 0.0328 -0.0677 0.1005 1.404 0.101 
pt3 -30 -52 172 0.608 0.1738 2.8262 0.8021 0.2045 0.5976 -0.5609 1.2384 -1.7993 1.712 -1.799 
pt4 47 -62 252 1.7719 -2.5525 5.5525 5.7944 -2.0605 7.8549 -0.3245 -0.8132 0.4887 6.704 0.489 
pt5 -60 -30 182 0.2894 0.2738 2.7262 5.7614 0.2027 5.5587 0.9811 1.4387 -0.4576 4.142 -0.458 
pt6 13 -57 152 1.3171 -0.351 3.351 2.3274 -0.2161 2.5435 -0.707 0.3843 -1.0913 2.947 -1.091 
pt7 60 -30 180 1.46 -2.3314 5.3314 0.6247 0.4014 0.2233 -3.8914 3.2333 -7.1247 2.777 -7.125 
pt8 -4 -19 178 0.0796 0.0975 2.9025 0.3446 0.1601 0.1845 -1.2567 -0.464 -0.7927 1.544 -0.793 
pt9 38 34 398 2.3922 -0.9823 3.9823 0.8565 0.7399 0.1166 0.9615 0.5466 0.4149 2.049 0.415 



























Figure 8-11: Statistical parametric mapping group t-test results for oddball and subject's own name experiments for pre-
intervention and post-intervention conditions. MMN=mismatch negativity, SON= Subject’s own name 
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8.3 CHAPTER SUMMARY 
Our baseline work showed that sleep and circadian rhythms were severely 
deranged in PDOC.  However, we were able to improve sleep and circadian 
rhythms with only five weeks of intervention which comprised of melatonin 
treatment at night, caffeine and blue light treatments in the morning.  
With the international study we were able to show that following circadian 
rhythm intervention there was a significant improvement in %Melatonin 
rhythmicity (p=0.012). 
Although, improvements in individual PSG parameters did not reach 
statistically significant levels, qualitative and quantitative improvement of sleep 
were evident for majority of patients as shown in figure 8.11.  
Most significantly, 7 patients had improvement of CRS-R scores with 
intervention which was statistically significant (p=0.034). 
Individually, those patients who responded well to the intervention also showed 
improvements in their functional brain imaging assessments (p=0.001). 
The improvements in sleep quality (more complex sleep patterns and 
presence of REM sleep), sleep quantity (Total and night time sleep time), 
circadian rhythm (melatonin % rhythm), clinical presentation (CRS-R changes) 
and ERP effect magnitudes during the mismatch negativity and subject’s own 
name experiments are given in table 8.15 for each subject. Correlation 
statistics revealed that improvements in melatonin rhythm and sleep time (total 
and night time) and, improvements in both event related potential tests were 
significantly correlated (See table 8.16).  However, there was no significant 
correlation between these measures and behavioural measures in this sample 
of 10 subjects with disorders of conscious ness who are two to eight years post 
brain injury.








Figure 8-12: Changes with intervention on the parameters examined. Green represents clear and significant improvement, orange some minor improvement 
and red no improvement 
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Pre Post Pre Post 
Pt-1 F/ 71/ MCS/ SAH 5 +14.5 -37.75 +0.5    4           5 -0.6 +2.5 2.441 -5.617 1.799 -1.317 
Pt-2 M/ 58/ MCS-/ Anoxia 5 +74.25 +68.38 +76.5 3           5 +41.45 +1 0.964 -4.443 1.404 0.101 
Pt-3 M/ 36/ VS/ Anoxia 2 -59 +29.25 0 2           2 +13.35 0 0.553 -1.577 1.712 -1.799 
Pt-4 M/ 52/ MCS/ SAH 4 +192.5 +180.63 +37.63 5           5 +45.55 0 4.121 -1.268 6.704 0.489 
Pt-5 F/ 30/ MCS/ TBI 5 +138.25 +158.13 +64.75 2           5 +29.4 +5 0.201 -3.287 4.142 -0.458 
Pt-6 F/ 43/ MCS/ Stroke 3 +349 +204.38 0 3           4 +63.8 -0.5 2.531 -3.249 2.947 -1.091 
Pt-7 M/ 73/ MCS/ Stroke 8 -163.25 -114.50 0 4           4 +17.1 +3 -0.099 -14.994 2.777 -7.125 
Pt-8 F/ 40/ MCS/ TBI 3 +66.75 -96.50 4.125 3           5 +2.85 +2.5 0.158 -1.437 1.544 -0.793 
Pt-9 M/ 68/ VS/ Vasculitis 6 +39.25 -16.00 0 2           2 +9.25 0 1.023 -2.250 2.049 0.415 
Pt-10 F/ 66/ MCS/ Anoxia 6 -266 -153.63 -21.25 3           2 -1.9 +0.5 -1.657 -3.058 2.669 -2.802 
Table 8-15: Changes in sleep quality, sleep quantity, circadian rhythm, clinical outcomes and event related potentials with intervention. Sleep pattern complexity 
scores are based on sleep pattern coding as defined by Valente: 1 =monophasic, 2 =cyclic alternating, 3 =rudimentary, 4= NREM, 5= REM (Valente et al., 2002) 
  








Table 8-16: Pearson correlations for changes occurred following intervention showing that melatonin rhythm increase was correlated with sleep time 
increase (total and night time) and ERP effect magnitude changes for both MMN and SON were also correlated with each other. 













TST increase Pearson Corr. 1 -.132 .775** .866** .426 -.099 -.324 
Sig. (2-tailed)  .716 .008 .001 .220 .786 .360 
N 10 10 10 10 10 10 10 
CRS-R 
increase 
Pearson Corr. -.132 1 -.270 -.152 .339 .272 .230 
Sig. (2-tailed) .716  .451 .676 .338 .448 .522 




Pearson Corr. .775** -.270 1 .866** .508 .148 .055 
Sig. (2-tailed) .008 .451  .001 .134 .684 .881 
N 10 10 10 10 10 10 10 
Night TST 
increase 
Pearson Corr. .866** -.152 .866** 1 .580 -.094 -.141 
Sig. (2-tailed) .001 .676 .001  .079 .796 .698 
N 10 10 10 10 10 10 10 
REM Increase Pearson Corr. .426 .339 .508 .580 1 -.010 -.213 
Sig. (2-tailed) .220 .338 .134 .079  .979 .554 




Pearson Corr. -.099 .272 .148 -.094 -.010 1 .651* 
Sig. (2-tailed) .786 .448 .684 .796 .979  .042 




Pearson Corr. -.324 .230 .055 -.141 -.213 .651* 1 
Sig. (2-tailed) .360 .522 .881 .698 .554 .042  
N 10 10 10 10 10 10 10 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Chapter 9 DISCUSSION 
Acquired brain injury is a worldwide and an important public health problem 
with a significant impact on people with brain injuries themselves, others 
involved in the care of them, and in wider societies.  Although stroke and 
trauma are the most common causes, it can be due to infection, inflammatory 
conditions, tumours, and degenerative diseases of the brain. It is a silent 
epidemic all over the world with very severe consequences. Disorders of 
consciousness (vegetative and minimally conscious states) are the most 
severe forms of acquired brain injury which are not scientifically well-
understood, currently with no treatment available for, and therefore creates a 
significant medical, ethical and legal conundrum. People with disorders of 
consciousness can live many years with good medical and nursing care but 
with very minimal chance of recovery of brain functions. The level of care they 
need is intensive, specialist, expensive and therefore scarce, even in the most 
modern countries of the world. 
In the introduction chapters of this thesis, I summarized the key information on 
disorders of consciousness, sleep and circadian rhythms in general; reviewed 
the literature to explore what is known about the sleep and circadian rhythms 
of people with DOC. It became clear that, a handful of studies showed sleep 
and circadian rhythms are possibly impaired in DOC. This was not a surprise 
for us, because in the Royal Hospital for Neuro-disability, Putney, London 
which is a big centre caring for people with DOC for many years, we often 
observed abnormal sleep-wake patterns in this population. What we needed 
to do now was, to conduct a robust study to explore sleep and circadian 
rhythmicity in this population and to design a treatment protocol. The methods 
development and methods chapters of this thesis summarized how I achieved 
this. 
The main aim of this research was to explore effect of circadian rhythm and 
sleep optimization on brain functions of people with PDOC. We first 
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investigated circadian rhythms of salivary melatonin and sleep of patients with 
PDOC and found that both processes were severely impaired. Then, we made 
an attempt to optimize circadian rhythm by giving melatonin at night, caffeine 
and blue light in the morning. Our results showed that, this simple and 
inexpensive intervention led to improvement of sleep quality and/or quantity in 
most patients, which then translated to improvement in bedside consciousness 
assessments and on neurophysiological paradigms we tested. This is a very 
significant outcome as it indicated that as scientists and clinicians we need to 
go back to the very basics, try to correct what is abnormal at the physiological 
and biological levels first. Sleep after all, one of the most important events in 
our lives and without good sleep we cannot function. 
In these final chapters of the thesis, I will discuss strengths and weaknesses 
of my research, what I learnt while working of this study, and what I would do 
differently in the future. 
9.1 SETTING and PATIENT POPULATION 
This research was undertaken at the RHN, which is a specialist centre in 
diagnosis and management of PDOC in Putney, London, UK. The RHN has 
been caring for people with severe brain injuries since 1854 and, it houses the 
largest PDOC assessment and rehabilitation unit in the United Kingdom. 
Almost half of the long-term nursing care beds are occupied by people with 
PDOC. 
In my research, 17 patients with PDOC took part in the baseline investigations 
and ten of those proceeded to interventional study. 
In the baseline investigations cohort, 5 of the patients were from Level 1 
rehabilitation unit and the remaining were from long-term care wards. While 
the patients in the rehabilitation unit had a limited length of stay (3-4 months) 
and at early stages of PDOC (6 to 9 months post brain injury), the patients 
from long-term care wards had no limitation for length of stay and were in 
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chronic stages of PDOC (2 to 8 years after brain injury). The interventional 
study cohort also had the advantage of being on stable medication regimen. 
They were well-known by the staff and their families who were extremely 
familiar with their usual repertoire of behaviours, sleep-wake patterns and 
usual arousal levels. Therefore, it can be safely said that any measured effect 
from interventions were not attributable to changes in the medications and 
were not due to their usual behavioural fluctuations.  
Diagnosis of PDOC is challenging and unfortunately misdiagnosis of PDOC 
remains to be a concern. Up to 40% misdiagnosis rate (mainly patients being 
diagnosed with VS while they retain a degree of consciousness or diagnosed 
as MCS when emerged or uncertain diagnosis) has been reported in several 
papers when the diagnosis is made by non-specialist clinicians and when 
structured assessments tools such as CRS-R and SMART were not used 
(Schnakers et al., 2009, Majerus et al., 2005, Seel et al., 2010, Andrews et al., 
1996).  
All our research participants were assessed, diagnosed and monitored at the 
RHN where all clinicians are trained and experienced in assessment and 
management of PDOC. For the diagnosis and monitoring standardized clinical 
assessment tools (SMART, WHIM, CRS-R, MATADOC) are used routinely. All 
cases are reviewed at the multi-disciplinary team meetings regularly (once a 
week in rehabilitation unit and once a month in long-term care wards) and any 
change in the patient’s status is recorded and actions are planned such as 
detailed assessment, trial with communication aids and further investigations. 
Therefore, chance of misdiagnosis in our research cohort was minimal.  
All the patients who participated in the study were medically stable. The most 
common aetiology for PDOC was anoxic brain injury (8 out of 17 participants). 
The second common cause was CVA (5/ 17). We only had 3 patients with TBI 
and one patient with vasculitis due to Stevens-Johnson Syndrome.  
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13 out of 17 patients who participated in our research had diagnosis of MCS 
and their CRS-R total scores varied between 8 and 16. Three of MCS patients 
were meeting the low MCS criteria where basic conscious behaviours such as 
visual tracking, localization to noxious stimulus, object manipulation were 
present but higher-level responses such as object localization and 
reproducible movement to command were absent. 
Almost all patients were on a medication which have a sedating side effect, 
but these medications were essential to treat their secondary complications 
such as spasticity, myoclonic jerks and seizures. Interestingly, two of the 
patients were on zopiclone in the evenings to treat insomnia and one patient 
was on long-term modafinil to combat daytime somnolence. We did not make 
any changes to their routine medications with the exception of two cases: one 
patient had increase of anti-epileptic dose due to frequent epileptiform 
discharges seen on EEG and for another patient modafinil was stopped at the 
time of enrolment to study to avoid interference with our interventions. In the 
latter case, there was two weeks of wash-out period after stopping modafinil 
and taking part in the research. There was no significant difference on patient’s 
arousal levels after stopping the modafinil. 
As all our patients were beyond the acute/ subacute stages of PDOC, the brain 
imaging studies were not repeated as they were not likely to provide additional 
information which could have been useful in interpretation of our results. At the 
RHN, brain imaging such as CT and MRI cannot be performed on site. If these 
tests are needed patients need to go to another hospital. However, the imaging 
on the CDs and reports are available. Therefore, we recorded findings of 
already performed brain imaging for our patients. All patients with anoxia and 
the patient with vasculitis had widespread ischaemic changes in their brain 
scans. Only one CVA was due to infarct and the remaining four were due to 
bleeding. Two of the TBI patients had changes in their brain scans in keeping 
with diagnosis of diffuse axonal injury.  
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In summary, our setting and cohort of patients who participated in the study 
provided following strengths:  
1. Patients had a robust initial diagnostic work-up and therefore, chance 
of misdiagnosis was minimal, 
2. Patients were in their familiar environment throughout the study and 
continued with their routine care, 
3. Patients who involved in the interventional study were medically stable 
and were on established medication regimes, 
4. Staff were very familiar with patients’ usual repertoire of behaviours and 
were able to alert us if there was any change. 
On the other hand, the following were the limitations of the study arising from 
setting and patient related issues: 
1. Patients were in the chronic stages of their illness and therefore, the 
effect of the intervention on circadian rhythm optimization might have 
been less than what we would have seen in more acute stages, 
2. Our setting did not have any facilities to repeat structural imaging, 
3. The patients were on several medications which could influence 
circadian rhythm and sleep.  
9.2 BASELINE INVESTIGATIONS 
9.2.1 Sleep at baseline 
Our baseline polysomnographic studies show that sleep-wake patterns of our 
patients (n=15) were deranged. Some had short episodes of sleep spread over 
24-hour period; some was awake at night and asleep at daytime; some slept 
mostly at night but for a short while; and some slept day and night time. The 
variation between the sleep-wake patterns of patients cannot be explained by 
the external factors as all patients were in a similar environment where daily 
routines of the staff are very similar at evening/ night-times. However, there 
was slight difference of daily routine between patients in rehabilitation unit 
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(n=4) and in long term care wards (n=11). The patients in rehabilitation unit 
received daily therapy input including consciousness assessments, 
occupational therapy and physiotherapy sessions. The patients in long-term 
care wards on the other hand received minimal therapy input but passively 
involved in many other activities such as attending music concerts, film 
screenings, church services and hydrotherapy sessions. Other than this all 
patients, regardless of where they were located, went to bed in the late 
afternoon/ early evening hours, lights went off between 8 and 10 pm with 
minimal disruption until 8-9 am. Their day then started with personal care 
followed by hoisting into wheelchair. Although this is an institutionalized routine 
mainly dictated by staff change and medication administration times, it was 
generally same for all patients. Nevertheless, especially for the patients who 
sleep mostly during the day and keep awake at night-time, there is a danger 
of not recognizing some conscious behaviours which may have been 
displayed when they are awake at night, or not providing adequate social 
interaction during their waking hours.  
At the group level the TST values were significantly reduced (mean= 246 
minutes). This is well below the recommended total sleep time of 7 to 9 hours 
at night. However, the range was wide: 34 minutes to 518 minutes over a 24-
hour period. Most interestingly, the most amount of sleep (day and night time) 
in two VS patients (patient-3 and patient-11) with anoxic brain injury and with 
the two lowest CRS-R scores and the least amount of sleep was observed in 
two TBI patients (patient-5 and patient-8). 
In the two anoxic brain injury/ VS patients with high TST, the common 
electrophysiological feature was presence of frequent waves/ spikes on their 
baseline EEGs which were of very low amplitude/ featureless and poorly 
reactive. Another common clinical feature between the two patients was being 
on Clonazepam twice a day to treat myoclonus. The possible causes of the 
sleep disturbance/ low arousal levels in these patients include;  
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- damage to ascending arousal system at the hypothalamic/ thalamic 
level during anoxic event, 
- frequent sharp waves/ spikes reflecting an ‘epileptogenic’ potential or 
even if nonepileptic, somewhat causing excitotoxic effects on the brain, 
- side effect of Clonazepam.  
The two of the TBI patients who had the least TST and sleep efficiency values, 
on the other hand were in MCS. Both patients’ brain imaging studies were 
suggestive of diffuse axonal injury. Neither of the patients were on antiepileptic 
medications.  
On the background of reduced TST and sleep efficiency, the number of 
awakenings were very high (mean=16.47, SD=10.83) suggesting that our 
patients had very fragmented sleep despite the fact they slept very little in a 
24-hour period. 
Review of sleep stages in PSGs showed that our patients spent majority of 
their eye-closed (appearing to be asleep) times in stage-1 which is a state of 
drowsiness. Furthermore, three of the patients had only stage-1 sleep. As 
mentioned before, stage-1 sleep is nor perceived as proper sleep by normal 
subjects and often described as catnapping/ dozing/ nodding off.  
Previous PSG studies in PDOC suggested that sleep spindles were more 
common in TBI patients than in non-traumatic brain injury patients, more 
common in MCS than in VS, and indicated favourable prognosis. As our stage-
2 scoring criteria was observation of spindle activity, all patients (11/15) who 
had stage-2 sleep scored by default had spindles on their PSGs re-confirming 
that spindles are more common in MCS than in VS (see table 9-1). We had 
only two patients with TBI and both had spindles. However, due to low 
numbers of TBI patients in our cohort, it is not possible to comment on 
frequency of spindles in relation to cause of brain injury.  
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Table 9-1: Sleep spindles in VS/ MCS patients 
 VS (n=4) MCS (n=11) 
Spindles + 2  9 
Spindles - 2 2 
 
On the other hand, the four VS patients had an interesting divide in relation to 
spindle activity on their PSGs and the time since their brain injury. While the 
two VS patients who did not have any spindles were long-term care patients 
and two years after their brain injuries (patient-3 and patient-9), the other two 
who had spindles were in rehabilitation unit and only six and nine months after 
their brain injuries (patient-11 and patient-13). Unfortunately, both patients 
were discharged to other healthcare/ nursing home facilities following their 
rehabilitation and therefore, we don’t know if they had late recovery of 
consciousness and emerged from VS later or not.  
Another striking result of polysomnographic studies was the deficiency of REM 
sleep and non-existence of slow wave sleep at the baseline. Our review of 
literature PSG findings in PDOC suggested that REM sleep is more common 
in MCS than in VS (see chapter 4). This was re-iterated in our study as all four 
patients who had REM sleep were in MCS. However, the amount of REM was 
less than normal (Mean=10.2%, Range=2.4% to 20.5%). Normally 20-30% of 
sleep is spent in REM which is crucial for dreaming, memory consolidation and 
learning.  
Identifying slow wave sleep is particularly difficult in PDOC patients as their 
background EEG is dominated by delta or theta waveforms which would 
indicate deep sleep in healthy individuals according to AASM criteria. 
Currently, there is no consensus on the method of sleep staging in this patient 
group. While some studies suggest that manual sleep scoring is possible, 
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some suggest this is almost impossible mainly due to general slowing of EEG, 
topographically contradicting “sleep” patterns and artefacts  in VS and MCS 
and recommends development of automated EEG signal analysis combined 
with machine learning techniques (Wielek et al., 2018, Malinowska et al., 
2013). Nevertheless, both manual and automated methods are still not very 
well established, and more research is needed on the subject. We opted for 
the manual scoring and our neurophysiologists were able to define a criteria 
for slow wave/ stage 3 sleep for PDOC based on detailed examination of many 
PSGs from PDOC patients and based on previously published work (Cologan 
et al., 2013). To be able to score stage 3, we needed to see higher amounts 
of delta activity (>20% of ongoing record) in higher amplitudes, accompanied 
by lack of muscle artefacts and eye blinks. All our PSGs were scored 
independently by two experienced neuro-physiologists which confirmed lack 
of slow wave sleep in our patients. As explained in the introduction chapters of 
this thesis, slow wave sleep plays an important role in strengthening memory 
circuits, consolidation of memories and motor learning.  
In summary, the baseline PSGs of our patients showed that not only the 
amount of sleep was fragmented and reduced, but the quality of the sleep they 
had was also very poor. Chronic sleep deprivation coupled with poor quality 
sleep is likely to cause further damage to consciousness levels or at least 
negatively impact on recovery of brain functions in PDOC. 
9.2.2 Circadian Rhythm Assessments 
Patients with very severe brain injuries as in PDOC population are likely to 
have an irregular sleep/ wake rhythm circadian sleep disorder. Circadian 
rhythms were previously studied in PDOC population. A wide range of 
circadian parameters were examined including body temperature, blood 
pressure, heart rate, cortisol levels, prolactin levels, and even urinary excretion 
of electrolytes. All these studies showed a variety of outcomes i.e. preserved 
circadian rhythmicity of hormones alongside of diminished circadian 
rhythmicity of physiological markers and vice versa. Nevertheless, it was 
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pointed out that there is a difference in circadian rhythm regulation between 
VS and MCS patients and circadian rhythms can be used as a marker of 
prognosis as they reflect hypothalamic and midbrain functions (Bekinschtein 
et al., 2009b).  
Only one study examined nocturnal melatonin regulation in six traumatic VS 
patients (Guaraldi et al., 2014). In the latter study, it was shown that VS 
patients had no significant increase of nocturnal plasma melatonin levels and 
they failed to supress melatonin levels when exposed to blue light.  In this 
study the focus was on night-time variation of melatonin only. Day melatonin 
levels and melatonin peak times were not examined. Therefore, it does not 
give information on presence/ absence of melatonin circadian rhythm, and if 
present on the characteristics of it.  
Our study showed that circadian rhythmicity of melatonin was severely 
impaired in PDOC patients as evidenced with abnormal melatonin peak times, 
poor differentiation of day/ night time melatonin levels and low % rhythmicity 
values.  
There is no normal range for melatonin levels. In each person, melatonin levels 
change in a rhythm throughout the 24-hour period. Its levels go down when 
person expose to bright light in the morning and remains low until dark in the 
evening. When the environment is dark, melatonin levels start to rise and peak 
between 2am and 4am.  
In our study, we measured saliva melatonin levels every four hours over two 
circadian cycles (48 hours). The saliva collection times were shifted by two 
hours in the second 24-hour period. Therefore, if the patient had a regular 
melatonin rhythm but a slight change in peak times, we would still be able to 
capture this in the second 24-hour period. Our results showed that only a small 
number of patients (six out of 15), had melatonin peak times occurring within 
the same two-hour window on the second 24-hour period. Even, by extending 
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the expected melatonin peak time window to midnight to 6am, we found that 
two of the peaks in this group occurred outside of this.   
Five of six patients who had melatonin peak times within the same two-hour 
on consecutive 24-hour periods were in MCS. None of these patients were on 
beta-blocker medication which is known to inhibit melatonin production (Arendt 
et al., 1985, Wetterberg, 1978, Cowen et al., 1983). In the remaining 11 
patients who did not have re-occurring of melatonin peaks within the same 
two-hour period however, four patients were on beta-blocker (bisoprolol) 
treatment. Therefore, it is not possible to comment whether the beta-blocker 
treatment negatively affected melatonin productions and supressed melatonin 
peaks on these four patients or not. 
It was previously shown that aging has an adverse effect on melatonin 
production- possibly due to degeneration of the retina-SCN-pineal axis (Tan et 
al., 2018, Pandi-Perumal et al., 2005, Wu and Swaab, 2005, Sharma et al., 
1989).  In our study there was no clear correlation between age of the subjects 
and melatonin rhythm peak times (six patients aged between 36-71 versus 
nine patients aged between 30-73). Again, it is not possible to comment on 
influence of age on melatonin levels due to small sample size. 
When the comparison between the mean diurnal and nocturnal values made 
we noted that the nocturnal values were higher than the diurnal values, but the 
difference was not statistically significant. However, there was evidence of 
melatonin rise in response to dark (8pm to midnight) with statistically significant 
t-test results at the group level which proved to be driven by the melatonin 
value changes of MCS patients- again, suggesting that MCS patients have 
better circadian rhythm reserves than VS patients.  
Cosinor analysis of melatonin data showed that melatonin % rhythmicity was 
very low in our patient group (mean 30.87%, SD: 16.5). In fact, 13 out of 15 
patients had % rhythm of less than 50%. When we re-ordered our patient list 
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according to their melatonin % rhythm results we noticed that most of the 
patients with higher melatonin % rhythm values were being fed during daytime. 
Although the difference between the day-time and night-time feeding groups 
was not statistically significant (p=0.22), this observation is important in PDOC 
clinical practice where the clinicians decide on timing of feeding via enteric 
tubes (clinically assisted hydration and nutrition).  
Although light is the most prominent synchronizer for the mammalian central 
biological clock which resides in the SCN, we now know that there are many 
other circadian molecular clocks in the peripheral tissues such as adipose 
tissue and digestive system as evidenced by presence of clock genes. Animal 
studies showed that there are peripheral clocks in liver, pancreas, stomach 
and intestines (Stenvers et al., 2012, Balsalobre et al., 1998, Damiola et al., 
2000, Hoogerwerf et al., 2010, Bostwick et al., 2010, Hoogerwerf et al., 2007). 
A literature review performed by Stenvers et al. (2012) outlines that not only 
these peripheral clocks have close working relationship with SCN, they also 
appear to be synchronized by energy metabolism and hormones that are 
released upon feeding.  
Two research studies performed on people with VS indicated that enteral tube 
feeding can affect circadian rhythm. Saito et al. showed that VS patients who 
fed continuously, did not show any consistent cortisol circadian rhythm. The 
patients who were being fed at night had cortisol peak but at a wrong time (at 
16:00 hours), and the ones who were being fed diurnally had appropriately 
timed cortisol peaks at 08:00 hours (Saito et al., 1989). Similarly, the same 
group studied body temperature and urinary excretions of water, sodium and 
potassium on 18 VS patients and showed that in the diurnal feeding group, 
there was a clear body temperature rhythm with a peak at 20:00 hours, whose 
pattern was similar to the well-established body temperature rhythm in normal 
subjects. While the nocturnal feeding group showed an altered temperature 
rhythm (the peak at 04:00 hours), the continuous feeding group did not show 
any consistent body temperature rhythms (Nishimura et al., 1992).   
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The schedule of enteric feed administration is mainly determined by practical 
issues. At the RHN, most rehabilitation unit patients are fed at night, so they 
can attend therapy and assessment sessions freely. It is often argued by 
nursing staff that, there is an increased risk of clinical incidents (i.e. forgetting 
to re-connect feed, wrongly setting up the pump rate by non-trained staff) when 
feeding is interrupted and re-started frequently to enable attendance to therapy 
sessions. Such incidents can have serious consequences if the patients are 
diabetic or are on medications such as hormone or enzyme replacement 
therapies. Patients who are residents in the long-term care wards however, 
can be fed during the day as there are less interruptions to feeding. In our 
study, even the patients who had their feed started in the afternoon, were being 
fed until 2am or 4am.  
While, the above concerns are valid, it can be argued that clinical needs of the 
patients should take priority over practicalities. Although, more research is 
required, nocturnal feeding appears to have negative effect on circadian 
rhythms. From recent research in humans we know that circadian rhythm 
abnormalities are associated with immunodeficiency, impaired cognitive 
performance, cardiovascular illness, obesity, diabetes and even cancer (Gery 
and Koeffler, 2010, Lange et al., 2010, Gale et al., 2011, Dominguez-
Rodriguez et al., 2010, Schmidt et al., 2007). Simple measures such as 
general training of therapy staff on feeding systems and placing warning signs 
by the bedside of patients may help to reduce the clinical incidents while 
enabling feeding during daytime and helping to optimize circadian rhythmicity.  
Final parameter used to assess circadian rhythmicity in our study was body 
temperature measurements using I-buttons. Two previous studies used I-
buttons on PDOC population to assess circadian rhythmicity (Bekinschtein et 
al., 2009b, Blume et al., 2017). While Bekinschtein et al. found only two out of 
five patients had preserved circadian rhythmicity of body temperature, Blume 
et al. detected circadian rhythms in all their 18 patients. Our study showed that 
although we measured proximal body temperatures, mean temperature values 
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of our patients resembled distal body temperature fluctuations of healthy 
people with rise in evening hours and dip in daytime hours. In addition to this, 
cosinor analysis revealed low % rhythmicity (mean=40.47%) in our cohort 
(n=8).  
The methodological differences between the three studies may explain the 
slightly contradicting results. First, it is not clear from Bekinschtein study that 
where the I-buttons were placed on the body, but regardless of where the 
measurements were from, they collected continuous data over two weeks. 
Blume et al. chose the distal–proximal skin temperature gradient as a proxy to 
core body temperature and showed presence of rhythmicity in all their patients. 
However, detailed examination of peak values in their study show a spread 
over 24 hours with some patients reaching maximum CBT values at night or 
morning hours. Our study on the other hand used proximal skin temperatures 
over 48-hours. 
Body temperature regulation depends on heat production and heat loss. Heat 
loss is mainly regulated by thermoregulatory distal skin flow and is affected by 
the temperature of environment. Our background work (Yelden et al., 2015) 
showed that the room temperatures were above recommended levels in our 
patient rooms. In the same study, it was noted that nursing staff in our 
rehabilitation unit believed that patients with profound brain injuries were not 
able to regulate their own body temperatures and therefore, needed warmer 
than recommended bedside environment.  Further research on body 
temperature regulation of patients with PDOC is necessary to correctly 
interpret results of circadian rhythm studies when body temperatures are used 
as a marker of circadian rhythmicity.  
 
9.3 INTERVENTIONAL STUDY 
The aim of the interventions which consisted of melatonin in the evening, 
caffeine and blue light treatment in the morning was to entrain circadian rhythm 
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of ten PDOC patients. By achievement of realignment between the circadian 
rhythm, timing of sleep and wakefulness, and environmental time, the PDOC 
patients may be able to maintain wakefulness during daytime and have a good 
quality consolidated sleep at night.  
We hypothesized that optimizing circadian rhythmicity will help to improve 
sleep quality and/or quantity which then will help to improve brain functions of 
patients. To detect any improvement in brain functions/ consciousness levels 
we used CRS-R as a bedside clinical assessment tool, and two different ERP 
paradigms as neurophysiological assessment tools.  
In order to detect any fluctuations at the baseline we repeated all baseline 
investigations twice- four weeks apart. These were; 4-hourly saliva melatonin 
levels for 48-hours, and body temperatures as markers of circadian rhythms, 
PSG to study sleep quality and quantity, and MMN & SON ERP paradigms to 
assess brain electrical responses to stimuli.  All of these tests were repeated 
after 5 weeks of intervention, while the patients were still receiving melatonin, 
caffeine and blue light treatment. Saliva melatonin measurements were 
repeated two more times after cessation of interventions: three days and three 
weeks after to see if any improvement of circadian rhythmicity was maintained 
or not. Here, the outcomes of the interventional study will be discussed. 
9.3.1 Intervention to entrain circadian rhythm in PDOC 
There is no standard dose, duration or treatment plan available for circadian 
rhythm entrainment. We chose to use a battery of interventions to optimize 
circadian rhythm in our ten PDOC patients rather than using a single agent or 
adding them on a step-wise manner. Although this precludes the information 
on which agent is more effective than the others, our main aim was to show 
that circadian rhythm is responsive to entrainment and once the circadian 
rhythm is entrained, this leads to improvement of consciousness.  
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PDOC is a result of catastrophic brain injury which leads to pathological 
functioning of many brain networks for a duration of months and years. A single 
agent used for a short-while may be sufficient to entrain circadian rhythm in 
any other patient population or pathological condition. For example, a few days 
of melatonin and/or light treatment may be sufficient to alleviate the symptoms 
of jet-lag sleep disorder or even to treat sleep phase disorders (Bjorvatn and 
Pallesen, 2009, Arendt and Skene, 2005, Duffy and Wright, 2005, Chang et 
al., 2012). On the other hand, it was shown that patients with Alzheimer’s 
disease benefitted from melatonin treatment of much longer durations (Brusco 
et al., 1999, Brusco et al., 2000, Cardinali et al., 2012, Jean-Louis et al., 1998). 
Our baseline study suggests that patients with PDOC suffer from irregular 
circadian sleep-wake disorder which is evidenced by erratic sleep-wake 
patterns coupled with circadian rhythm abnormalities. Irregular sleep-wake is 
mostly seen in patients with neurological disorders and thought to be due to 
neuronal damage within the SCN and hypothalamus, contributed by 
inadequate environmental light and lack of physical activity. For this condition 
a combination approach which include melatonin and bright light treatment is 
recommended (Smith et al., 2008). Taking into account of above and the 
severity of brain injury in PDOC patients, it is reasonable to try interventions 
which consist of combination of chronobiotic agents of reasonably long 
duration (weeks rather than days).  
In our study melatonin and bright light treatment were used as chronobiotic 
agents and caffeine was used as an adjuvant as it inhibits melatonin production 
and has neuro-stimulating effects by blocking adenosin receptors. We also 
made sure that patients are exposed to adequate daylight during the day and 
night-time environment kept dark and quiet as much as possible. We were not 
able to increase physical activity levels due to disability levels of our patients 
and practical limitations in a long-term care environment. As the people with 
PDOC are at high risk of acute medical complications it was decided that five 
weeks of intervention duration would allow sufficient time for entrainment and 
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at the same time minimizing risk of false-negative results due to medical 
instability or drop out due to illness.  
9.3.2 Changes to circadian rhythmicity with intervention 
Our baseline investigations showed that circadian rhythm of melatonin was 
impaired, and this did not fluctuate significantly. With the intervention however, 
there was statistically significant improvement of melatonin % rhythmicity and 
melatonin peak times. This suggests that, although impaired, the circadian 
rhythms in PDOC is responsive to entrainment. We were also able to show 
that the improvement of melatonin & rhythmicity was maintained even three 
weeks after the cessation of treatment with melatonin, caffeine and bright light.  
Failure to entrain circadian rhythms were observed in blind people but also in 
people who suffer from advanced or delayed phase disorders especially when 
patients have no light perception and social/ environmental time and biological 
time are misaligned (Duffy and Wright, 2005). On the contrary, some blind 
people were observed to entrain and this was thought to be due to strong 
enough non-photic cues such as exercise, scheduled meal-times and social 
cues (Mistlberger and Skene, 2005). 
Upon close examination of the patient who had improvement of circadian 
rhythmicity, we observed that older patients (>60 years age) with non-
traumatic brain injuries did not have much improvement of melatonin % rhythm 
or peak times with intervention in comparison to younger patients. It is quite 
possible that older patients need longer duration of treatment in higher doses 
due to additional age-related degeneration of circadian system and further 
reduced melatonin production. As we did not have any prior reference point, 
all our patients received the same dose and duration of light, melatonin and 
caffeine. However, it makes sense to take into consideration of additional age-
related changes when designing future studies and adjust interventions. 
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We were not able to show any improvement of body temperature % rhythmicity 
which suggests that body temperature regulation in PDOC patients is 
somewhat complicated- possibly due to impairment of autonomic 
thermoregulatory mechanisms which need to be investigated further. With an 
attempt to boost body temperature circadian rhythmicity Blume et al. piloted 
bright light stimulation on eight PDOC patients and found that although results 
were not statistically significant at the group level, three of the patients showed 
signs of improvement of body temperature circadian rhythms as well as 
diagnosis change (VS to MCS), as evidenced by shift in body temperature 
peak times and improvement of CRS-R scores (Blume et al., 2017). This re-
iterates the need to explore circadian rhythm optimization in this particular 
patient group as there is a correlation between the consciousness state and 
intactness of the circadian rhythm, and more importantly, improvement of 
circadian rhythm is associated with clinical improvement. 
9.3.3 Changes to sleep with intervention 
24-hour PSGs were performed three times for each subject during the study: 
twice at the baseline (4 weeks apart) and once more in the fifth week of 
interventions. This enabled us to see if there were any significant fluctuations 
of qualitative and quantitative sleep data in PDOC patients or not. Due to 
previously outlined challenges of scoring sleep stages in PDOC population, 
two different neuro-physiologists, who did not know which stage of the study 
the PSGs were from, reported each PSG independently. By using intra-class 
correlations, we were able to show that there was an excellent agreement 
between the two neuro-physiologists. This suggest that, although difficult, 
visual sleep staging can be performed by using the staging criteria we 
employed in this patient group.  
The changes on PSG parameters following interventions were interesting. 
Although none of the sleep parameters improvement reached statistically 
significant levels at the group level, we observed a variety of changes. Some 
patients slept longer as evidenced with increased total sleep time and sleep 
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efficiency, some slept deeper as evidenced by less stage 1 sleep with 
increased spindles and/or increased slow wave sleep, some had more REM 
sleep and some had better sleep-wake patterns. Please see Appendix 2 for 
hypnograms and sleep stage pie-charts of patients at baseline 1, baseline 2 
and post-intervention.  
It is difficult to draw conclusions on why such variety of changes were observed 
in the sleep of these ten people with PDOC. The heterogeneity in mode of 
brain injury, anatomical variations of brain damage, age, medications and even 
pre-morbid sleep habits all influence outcomes of circadian rhythm 
interventional studies like ours. Unless a large group of patients with same/ 
very similar pathophysiological characteristics and clinical features studied, it 
will be very challenging to conclude. However, based on the previous research 
on healthy and other pathological conditions, one can attempt to speculate.  
It was previously reported that exogenous melatonin which was administered 
during daytime led to increased sleep efficiency in young healthy volunteers 
(Hughes and Badia, 1997). However, timing of melatonin administration in 
certain conditions dictate the outcomes due to its phase advancing effects. In 
some subjects it may even cause increased fragmentation of sleep or early 
sleep off-set in the second half of sleep (Dijk and Cajochen, 1997). This may 
be particularly important in older patients where tendency to wake up in early 
morning hours is prominent. It was suggested that older patients may require 
administration of melatonin in the second half of the sleep episode. In our 
study, we did not see much improvement of sleep-wake patterns in older 
patients. Indeed, two of the patients (pt-7 who was 73 years old, and pt-10 who 
was 66 years old) had even worsening of their sleep efficiency with 
intervention. On the other hand, younger patients had much more consolidated 
sleep with intervention. 
Several studies examined the effect of melatonin on sleep architecture. 
Improvement of symptoms of REM sleep behaviour disorder which is a 
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parasomnia and presents itself with violent behaviours during REM sleep was 
observed with exogenous melatonin (McGrane et al., 2015). Increase of stage 
2 sleep and REM were reported in other patient groups following melatonin 
administration (Kunz et al., 2004, Fischer et al., 2003).  
In addition to known circadian, mild hypnotic and sleep regulatory effects of 
melatonin, we need to consider the effect of caffeine and blue light which were 
given in our study to inhibit melatonin secretion during the day and, also to 
increase daytime arousal levels due to their stimulating effects. Caffeine stops 
urge to sleep by counteracting adenosine.  
Adenosine regulates sleep inhibiting and sleep initiating regions of the brain. 
Adenosine levels build up during the day and peak usually 12 to 16 hours of 
being awake in people with normal circadian rhythm. This creates the sleep 
pressure (desire to sleep). Caffeine binds adenosine receptors and inactivates 
them. Therefore, despite building up of adenosine levels, brain does not get 
the desire to sleep. This continues as long as there are enough caffeine 
molecules binding to the adenosine receptors. Once the caffeine is 
metabolized, the adenosine freely binds its own receptors which creates high 
sleep pressure (Walker).  (See figure 9-3). By giving caffeine as part of the 
intervention, we might have facilitated increased alertness/ less urge to sleep 
during daytime and increased sleep pressure at night. It is possible that this 
might consequently have led to production of more consolidated sleep and 
increased slow wave activity. 
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Figure 9-1: The interactions between sleep drive and circadian wake drive. (Modified 
from "Why we sleep? The new science of sleep and dreams. Matthew Walker, 2017) 
 
9.3.4 Improvement of awareness/ consciousness levels with 
intervention 
A statistically significant increase of CRS-R scores was the most important 
outcome of this study however due to small sample size the results of this 
study should be interpreted with caution. As majority of our patients were in 
MCS some fluctuation in the consciousness levels are expected. The feedback 
given (subjectively) by the nursing and healthcare assistants were that the 
patients appeared more alert when they were awake during the intervention. 
Repeated CRS-R assessments showed that, the younger MCS patients had 
the most apparent change in their repertoire of behaviours in response to 
standard stimuli. This was in parallel with the improvements in sleep and 
circadian rhythmicity. The results of this research suggest that despite being 
in the chronic stage of their illness and, even years after brain injury, PDOC 
patients may benefit from optimization of circadian rhythmicity. 
While the positive results seen in younger MCS patients are very exciting, the 
neutral or negative results obtained in VS and older MCS patients are 
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scientifically also very significant, as gaining insight into their situations may 
help to solve some of many puzzles of disorders of consciousness. Here, I will 
be discussing them further. 
The two VS patients, who already had longer baseline TST than the others 
(albeit stage 1 sleep), showed improvement of melatonin % rhythmicity and 
peak times but they did not show any improvement of CRS-R scores or sleep 
quality/ stages. This situation raises further questions which need to be 
explored in future research: Is the brain damage so severe that despite positive 
reaction of the circadian system, other brain networks are not able to activate? 
Or, do the VS patients need longer duration or higher doses of intervention to 
generate higher level brain responses? 
Another set of interesting results were in the older patients who did not have 
any significant improvement of circadian rhythmicity and even worsening of 
sleep with intervention. Despite this, these patients still became very animated 
during intervention and had improvement of their CRS-R scores. Outside of 
formal assessments with CRS-R, they were observed to display behaviours 
which were unusual for them, such as looking at television screen directly, 
pulling on bedside rails and nodding head with music. It is likely that these 
patients are more resistant to circadian rhythm changes due to natural 
degeneration of circadian system with age, but more sensitive to stimulating 
effects of blue light and especially caffeine. Do they need melatonin at higher 
dose than we gave them? Does the timing of melatonin administration need to 
be changed to later at night, or even given twice- once in the evening and once 
more middle of the night? Do we need to give them caffeine in a smaller dose- 
may be once in the morning only to avoid sleep disruption at night? 
The results of the MMN and SON event related potential studies confirmed 
that the clinical improvements that we observed were associated with event 
related potential improvements too. This is an encouraging outcome which 
indicates that in PDOC patients brain responses, either to changes in trains of 
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meaningless stimuli (tone MMN) or personally meaningful stimuli (SON) 
sensory stimuli, can also improve in response to circadian rhythm optimization 
allowing it to be assessed quantitatively. Although clinical assessment tools 
such as CRS-R are still the gold standard for diagnosis, neurophysiological 
tests such as ERPs can help to track responses to any given treatment more 
objectively and allow more reliable quantification of changes. To my 
knowledge this is the first study which examined changes to brain’s 
electrophysiological activity as a response to clinical treatment in PDOC 
population. 
As summarized in chapter 2 of this thesis, ERPs help us to examine 
information processing and are designed to measure brain responses to 
different types of stimuli. On the other hand, challenges associated with event 
related potential studies in this patient group were previously reported 
(Kotchoubey, 2017). Due to very abnormal EEGs at the baseline and lack of 
obvious clinical/ behavioural feedback inherent to the disorders of 
consciousness, it is difficult to interpret time-locked responses in this patient 
group. Even in the less severe brain injured patients cognitive processing 
speed and reaction times are expected to be delayed. Therefore, one can 
argue that both temporal and topographical features of ERP responses would 
be atypical in DOC and therefore, outcomes of the ERP studies will need to be 
interpreted cautiously.  
MMN responses usually appear as a frontocentral negative wave with slight 
right preponderance (Morlet and Fischer, 2014). MMN is an indicator of pre-
attentive sensory memory process and shown to help predicting outcomes in 
coma and other disorders of consciousness states. On the other hand, MMN 
can also modulated by attention and therefore, it can be a useful tool for 
assessing potential to regain conscious brain functions (Holler et al., 2011). In 
a longitudinal study Wijnen et al. showed that MMN amplitudes increased with 
recovery of consciousness while VS patients were transitioning to MCS 
(Wijnen et al., 2007). It was suggested that this may be an indicator of 
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consolidation of the neural networks even before clinical observation of 
behavioural responses.  
Own name is one of the most powerful auditory stimuli which captures the 
attention of the named person and can elicit a robust electrophysiological 
response, mainly in the right hemisphere of the brain due to its self-relevance 
and emotional content (del Giudice et al., 2014). By using the SON, Qin et al. 
showed that presence of MMN carried a prognostic value in recovery from VS 
to MCS (Qin et al., 2008). Several other studies indicated that SON may have 
value in differentiating VS from MCS as well as in assisting to predict recovery 
(Schnakers et al., 2008, Risetti et al., 2013, Hauger et al., 2015). 
In this study we looked for the increase in MMN and SON amplitude with 
intervention, which both showed statistically significant results. The MMN 
responses observed in our study were later than usually observed in healthy 
people (350ms to 400ms time window as opposed to 160ms to 220ms) and 
topographically resembled the normal MMN responses (frontal with right 
preponderance). Response to SON were mainly located in left hemisphere, 
but almost resembling an MMN response within the 150ms-200ms window. 
This is not that surprising as most ERP studies conducted on PDOC patients 
show some temporal and topographical abnormalities of ERP components 
especially in the MCS patients. The functional meaning of this is not clear and 
undoubtedly more research needs to be conducted in this area. It is also 
important to note that even in some healthy people ERP responses are not 
always present and early ERP responses- like in our study, do not prove that 
the patients are consciously processing information. However, they indicate 
that the neural networks which required for actual conscious information 
processing (measured with task-related or late latency evoked responses) are 
intact.  
Simply based on the results of neurophysiological testing, it is not possible to 
conclude that optimization of circadian rhythm and/ or improvement of sleep 
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led to higher levels of conscious processing in our patients. This study was not 
designed to examine this. However, what this study shows is that, the patients 
who had clinical improvement also had better electrophysiological responses 
to auditory stimuli,  which require some form of higher order processing (supra-
segmental processing in the case of MMN and semantic meaning in the case 
of SON),  indicating that hierarchical processing by these patients’ neural 
networks is was likely improved by  optimization of their circadian rhythm, sleep 
and arousal.  
9.4 Methodological considerations 
This study was designed to explore effects of circadian rhythm optimization on 
sleep and brain functions of patients with PDOC. The first two years of the PhD 
work was spent on setting up the laboratory and developing methods. Several 
pieces of equipment, sample collections for melatonin measurements and 
electrophysiological recordings techniques were trialled to find ways of 
collecting most robust data, without causing any discomfort or harm to 
patients.  
Due to measuring many modalities to assess circadian rhythmicity, sleep, 
behavioural and neurophysiological assessments twice at the baseline and 
again after the interventions, each patient spent minimum of 13 weeks in the 
study. Although for many pathological conditions this is not a very long-time 
frame, for PDOC patients it can be, as patients with PDOC are at high risk of 
developing infections, other medical complications and death. Therefore, the 
intervention time was decided as five weeks. Although circadian rhythms can 
be re-synchronized much quicker in otherwise healthy subjects in conditions 
such as jet-lag and mild phase delay circadian sleep disorder, there was no 
clear guideline on how long this would take in patients with severe brain 
damage. It is possible that the five weeks intervention was not long enough to 
see optimum effect. Nevertheless, it was long enough to show some effect 
which led to positive clinical outcomes.  
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There are two methods of studying circadian rhythm (Minors and Waterhouse, 
1981): 
1) In a longitudinal study design where one or a few subjects are studied 
over many cycles 
2) In a transverse study design where many subjects are studies over one 
or few cycles. 
Minors and Waterhouse recommend that both methods have their own 
strength and weaknesses and in an ideal study both designs should be used. 
While longitudinal study design allows assessment of reproducibility of a 
rhythm for that individual, the transverse rhythm allows assessment of the 
reproducibility of a rhythm between individuals. In our baseline study we had 
two cycles (two 24-hour periods) to examine melatonin circadian rhythm of 15 
patients. Saliva collection was scheduled for every four hours. It was not 
practical to increase number of cycles further due to practical difficulties. 
Therefore, an additional marker of circadian rhythmicity- body temperature 
measurements were included in the study.  
Although, we aimed to collect body temperature data for a minimum of seven 
days, we only had complete data for 48 hours. We often found the I-buttons 
loose on the bed or not in contact with skin properly after shower and personal 
care of patients.  
At the RHN, every effort is made to mimic patients’ pre-morbid life-styles and 
habits. There are no hospital gowns, so patients wear their own night clothes 
at night, get washed in the morning and dressed in day clothes. Then, if there 
is no medical contra-indication they are hoisted to their own wheelchairs. Most 
patients get their hair done at the hospital’s hairdresser and some female 
patients even get to put on make-up. At the end of daily activities, and once 
the allowed sitting out time is reached, they are hoisted back to bed for 
personal care and clothes change. When in bed, most patients are re-
              Optimizing Circadian Rhythm and Characterizing Brain Function in DOC





positioned every four hours and often there are additional personal care 
episodes if the patients need it. Such an active daily routine and frequent 
manual handling activities prevented data collection with I-buttons to assess 
circadian rhythm assessments over many cycles. When the advantages and 
disadvantages weighted, it was decided that it was better to compromise on 
data collection, than to interrupt daily routine of patients which potentially could 
have affected their rhythms and sleep negatively. 
Similarly, with polysomnographic investigations, the initial aim was to obtain 
PSG data for at least 72 hours. Again, due to practical issues explained above 
and scalp irritation observed, PSG was limited to 24-hours.  
ERP studies were easier to perform than circadian rhythm assessments and 
PSG studies. When designing the paradigms, we decided to utilize simple and 
passive ERP experiments only. If I was to repeat this work in the future, I would 
also include at least two cognitive ERP experiments such as task-relevant 
paradigms (P3b components) and language-related paradigms (N400 
components for semantic violations). 
With regards to sample size, inclusion of 17 patients for baseline investigations 
was sufficient to conclude that patients with PDOC have abnormal circadian 
rhythms and sleep. However, this was not a large enough number to make 
sub-group analysis when the patients were of different ages, had a variety of 
aetiologies and a wide range of time passed since their brain injuries.  
Similarly, for the interventional study, I was able to show that an attempt to 
optimize circadian rhythmicity was a worthwhile exercise as the majority of 
patients had improvement of their circadian rhythmicity, sleep, behavioural and 
neurophysiological markers. However, I was not able to expand the results 
analysis to a variety of responses observed in patient sub-groups. This made 
it clear that, although piloting the treatment in 10 patients yielded promising 
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results in this very specific area of neuroscience, future studies are warranted, 
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Chapter 10 CONCLUSIONS AND FUTURE 
DIRECTIONS 
This PhD study makes the following contributions to the scientific body of 
evidence in PDOC; 
• Sleep and circadian rhythms are severely deranged in PDOC.  
• Optimization of circadian rhythms and sleep with melatonin, caffeine 
and blue light treatment led to improvement of all physiological 
parameters measured. 
• And, most importantly, this simple and inexpensive treatment protocol 
led to improvement of awareness/ consciousness levels as evidenced 
by improvement of CRS-R scores and supported by enhanced 
amplitudes of event-related potential responses in MMN and SON 
experiments. 
It is important to note that the participants of this research study received only 
five weeks of treatment and they were chronic PDOC patients whose circadian 
rhythms and sleeps run abnormally for many months and years. It is very likely 
that if optimization of circadian rhythms was achieved in earlier stages of the 
DOC, maybe even when patients are still in an intensive care environment, 
and this was maintained during rehabilitation and long-term care, the clinical 
outcomes would be much better. 
Based on the outcomes of this PhD research study, I finally conclude that 
future research studies are warranted to further explore the effects of circadian 
rhythm and sleep optimization in PDOC patients. The future work should 
include; 
a) Bigger cohort of patients to perform in depth analysis of results obtained 
in different sub-groups i.e. traumatic vs. non-traumatic brain injuries, 
young patients vs. older patients, 
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b) A larger sample size to further explore the relationship between feeding 
times and sleep/ circadian rhythm optimization, 
c) Future studies should be multi-centric to enable inclusion of patients 
from acute, sub-acute and chronic disorders of consciousness stages, 
d) A wide collaborative work should be considered to include expertise of 
neuro-rehabilitation clinicians, chronobiologists, neurophysiologists and 
neuroscientists to achieve robust methodology and data analysis in this 
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APPENDIX 1: DETAILED CLINICAL 
INFORMATION FOR INTERVENTIONAL STUDY 
PARTICIPANTS   
The clinical features of the participants are summarized below: 


















Score at the 
time of 
participation 
Patient-1 71/Female SAH 13 
months 
5 VS  16 
Patient-2 58/Male Anoxic 12 
months 
5 VS 8 
Patient-3 37/Male Anoxic 6 months 2 VS 7 
Patient-4 51/Male CVA(Bleed) 18 
months 
4 MCS 11 
Patient-5 30/Female TBI (DAI) 5 years 7 MCS 17 
 
Patient-6 43/Female CVA(Bleed) 11 
months 
3 VS 17 
Patient-7 73/Male CVA 18 
months 
8 MCS 12 
Patient-8 40/Female TBI (DAI) 12 
months 
3 VS 11 
Patient-9 68/Male Vasculitis 13 
months 
2 VS 5 
Patient-
10 
66/Female Anoxic 38 
months 
6 VS 9 
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Clinical Background: Patient-1 is a 70 year old woman who suffered from 
right frontal intracranial bleeding secondary to thrombolysis treatment for 
pulmonary embolism in 2008 while undergoing treatment for tuberculosis 
meningitis. She later on developed hydrocephalus which required ventriculo-
peritoneal (VP) shunt insertion. She received initial rehabilitation at the Brain 
Injury Services of the Royal Hospital for Neuro-disability and underwent 
SMART and WHIM assessments in 2009. Both assessments were completed 
13 months post brain injury. Her diagnosis was vegetative state. She had a 
period of two weeks where she showed increased levels of alertness and 
single word replies to simple questions following VP shunt insertion. However, 
these responses disappeared, and neuro-surgical opinion was that there was 
no VP shunt malfunction to explain this. She remained in vegetative state with 
occasional and very brief periods of increased alertness and responsiveness 
while with close family members. She was then transferred to a long term care 
ward at RHN for provision of specialist nursing home care.  
Brain Imaging: CT Brain, 2009- dilatation of the ventricular system in 
comparison with the degree of sulcal prominence in keeping with a 
communicating hydrocephalus, together with extensive white matter low 
attenuation which could reflect transependymal oedema. 
Medications at the time of study: Co-Careldopa, Levetiracetam, Lansoprazole, 
Ramipril, Laxatives, Hyoscine Patch, Dalteparin. No PRN sedatives were 
given to patient at the time of study. 
Feeding Regime: Daytime via PEG. 
Brainstem Auditory Evoked Potentials: BAEP responses elicited with 
monoaural stimulation delivered to the right and left ears were within normal 
limits for waves III, IV and V bilaterally. Wave II was slightly delayed for the 
right and left ears. Wave I was slightly delayed for the left ear. Interpeak latency 
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between waves III and IV were within normal limits on the right, however, on 
the left the latency was short.  The interpeak latency between waves I-V on 
the right was 3.7 and on the left was 3.6. These values were within normal 
limits. 
Right Ear         
Wave I II III IV V Interpeak I-III Interpeak III-V V* 
Latency 1.8 3.0 3.8 4.9 5.5 2 1.7 5.4 
Left Ear         
Wave I II III IV V Interpeak I-III Interpeak III-V V* 
Latency 1.9 3.0 3.9 4.6 5.5 2 0.7 5.7 
 
Baseline EEG: Baseline EEG taken on 09/07/2012 prior to commencing 
polysomnographic recording for a period of 24Hrs. The ongoing EEG showed 
mainly diffuse polymorphic delta activity at 2.0-2.5Hz, at 20-30µV. Small 
amounts of beta activity at 16-18Hz was seen superimposed diffusely, with 
patchy distribution. Throughout the baseline recording, focal slow activity was 
seen over the left parietal region.  
10.2 Patient-2 
Clinical Background: Patient-2 is a 58 year old man who suffered from anoxic 
brain injury following severe asthma attack in 2008. Following the brain injury, 
he was also diagnosed with supra-ventricular tachycardia, congestive cardiac 
failure, tonic-clonic seizure activity and myoclonic jerks. He received initial 
rehabilitation at the Brain Injury Services of the Royal Hospital for Neuro-
disability and underwent SMART and WHIM assessments in 2009. 
Assessments were completed at 8 months post brain injury which both 
indicated diagnosis of vegetative state and patient was closely monitored for 
further 4 months. No significant changes were observed, and patient was 
transferred to a long term care ward at RHN for provision of specialist nursing 
home care. 
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Brain Imaging: CT Brain, 2008- widespread cortical ischaemia and widespread 
loss of gray-white matter differentiation both in the cortex and basal ganglia. 
Medications at the time of study: Amiodarone, Clonazepam, Diltiazem, 
Ramipril, Frusemide, Levetiracetam, Sodium Valproate, Levothyroxine, 
Domperidone, Laxatives. Lansoprazole. 
Feeding Regime: Daytime via PEG. 
Brainstem Auditory Evoked Potentials: Brainstem auditory evoked responses 
were obtained using monoaural stimulation of the right and left ears. 
Responses from the right ear were absent. Responses from the left ear were 
present. Waves I to V were seen however the latencies of waves I to IV were 
delayed, with wave V arising at the upper limit of the reference range. Interpeak 
latencies were within normal limits. 
Right Ear 







Latency - - - - - ******** ******** - 
Left Ear 







Latency 1.9 3.5 4.4 5.6 6.0 2.5 1.2 ***** 
 
Baseline EEG: Baseline EEG taken prior to commencing polysomnographic 
recording for a period of 24Hrs. The ongoing EEG showed diffuse polymorphic 
delta activity at 1.0-2.5Hz between 10-20µV (low amplitude record). Beta 
components at 18-20Hz was seen diffusely at <15µV. The ongoing recording 
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was occasionally disrupted by single generalised sharp waves or spike 
discharges. 
10.3 Patient-3 
Clinical Background: Patient-3 is a 36 year old man who suffered from anoxic 
brain injury following cardiac arrest in 2012. He received initial rehabilitation at 
the Brain Injury Services of the Royal Hospital for Neuro-disability and 
underwent SMART and WHIM assessments which completed 6 months post 
brain injury. Both assessments indicated diagnosis of vegetative state. Patient 
was transferred to a long term care ward at RHN for provision of specialist 
nursing home care and closely monitored. No changes to consciousness 
levels were observed.  
Brain Imaging: CT Brain, 2012- abnormalities consistent with hypoxic brain 
injury. 
Medications at the time of study: Hyoscine Patch, Lansoprazole, Metformin, 
Aspirin, Simvastatin, Bisoprolol, Clonazepam, Dantrolene. 
Feeding Regime: Daytime via PEG. 
Brainstem Auditory Evoked Potentials: Right Ear-Wave I, III, IV, V latencies 
were within normal limits. Interpeak latency between waves I to III, between 
waves III to V, between waves I to V were within normal limits. Wave II latency 
was delayed. 
Left Ear-Wave I, IV, V latencies were within normal limits. Interpeak latency 
between waves I to III are within normal limits. Interpeak latency between 





              Optimizing Circadian Rhythm and Characterizing Brain Function in DOC





Right Ear       






Latency 1.9 3.2 4.0 5.1 6.2 2.1 2.2 4.3 6.2 
Left Ear          






Latency 1.8 3.1 4.3 5.4 6.1 2.5 1.1 4.3 6.1 
 
Baseline EEG: The patient was unresponsive. The EEG was taken whilst the 
patient was in his wheelchair as an initial baseline preceding a 24-hour 
polysomnography. The ongoing EEG comprised frequent spike wave 
discharges which were separated by intervals of low amplitude featureless 
background. These intervals tended to be short (1-2seconds). 
10.4 Patient-4 
Clinical Background: Patient-4 is a 51 year old man who suffered from 
intracerebral and subdural haemorrhage following craniotomy and 
embolization for right temporal arteriovenous malformation in 2009. He 
received initial rehabilitation at the Brain Injury Services of the Royal Hospital 
for Neuro-disability and underwent SMART and WHIM assessments in 2010. 
Both assessments elicited tracking responses to visual stimuli and were 
suggestive of diagnosis of Minimally Conscious State. These were completed 
at 18 months post brain injury. The patient was transferred to a long term care 
ward at RHN for provision of specialist nursing home care. 
Brain Imaging: Right temporal AVM, intracerebral and subdural haemorrhage 
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Medications at the time of study: Baclofen, Dantrolene, Gabapentin, 
Lansoprazole, Sodium Valproate 
Feeding Regime: Between 16:00 and 04:00 via PEG. 
Brainstem Auditory Evoked Potentials: Right Ear: Stimulation of the right ear 
did not elicit any reproducible BAEP responses. Left Ear: Responses were 
elicited on stimulation of the left ear. Waves I, II, III were present and latencies 
were within normal limits. Wave IV was absent. Wave V was delayed. 
Right Ear     
Wav
e 


















NT   
ABSE
NT 
Left Ear      
Wav
e 








cy 1.5 2.7 3.9 
ABSE





Baseline EEG: The ongoing EEG was asymmetric. Right Hemisphere: Over 
the right hemisphere EMG artefact obscured the frontal derivations. The 
quiescent channels were of impoverished amplitude devoid of distinguishing 
characteristics over the central to anterior parietal region. Low amplitude 6Hz 
theta components seen occipitally.  
Left hemisphere: was of higher amplitude, the dominant rhythm was theta 
activity seen centrally to posteriorly at 6-7Hz. Admixture of delta activity at 1.5-
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2.5Hz was seen over the posterior quadrant. Negligible amounts of beta 
activity were seen anteriorly at 18-22Hz. 
10.5 Patient-5 
Clinical Background: Patient-5 is a 30 year old woman who suffered from 
diffuse axonal injury secondary to road traffic accident in 2006. She was 
treated in the UK following her brain injury and transferred to a nursing home 
abroad. She was admitted to the Brain Injury Services of the Royal Hospital 
for Neuro-disability for further rehabilitation and assessment in 2011. The 
assessments at the RHN indicated that she was in Minimally Conscious State. 
The patient was transferred to a long term care ward at RHN for provision of 
specialist nursing home care where she remained in same clinical condition.  
Brain Imaging: CT Brain, 2006 - multiple widespread petechial haemorrhage. 
Medications at the time of study: Baclofen, Citalopram, Gabapentin 
Feeding Regime: Between 16:00 and 02:00 via PEG. 
Brainstem Auditory Evoked Potentials: Right and Left Ear-Wave I, II, III, IV and 
V latencies were within normal limits. Interpeak latency between waves I to III, 
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Latency 1.4 2.4 3.5 4.6 5.2 2.1 1.7 3.8 5.3 
Left Ear          







Latency 1.9 2.7 3.7 4.7 5.3 1.8 1.6 3.4 6.2 
 
Baseline EEG: The ongoing EEG was dominated by delta activity at 1.5-2.0Hz, 
up to 50µV seen diffusely. Occasional ripples of theta activity at 6-7Hz were 
seen superimposed over the posterior regions with subtle predilection towards 
the left side. Beta activity at 15-17Hz was seen over the frontal and central 
regions bilaterally. 
10.6 Patient-6 
Clinical Background: Patient-6 is a 43 year old woman who had a history of 
glioma which was removed at the age of 9 years but complicated with 
hydrocephalus requiring bilateral ventriculo-peritoneal shunt insertion. She 
further suffered from severe left temporo-parietal haemorrhage in 2009 which 
cause worsening of her hydrocephalus and necessitated shunt revision 
surgery in 2010. She was admitted to the Brain Injury Services of the Royal 
Hospital for Neuro-disability for further rehabilitation and assessment in 2010. 
The assessments at the RHN indicated that she was in Vegetative State. The 
patient was transferred to a long term care ward at RHN for provision of 
specialist nursing home care where she remained in same clinical condition.  
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Brain Imaging: CT Brain, 2009- haemorrhage occupying the left temporo-
parietal region with surrounding oedema and associated midline shift with 
extension into the posterior horn of the left lateral ventricle. In addition to this 
there was high attenuation to the right of the third ventricle which represents 
further haemorrhage. There was evidence of bilateral shunts and the third 
ventricle appeared narrow when compared to the previous CT. 
Medications at the time of study: Amlodipine, Doxazocin, Levetiracetam, 
Oxybutinine, Simvastatin 
Feeding Regime: 18:00 to 02:00 via PEG 
Brainstem Auditory Evoked Potentials: Brain stem responses were poorly 
formed bilaterally, but the waveforms were still discernible. 
Right ear: Wave I, II, IV, V latencies are delayed. Increased interpeak latencies 
between waves I and III, and also waves III and V were seen. 
Left ear: Wave I, II, IV latencies are within normal limits. Interpeak latency 
between waves III to V are within normal limits. Interpeak latency between 
waves I to V are within normal limits. Wave V latency is delayed. Delayed wave 
V with normal latencies for waves I and III indicates possible lesion affecting 
auditory pathways above the caudal pons, considered as an extreme 
prolongation of the III-V interval.  
Summary- prolongation of the I-III Interpeak latencies bilaterally indicate defect 
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Latency 2.0 3.2 5.5 7.1 7.8 3.2 2.6 5.8 absent 
Left Ear          







Latency 1.6 2.8 4.8 5.7 6.3 3.2 1.5 4.7 6.4 
 
Baseline EEG: Asymmetric EEG, dominant δ and θ activity on the right. 
10.7 Patient-7 
Clinical Background: Patient-7 is a 73 year old man who suffered from bilateral 
ganglia infarcts, and infarction in the left occipital lobe following elective 
cardiac surgery in 2004.  He was admitted to the Brain Injury Services of the 
Royal Hospital for Neuro-disability for further rehabilitation and assessment in 
2005. The SMART and WHIM assessments at the RHN indicated that he was 
in Minimally Conscious State. The patient was transferred to a long term care 
ward at RHN for provision of specialist nursing home care where he remained 
in same clinical condition.  
Brain Imaging: Brain CT in 2004- bilateral ganglia infarcts, and infarction in the 
left occipital lobe, adjacent to the falx. Calcification of both internal carotid 
arteries and the right vertebral artery was also noted. 
Medications at the time of study: Bisoprolol, clonazepam, gabapentin, warfarin 
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Feeding Regime: 16:00 to 02:00 via PEG 
Brainstem Auditory Evoked Potentials: Intermittently agitated during testing, 
mainly head movements which effected the technical quality of the recorded 
signals. 
Right Ear          







Latency 2.0 0 0 5.2 5.9    5.9 
Left Ear          







Latency 1.7 0.0 4.0 4.9 5.2    6.2 
 
Baseline EEG: The ongoing EEG during quiescence was dominated by theta 
activity at 6-7Hz seen over precentral to posterior regions bilaterally. 
Occasional delta components at 2-3Hz were intermingled across post central 
areas. Beta activity at 18-20Hz was seen over the frontal regions bilaterally. 
Brief episodes of somnolence were demarcated by the appearance of slow 
lateralised eye movements and quiescent EEG recording. 
10.8 Patient-8 
Clinical Background: Patient-8 is a 39 year old woman who suffered severe 
traumatic brain injury (diffuse axonal injury) following a fall from height in 2010. 
The SMART and WHIM assessments at the RHN in late 2010 indicated that 
she was in Vegetative State. The patient was transferred to a long term care 
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ward at RHN for provision of specialist nursing home care where she remained 
in same clinical condition.  
Brain Imaging: Brain CT in 2010- multiple widespread, predominantly frontal, 
petechial haemorrhages; blood in the ventricles, in the interpeduncular cistern 
and subarachnoid space. 
Medications at the time of study: Baclofen, hyoscine patches, laxatives, 
lansoprazole 
Feeding Regime: 10:00 to 20:00 via PEG 
Brainstem Auditory Evoked Potentials: 
 
 
Right Ear          







Latency 2.4 3.2 4.0 4.6 5.6    7.7 
Left Ear          







Latency 2.1 3.3 4.7 6.0 6.8    7.5 
 
Baseline EEG: The ongoing EEG was dominated by delta activity at 1.5-2.0Hz, 
up to 50µV seen diffusely. Occasional ripples of theta activity at 6-7Hz were 
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seen superimposed over the posterior regions with subtle predilection towards 
the left side. Beta activity at 15-17Hz was seen over the frontal and central 
regions bilaterally. 
10.9 Patient-9 
Clinical Background: Patient-9 is a 58 year old man who was diagnosed with 
toxic epidermal necrolysis/ Steven-Johnson Syndrome which led to severe 
inflammatory brain disease in 2011. The SMART and WHIM assessments at 
the RHN in late 2012 indicated that he was in Vegetative State. The patient 
was transferred to a long term care ward at RHN for provision of specialist 
nursing home care where he remained in same clinical condition.  
Evoked potentials investigation has been performed at St Georges Hospital on 
9.2.2012. Visual flash evoked potentials showed: no ERG response, fairly 
formed occipital cortex evoked responses with normal latencies which 
indicates presence of an intact visual pathway. Auditory evoked potentials 
were suggestive of mild dysfunction of auditory pathway. 
Brain Imaging: MRI scan 1- showed diffuse symmetrical white matter changes 
suggestive of cytotoxic oedema. Repeat MRI scan showed progression of 
widespread necrotising process- necrotising leukoencephalopathy. 
Medications at the time of study: Bisoprolol, pregabalin 
Feeding Regime: 16:00 to 04:00 via PEG 
Brainstem Auditory Evoked Potentials: Initial Auditory evoked potentials were 
suggestive of mild dysfunction of auditory pathway. Repeat BAEP showed:  
The right ear -No reproducible responses were obtained on stimulation of the 
right ear. 
The left ear -Wave I latency is within normal limits. Wave IV latency is within 
normal limits. Interpeak latency between waves I to III are within normal limits. 
Interpeak latency between waves III to V are within normal limits. Interpeak 
              Optimizing Circadian Rhythm and Characterizing Brain Function in DOC





latency between waves I to V are within normal limits. Wave II latency is 
delayed. Wave V latency is delayed. Delayed wave V with normal latencies for 
waves I and III indicates possible lesion affecting auditory pathways above the 
caudal pons. This can be considered as prolongation of the III-V interval. 
Righ
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Baseline EEG: Diffuse δ 1-2,5Hz, occasional θ 
10.10 Patient-10 
Clinical Background: Patient-10 is a 66 year old woman who suffered from 
anoxic brain injury due to complications following an elective surgery for 
ovarian cyst removal in 2004. Following extensive neurological investigations 
and rehabilitation she was admitted to RHN in 2007 for further rehabilitation 
and specialist assessments. The SMART and WHIM assessments at the RHN 
in 2007 indicated that she was in Vegetative State. The patient was transferred 
to a long term care ward at RHN for provision of specialist nursing home care 
where she remained in same clinical condition.  
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Brain Imaging: MRI scan 2004- extensive diffuse signal change in the left 
temporal lobe, the left occipital and parietal cortices consistent with ischaemic 
damage. 
Medications at the time of study: Clobazam, diazepam levetiracetam, 
mebeverine, mirtazapine, omeprazole, paracetamol, ramipril, zopiclone, 
amlodipine, atorvastatin 
Feeding Regime: three milkshakes during the day PO, water at night via PEG 
Brainstem Auditory Evoked Potentials:  
Right and Left Ear-Wave I, II, III, IV, V latencies are within normal limits. 
Interpeak latency between waves I to III, between waves III to V, between 
waves I to V are within normal limits.  
 
Right Ear          







Latency 1.7 2.6 3.8 5.1 5.6 2.1 1.8 3.9 5.6 
Left Ear          







Latency 1.5 2.5 3.9 5.3 ?5.8 2.4 1.9 4.3 5.8 
 
Baseline EEG: The wake EEG showed copious amounts of beta activity seen at 15-
17Hz. 










APPENDIX-2: INTERVENTIONAL STUDY SLEEP DATA AND HYPNOGRAPHIES  













Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1163 - 80.40% 
Stage 1 192.5 67.80% 13.30% 
Stage 2 91.5 32.20% 6.30% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
284 100.00% 19.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1349 - 93.30% 
Stage 1 51.5 53.40% 3.60% 
Stage 2 31.5 32.60% 2.20% 
Stage 3 13 13.50% 0.90% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0.5 0.50% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
96 99.50% 6.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1370 - 88.00% 
Stage 1 83.5 44.90% 5.40% 
Stage 2 71.5 38.40% 4.60% 
Stage 3 25 13.40% 1.60% 
Stage 4 0 0.00% 0.00% 
REM 1 0.50% 0.10% 
MT 5 2.70% 0.30% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
180 96.80% 11.60% 
 
 


















WAKE 1206 - 90.40% 
Stage 1 78 60.70% 5.80% 
Stage 2 50.5 39.30% 3.80% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
128.5 100.00% 9.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1521.5 - 95.50% 
Stage 1 72 100.00% 4.50% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
72 100.00% 4.50% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1270 - 85.80% 
Stage 1 132 62.70% 8.90% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 78.5 37.30% 5.30% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
132 62.70% 8.90% 
 
 



















WAKE 919.5 - 63.30% 
Stage 1 527 99.00% 36.30% 
Stage 2       
Stage 3       
Stage 4       
REM       
MT 5.5 1.00% 0.40% 
UNS   -   
NREM 
(1+2+3+4) 
527 99.00% 36.30% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1343.5 - 82.20% 
Stage 1 288 98.60% 17.60% 
Stage 2       
Stage 3       
Stage 4       
REM       
MT 4 1.40% 0.20% 
UNS   -   
NREM 
(1+2+3+4) 
288 98.60% 17.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1173.5 - 77.00% 
Stage 1 346.5 98.90% 22.70% 
Stage 2       
Stage 3       
Stage 4       
REM       
MT 4 1.10% 0.30% 
UNS   -   
NREM 
(1+2+3+4) 
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WAKE 1309.5 - 80.50% 
Stage 1 300 94.80% 18.40% 
Stage 2 9 2.80% 0.60% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 7.5 2.40% 0.50% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
309 97.60% 19.00% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1115 - 71.80% 
Stage 1 302 68.90% 19.40% 
Stage 2 1.5 0.30% 0.10% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 43 9.80% 2.80% 
MT 92 21.00% 5.90% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
303.5 69.20% 19.50% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 682.5 - 49.40% 
Stage 1 547.5 90.90% 39.60% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 54.5 9.10% 3.90% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
547.5 90.90% 39.60% 
 
 





















WAKE 1576 - 95.80% 
Stage 1 67 96.40% 4.10% 
Stage 2 2.5 3.60% 0.20% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
69.5 100.00% 4.20% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1455 - 95.10% 
Stage 1 70.5 100.00% 4.60% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
70.5 100.00% 4.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1262 - 84.90% 
Stage 1 156.5 69.70% 10.50% 
Stage 2 11 4.90% 0.70% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 56.5 25.20% 3.80% 
MT 0.5 0.20% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
167.5 74.60% 11.30% 
 
 





















WAKE 1308.5 - 87.90% 
Stage 1 180.5 100.00% 12.10% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
180.5 100.00% 12.10% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1215 - 81.80% 
Stage 1 224 82.70% 15.10% 
Stage 2 46 17.00% 3.10% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 1 0.40% 0.10% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
270 99.60% 18.20% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 869.5 - 58.00% 
Stage 1 603 95.90% 40.30% 
Stage 2 22 3.50% 1.50% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 3.5 0.60% 0.20% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
625 99.40% 41.70% 
 
 





















WAKE 1123.5 - 79.10% 
Stage 1 173 58.30% 12.20% 
Stage 2 116.5 39.30% 8.20% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 7 2.40% 0.50% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
289.5 97.60% 20.40% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1319 - 86.10% 
Stage 1 100.5 50.20% 6.60% 
Stage 2 98 49.00% 6.40% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 1.5 0.80% 0.10% 
UNS 13 - 0.80% 
NREM 
(1+2+3+4) 
198.5 99.20% 13.00% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1359.5 - 91.80% 
Stage 1 87 88.30% 5.90% 
Stage 2 11 11.20% 0.70% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0.5 0.50% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
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WAKE 1508.5 - 97.60% 
Stage 1 31 82.70% 2.00% 
Stage 2 6.5 17.30% 0.40% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
37.5 100.00% 2.40% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1308 - 92.20% 
Stage 1 83.5 75.90% 5.90% 
Stage 2 26 23.60% 1.80% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0.5 0.50% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
109.5 99.50% 7.70% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1174.5 - 80.10% 
Stage 1 49.5 25.20% 3.40% 
Stage 2 93.5 47.60% 6.40% 
Stage 3 53.5 27.20% 3.60% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
196.5 100.00% 13.40% 
 
 





















WAKE 1278.5 - 77.70% 
Stage 1 306 100.00% 18.60% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 59.5 - 3.60% 
NREM 
(1+2+3+4) 
306 100.00% 18.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1558 - 95.00% 
Stage 1 82.5 100.00% 5.00% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
82.5 100.00% 5.00% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1553.5 - 90.70% 
Stage 1 159 99.40% 9.30% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 1 0.60% 0.10% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
159 99.40% 9.30% 
 
 





















WAKE 1222.5 - 78.40% 
Stage 1 49.5 14.90% 3.20% 
Stage 2 210.5 63.50% 13.50% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 68 20.50% 4.40% 
MT 3.5 1.10% 0.20% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
260 78.40% 16.70% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1054.5 - 71.30% 
Stage 1 423 100.00% 28.60% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
423 100.00% 28.60% 
 
Stages Time % Sleep 
Time 
% Time in 
Bed 
WAKE 1483.5 - 96.00% 
Stage 1 62 100.00% 4.00% 
Stage 2 0 0.00% 0.00% 
Stage 3 0 0.00% 0.00% 
Stage 4 0 0.00% 0.00% 
REM 0 0.00% 0.00% 
MT 0 0.00% 0.00% 
UNS 0 - 0.00% 
NREM 
(1+2+3+4) 
62 100.00% 4.00% 
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Purpose: The aim of this study was first of all to investigate the sound, light, 
temperature and humidity levels in a rehabilitation ward and to establish whether the 
measured levels were within the recommended levels or not; secondly to explore 
influence of the type of the patient rooms on obtained measurements. 
Methods: Measurements of environmental characteristics were recorded on three 
non-consecutive nights by data loggers in a 12-bedded residential neurological 
rehabilitation unit for patients with disorders of consciousness. The obtained 
measurements were compared with the recommendations of the World Health 
Organization and the Society of Light and Lighting.  





Results: Recordings were within recommended levels for light and humidity overnight. 
Average noise levels were above the recommended levels. There were abrupt 
increases of light and noise levels which were high enough to cause sleep 
fragmentation. Mean temperature levels were higher than recommended. 
Conclusions: Our results indicated that the patients are at risk of disturbed sleep for 
the duration of their stay in rehabilitation unit. Exposure to generally high noise levels, 
as well as the sudden increases of noise and light intensities can prevent reaching 
restful nighttime sleep and may negatively impact on rehabilitation process due to 
impaired memory, learning and well-being.  
Introduction 
Fatigue, lethargy, day time reduced arousal level and low mood are common problems 
that are encountered in neurological rehabilitation units. These problems are usually 
attributed to physical, or if present, cognitive impairment of patients. However, very 
little attention is paid to sleep patterns. It has been previously demonstrated that sleep 
fragmentation caused by relatively brief interruptions leads to measurable changes in 
daytime alertness, cognitive functioning including memory and learning, psychological 
functioning and neuroplasticity.1-5 Daytime sleepiness and fatigue have been shown 
to be related to difficulties in sleeping.6 Sleep disturbance is also a significant risk 
factor for obesity, diabetes, myocardial infarction, stroke and coronary artery disease.7 
Impaired immune function, decreased inspiratory muscle endurance and delirium 
have also been reported as adverse consequences of sleep disruption.8-10  
The commonest preventable causes of such interruptions in ward based settings are 
background noise and light with sudden interruptions being particularly disruptive. 





Noise levels are expressed as in decibel (dB). While the noise level in a quiet bedroom 
at night is around 30 dB, the noise generated by loud hand clapping at one meter 
distance is 130 dB. To the human ear, a gain of 10 dB is perceived as twice as loud. 
Light intensity levels on the other hand, are expressed as in lux. While average 
luminance in well-lit office is around 500 lux, good main road lighting luminance levels 
are approximately 100 lux. Environments that are too hot or cold may also be 
disturbing. Standards for ward based hospital environments to minimise sleep 
disturbance developed by the World Health Organization (WHO) and The Society of 
Light and Lighting. 
According to the Guidelines for Community Noise11, the noise levels in hospital rooms 
should be 35 dB or less. The recommended maximum intensity for individual events 
at the patient’s bedside is 45 dB. Temperature and humidity should be maintained 
between 20-22 C° and 30-60 % respectively.12 The Society of Light and Lighting 
recommends that night and observation illuminance in patient rooms should be below 
5 lux and should not exceed 10 lux.13 
Studies examining the environmental characteristics in intensive care and acute health 
care settings have demonstrated that the levels of noise and light were above the 
recommended levels for hospitals and sleep disruption was common.14, 15  
The duration of stay in a rehabilitation unit varies greatly but in comparison with other 
types of inpatient admissions is very lengthy. Therefore night time environmental 
characteristics of patient rooms, namely light, noise, temperature and humidity levels 
need to be optimised not only to provide comfortable accommodation but to improve 
sleep quality and consequently to minimize the problems that may be faced due to 
poor sleep. 





This is the first study to examine levels of sound, light, temperature and humidity in a 
rehabilitation setting. The aim of this study was first of all to investigate the sound, 
light, temperature and humidity levels in different types of rooms in a rehabilitation 
ward and to establish whether the measured levels were within the recommended 




The study setting was a 12-bed inpatient neurological rehabilitation unit part of a large 
rehabilitation center located in London, United Kingdom. The unit is located on the 
third floor of the main building which is approximately 20m away from a busy main 
road. There are one 4-bedded, two 2-bedded and four one-bedded rooms in the unit.  
The unit specializes in assessment and rehabilitation of patients with severe acquired 
brain injuries leading to disorders of consciousness such as vegetative and minimally 
conscious states.  
Patients are usually returned to bed in the late afternoon due to limited sitting tolerance 
and are repositioned in bed every four hours. Evening medications are given by 
nursing staff at 18.00, 20.00 and 22.00 hours and morning medications are given at 
08.00 hours. Due to their disability patients are not able to control any of the devices 
that might be a source for light or noise.  
Design 





Measurements of light, sound, temperature and humidity over a 12 hour period, 
between 7pm and 7am, were obtained in occupied one bedded, two bedded and four 
bedded patient rooms. The measurements were repeated on another night within an 
unoccupied one-bedded room in order to gain better understanding of contributory 
factors arising from presence of patients such as increased room temperature, and 
more frequent entry of nursing staff to the rooms. Measurements were repeated on 
three separate occasions during late autumn/winter months in order to obtain 
information on use of artificial lighting by staff.  
Six two-hourly intervals beginning at 7pm were chosen to capture the variability 
between high and low activity times. Between 7pm and 9pm nursing staff handover 
takes place and some patients may have still have visitors on the ward. On the other 
hand, between 11pm till 5am, only bed positioning and observation of patients are 
performed. After 5am activity increases due to administration of medications and feed.  
The study was approved by the local audit committee. Due to the nature of their illness 
the patients were not able to consent or communicate. Nevertheless, at the time of 
data logger placement they were told of the purpose and nature of the study. The night 
shift ward staff and the patient relatives were informed of the audit study through 
written information sheets and verbal communication.  
Measurement of Environmental Characteristics 
SOUND 
Sound levels were measured using a Tecpel 331 sound level meter (Tecpelco Ltd, 
Taiwan). The Tecpel 331 sound level meter has an accuracy of ± 0.5 decibels (dB). 
The dimensions of the device are 275 x 64 x 30 millimeters. The sound level meter 





was programmed to measure sound level ranges of 30 to 130 dB. The Tecpel 331 
sound level meter can measure from 25 dB in a quite closed environment. Sound 
measurements were sampled every 30-seconds and stored in the data logger’s 
internal memory. The data collected by the device was downloaded onto a computer 
using the SE322 software provided by Tecpelco to be used with the sound data logger. 
During a 12 hour period 1440 sound measurements were obtained. 
LIGHT 
Light levels were measured with the Tecpel 536 light meter/ RS232 data logger device 
(Tecpelco Ltd, Taiwan), and stored in the device’s internal memory. The Tecpel light 
meter sensor measures light intensity with a range of zero to 2000 Lux. This device 
measures 146 x 70 x 39 millimeters. The light measurements were sampled every 5 
seconds. The data collected by the light meter was downloaded onto a computer using 
RS232 software provided by Tecpelco. Over a 12 hour period 8640 light 
measurements were recorded. 
TEMPERATURE AND HUMIDITY 
Temperature and humidity were measured using CEM DT-172 temperature and 
humidity data logger (CEM, China). This device has measurement range of zero to 
100%RH (relative humidity) and -40 to 70 °C with accuracy of ±3%RH and ±1% °C. 
The dimensions of this device are 94 x 48 x 33 millimeters. Both temperature and 
humidity levels were sampled every 30 minutes. Twenty-four measurements of 
temperature and humidity were collected in the 12 hour period. 
 





Data Collection Procedures 
At the onset of data collection all data loggers were initialized using their software. All 
three data loggers were mounted to a hard plastic frame measuring 20cm x 30cm and 
placed within one meter distance of patient’s bedside at the level of the head and at 
least two meters away from the room door. The location of data loggers did not 
interfere with nursing care activities. Overnight nursing care of the patients was not 
altered during the study. The patients were continued to be observed as normally and 
re-positioned in bed every four hours as part of their postural management program. 
Despite being in vegetative state some patients are able to make sounds such as 
groaning or laughing. At the time of the study, none of the patients were known to 
vocalize, and no monitoring equipment was being used that generated noise or light 
signals.  
Data was collected continuously between 7:00pm and 7:00am on three different nights 
in one-bedded, two-bedded and four-bedded rooms which were occupied by patients 
to their maximum capacity i.e., all four beds were occupied in four-bedded room. The 
measurements were repeated on another night within an unoccupied one-bedded 
room in order to gain better understanding of contributory factors arising from 
presence of patients such as increased room temperature, and more frequent entry of 
nursing staff to the rooms.  
At the end of the measurements nursing staff were asked to find out if there were any 
unusual events during the night, such as a medical emergency in the adjacent ward. 
Results of the study were presented to nursing staff in order to obtain their feedback 
and views on nighttime sleep environment of patients.  






All stored data was downloaded from data loggers into a desktop computer for analysis 
using their own connection USB cables and specific software. Numeric data was then 
loaded into Excel (Microsoft, USA) and transferred into Origin-Pro version 8.5 
(OriginLab Corp., USA) for statistical analysis. Light and noise during each 2-hour 
interval and temperature and humidity during 12-hour period were calculated using 
descriptive statistics (mean, SD, SE and range). Examination of the data represented 
graphically suggested that this was normally distributed. Variability of environmental 
measures for the three different types of rooms was analyzed with one way 
independent ANOVA, followed by Tukey’s means comparison post hoc test. 
Results 
TEMPERATURE AND HUMIDITY 
The mean temperature within the unoccupied one bedded room was 25.28 C° which 
was higher than in the occupied rooms and well above recommended levels. The 
average nighttime temperature within the occupied one and two-bedded rooms were 
24.21°C (SE= 0.17) and 23.29°C (SE= 0.30) respectively. These were above the 
recommended upper threshold of 22°C. The average nighttime temperature in the four 
bedded room was 21.72°C (SE= 0.19), which was within the recommended range of 
room temperature in patient rooms (figure 1).  
The results show that the type of room significantly affected the room temperature 
levels, F(2, 213) = 29.24, p<0.05. Tukey’s post hoc tests revealed significant 
differences between all types of rooms at the 0.05 level. 






Figure 2: Mean temperature levels in empty and occupied rooms recorded over three nights. 
 
Mean humidity levels in all rooms were between 29 %RH and 41 %RH, hence 
maintained within the recommended range. Minimal variation in humidity was present 
throughout each nighttime period (figure 2).  






Figure 3: Mean humidity levels in empty and occupied rooms recorded over three nights. 
 
Both temperature and humidity levels were consistent throughout the night without any 
sudden changes. 
NOISE 
Recorded noise levels ranged between 28 and 84 dB throughout the study. Mean 
noise levels of the occupied rooms within the two-hour periods, however, varied 
between 36 and 52 dB. There were abrupt increases of noise levels in excess of 70 
dB in all types of rooms.  The mean noise levels in all different types of patients’ rooms 
within the each 2-hour interval are shown on figure 3. 






Figure 4: Mean noise levels in each two hourly intervals recorded in different rooms from 7pm 
to 7am. 
 
Overall one way ANOVA test revealed that at the 0.05 level the means were 
significantly different for the measurements obtained in two-hour periods (F(5, 1434) 
= 1001.57). Tukey’s post hoc test confirmed the significant differences between the all 
two hourly intervals except, between 1 and 3 am indicating sound intensities were less 
variable within this time period. The mean noise levels obtained on three different 
nights were collapsed and one way ANOVA test was performed. This revealed that at 










The recorded levels of light in the unit ranged between 0 and 164 lux. Overall light 
intensity was greatest between 7pm and 9pm, consistent with the visiting and nursing 
activity times. Mean light levels after 9 pm varied between 0 and 108 lux. There were 
abrupt increases of light levels in excess of 100 lux in occupied one bedded room on 
night 1 and night 2 which indicates main lights being turned on. The mean light levels 
in all different types of patients’ rooms within the each 2-hour interval are shown on 
figure 4.  
 
Figure 5: Mean light levels in each two hourly intervals recorded in different rooms from 7pm to 
7am. 
 





Overall one way ANOVA test revealed that at the 0.05 level the mean light levels were 
not significantly different for the measurements obtained in two-hour periods between 
11pm and 7am (F(3, 12) = 2.86) indicating that rooms were reasonably dark within this 
time frame and within the recommended light levels. The mean light levels between 
11pm and 7 am ranged from 1.61 to 7.42. Tukey’s post hoc test confirmed was not 
significant at 0.05 level. 
Further statistical tests were performed to reveal any differences arising from the 
number of patients occupying the rooms however no significant difference was found. 
(F (3, 20)= 1.40). 
STAFF FEEDBACK 
Following the presentation of the study findings to staff positive and constructive 
feedback were received and following points were noted: Door fittings and bins may 
be the source of noise, night staff may need training on which light sources to use for 
nighttime observations and patients with severe brain injuries may not be able to 
regulate their body temperatures.  
Discussion 
This study showed that the environmental characteristics are not at optimum levels 
during night time in the patient rooms. Interestingly the only parameter which was 
consistently within ideal levels was humidity levels which we had the least control over.  
Temperature measurements showed that, although throughout the night stable, the 
levels were above the recommended levels in one bedded and two bedded rooms. 
Temperature in the four bedded room was maintained within the recommended range. 





On the other hand, humidity levels within the rooms were stable and within the 
recommended range for healthcare settings in all rooms throughout the night. 
The findings of this study identified that measurements of sound levels in our 
rehabilitation ward for patients with profound brain injuries were not always within the 
recommended levels. Mean sound levels in all occupied rooms were consistently in 
excess of the 35 dB and therefore, not within the recommendations made by the World 
Health Organization for healthy sleep environment in healthcare settings. Moreover, 
there were abrupt increases of sound levels as high as 84 dB which is equivalent to 
sound of an alarm clock at two feet distance. Hence, the 45 dB threshold of 
recommended maximum intensity for individual events at the patient’s bedside was 
exceeded in all three types of patient rooms. Interestingly, in the unoccupied one 
bedded room, mean sound levels varied between 32 and 41 dB throughout the night. 
This indicates that entries to the rooms by night staff significantly contributed to the 
increased noise levels in patient rooms as it is unlikely that the patients with disorders 
of consciousness would be the source of noise. 
In our rehabilitation ward, light intensity levels were reasonably maintained within the 
recommended levels by the Society of Light and Lighting between 11pm and 7am. 
The differences amongst the different types of rooms, including the unoccupied one 
bedded room, were not statistically significant. This suggests that nursing staff were 
able to perform their clinical care activities using the night observation lights. However, 
there was also evidence of use of main lights, on occasions, in one bedded occupied 
room.  
The major limitation of this study was that all measurements were performed within 
the same season- late autumn/winter. This study was focusing on the bedside care 





environment of patients with disorders of consciousness; therefore, findings may not 
necessarily be generalized to other rehabilitation settings where patients can 
potentially influence the environmental factors more than in our unit. On the other 
hand, our study provides better understanding of nighttime environmental factors 
mainly influenced by nursing staff activity and buildings rather than factors depend on 
patients. This study did not aim at identifying sources of increased noise or light 
intensity. Nevertheless, it is also possible that night staff may have altered their 
behavior as they were aware of the study. 
The findings of this study indicate that there is a need to explore sources of excessive 
nighttime noise in order to create a healthier sleep environment for patients. These 
may include check and maintenance of fixture and fittings present in the rooms, such 
as doors and rubbish bins. More importantly, education and training may be needed 
to increase awareness on importance of sleep and environmental factors. Although, 
the temperature levels in the rooms were above the recommended levels, it was noted 
that nursing staff in our rehabilitation unit believed that patients with profound brain 
injuries were not able to regulate their own body temperatures and therefore were in 
need of warmer than recommended bedside environment. We were not able to find 
any studies done on group of patients with disorders of consciousness that can 
support this theory.  
Nighttime patient care i.e. changing feed, turning the patients will always need to be 
performed by nursing staff nevertheless, implications of this study for clinical practice 
include assessment of current practice, education and training of night staff to raise 
awareness on importance of sleep and environmental factors and development of 
strategies to reduce noise levels at night with the objective of providing better sleep 





environment and reduce possible complications of interrupted sleep. During their stay 
patients undergo a series of clinical assessments looking for the evidence of 
consciousness and awareness. Therefore, it is imperative that the patients maintain 
good arousal levels during the assessments. 
The results of this study suggest that there is a need for further studies exploring the 
bedside care environment in other rehabilitation settings. Studies that are designed to 
identify the sources of excessive sound and light intensity such as observational 
studies on night time care are also needed. Once the sources of excessive sound and 
light identified, interventional studies aiming to optimize bedside environment in 
rehabilitation settings are warranted. Further research on body temperature regulation 
of patients with profound brain injuries is considered necessary with the intention of 
investigating whether recommended levels of room temperatures are applicable to this 
patient population.  
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Abstract 
Purpose: To detect any improvement of awareness in prolonged disorders of 
consciousness in the long term.  
Methods: 34 patients with Prolonged Disorders of Consciousness (27 vegetative state 
and 7 minimally conscious state; 16 male; aged 21 to 73) were included in the study. 
All patients were initially diagnosed with vegetative/ minimally conscious state on 
admission to our specialist neurological rehabilitation unit. Re-assessment was 
performed 2 to 16 years later using Coma Recovery Scale-Revised. 
Results: Although remaining severely disabled, 32% of the patients showed late 
improvement of awareness evidenced with development of non-reflexive responses 
such as reproducible command following and localization behaviours. Most of the late 
recoveries occurred in patients with subarachnoid haemorrhage (5/11, 45.5%). The 
ages of patients within the late recovery group (Mean=45, SD=11.4) and non-recovery 
group (Mean=43, SD=15.5) were not statistically different (p=0.76). 





Conclusions: This study shows that late improvements in awareness are not 
exceptional in non-traumatic Prolonged Disorders of Consciousness cases. It 
highlights the importance of long term follow up of patients with Prolonged Disorders 
of Consciousness, regardless of the aetiology, age and time passed since the brain 
injury. Long term follow up will help clinicians to identify patients who may benefit from 
further assessment and rehabilitation. Although only one patient achieved recovery of 
function, recovery of awareness may have important ethical implications especially 
where withdrawal of artificial nutrition and hydration is considered.  
Keywords: Disorders of Consciousness, Vegetative State, Minimally Conscious 
State, Recovery, Consciousness, Unresponsive Wakefulness Syndrome 
INTRODUCTION 
Severe disorders of consciousness (DOC) which include vegetative state (VS) and 
minimally conscious state (MCS) are known to have a very poor clinical outcome and 
despite extensive research are still poorly understood.1-4 VS is characterized by 
complete lack of awareness of the self and the environment, accompanied by sleep-
wake cycles with either complete or partial preservation of hypothalamic and brain 
stem autonomic functions5. The diagnosis of MCS is based on the presence of minimal 
but definite behavioural evidence of self or environmental awareness on clinical 
assessment6. In MCS behavioural responses are characteristically inconsistent and 
often subtle; hence patients require repeated assessments by experienced clinicians 
to differentiate MCS from VS. When DOC lasts more than one month it is defined as 
Prolonged Disorders of Consciousness (PDOC). 





Several research studies have shown that it is possible to detect the presence of covert 
awareness/ consciousness in such patients, by utilizing advanced electrophysiological 
methods and/or advanced functional neuroimaging techniques in cases where clinical 
assessments are unable to detect any behavioural sign of awareness. 7-11 Despite 
these promising developments within severe DOC brain research, currently the 
diagnosis of VS and MCS is made on clinical grounds. 
 
Although limited and inconsistent, patients with MCS may demonstrate agency and, 
on rare occasions, may be able to communicate their choices and opinions with 
respect to their basic treatment and care. Therefore, the distinction between VS and 
MCS has important ethical implications for the patient, their family and carers, medical, 
nursing and therapy staff and for wider society especially where withdrawal of clinically 
assisted nutrition and hydration is considered. 
National Clinical Guidelines on Prolonged Disorders of Consciousness2 state that 
vegetative state may be classified as a ‘permanent VS’ if it has persisted for more than 
six months following non-traumatic brain injury and more than one year following 
traumatic brain injury as after these time points recovery is deemed ‘highly 
improbable’. 
Our current knowledge of long-term outcome in severe DOC is incomplete largely 
because once a diagnosis is made, patients are discharged to diverse care settings 
and their follow up rarely extends beyond 12 months after brain injury.1,12,13 A recent 
study examined the long-term prognosis (for a mean of 25.7 months from onset of 
brain injury) in 50 patients with VS.  This study reported that late recovery was detected 
in 25% of the patients; suggesting that late recovery of responsiveness may occur 





more frequently than previously appreciated.14 The study also demonstrated a higher 
chance of recovery in the post-anoxic brain injury sub-group (21.4%) than in earlier 
published studies which were in the form of case reports.15-21 Luauté et al. showed 
that a third of patients in MCS with mixed aetiologies improved more than 1 year post 
ictus.22 In this study however, Glasgow Outcome Scale was used as main outcome 
measure with no specific attention to improvement of awareness/ responses to given 
stimuli . We wished to add to the small but growing body of knowledge on the long-
term prognosis of PDOC. We specifically wanted to focus on detecting changes in in 
awareness which can be detected only with structured and detailed assessments and 
otherwise may be unnoticed. The clinical setting of our unit gave us the unique 
opportunity to investigate outcomes in PDOC patients many years and even decades 
after the original ictus.  
METHODS 
The study was conducted in a long term care setting specializing in management and 
care of patients with profound brain injuries. The patients were given regular sensory 
stimulation provided in sensory rooms and were exposed to art and music therapy 
sessions as well as to regular social events.  The number of residents in the long term 
care setting is around 140 and 55 of these had diagnosis of DOC and 34 of these 
patients received their initial assessments and rehabilitation at our rehabilitation unit 
where Sensory Modality Assessment Rehabilitation Technique (SMART) assessment 
is most commonly used to diagnose DOC. SMART 23 is a valid and robust tool used 
in the assessment of DOC. It is recognised by the Royal College of Physicians 
guidelines and in the English high courts as the tool of choice to detect awareness and 
identify potential in patients with DOC.  





Although recommended as a good practice, regular and formal re-assessment of 
PDOC patients is not routinely and widely carried out in the United Kingdom. Following 
discharge to long term care setting, our patients were monitored closely by clinicians 
who are experienced in care of people with disorders of consciousness and no 
apparent recovery of awareness was reported. Nevertheless, due to lack of regular 
and formal re-assessments subtle changes or improvements masked by aphasia 
and/or severe motor weakness may have gone unnoticed. 
The patients were in a stable medical condition. Case notes of all the patients with a 
disorder of consciousness were screened and the following features were considered 
as exclusion criteria: disorders of consciousness secondary to neurodegenerative 
illnesses; patients who did not have an initial formal assessment of consciousness 
using validated assessment techniques (SMART± Coma Recovery Scale-Revised 
(CRS-R) or Wessex Head Injury Matrix) and, patients with severe pathologies 
independent from the brain injury such as advanced cancer.  
The eligibility criteria for this cohort study were that patients: had a diagnosis of VS or 
MCS established by using SMART assessment, as it was the validated assessment 
tool most often used in our cohort ± another validated assessment tool; had a brain 
injury secondary to acquired and non-progressive neurological illness; and, were 
medically stable at the time of re-assessment. The flow chart in Figure 1 shows the 
selection criteria for the follow up study. 






We documented a range of demographic variables (age and sex), cause of brain injury 
(e.g. traumatic, anoxic, subarachnoid haemorrhage, ischaemic stroke), time from brain 
injury to initial SMART assessment, the initial SMART assessment outcome, time from 
brain injury to follow up assessment, time between first SMART assessment and the 
follow up assessment and the outcome of the follow up assessment.  
All the patients were re-assessed 2 to 16 years after the initial DOC diagnosis by two 
clinicians who were experienced in clinical assessments of patients with disorders of 
consciousness.  The assessments were undertaken in a quiet, well lit room while 
patients were in the sitting position. The main outcome measure was recovery of 
awareness/ responsiveness according to the clinical criteria for MCS and for 
emergence from MCS, assessed with CRS-R.24 The SMART and CRS-R apply similar 
stimuli and specify the method of application, to exclude extraneous variables. CRS-





R was chosen as the method of re-assessment as it is a quick and reliable assessment 
tool for screening purposes.25 CRS-R includes all the modalities of the SMART 
assessment with the exclusion of the gustatory and olfactory sensory stimulation 
techniques. Another difference between SMART and CRS-R is that, CRS-R uses a 
mirror to assess visual tracking, whereas SMART uses a moving person and a picture 
of a baby. On the other hand, both tools assess visual tracking in both horizontal and 
vertical planes. As it was shown that assessment of visual pursuit with mirror is 
superior to with moving person or object26,27; SMART assessment proformas were 
examined in detail and all additional behaviours which suggested MCS were recorded.   
Two clinicians were present during CRS-R assessments. One of the investigators (SD 
or AK) was not involved in the initial review of case notes and was blinded to the initial 
diagnosis of the patients. Due to resource constraints, we were not able to have two 
blinded examiners at the same time however, CRS-R scoring sheets were only 
completed upon consensus of both clinicians on patients’ responses during the 
assessment. In a few occasions where there was disagreement between the 
assessors on the responses elicited, the CRS-R scores were recorded for the lower 
assessment. For example, if one of the clinicians did not agree on the presence of a 
consistent movement to command, this was scored as “not present”.  
Data were analysed with SPSS 21 (IBM SPSS, Chicago, IL, USA).  Permission for the 
study was obtained from the Royal Hospital for Neuro-disability audit committee.  
RESULTS 
34 patients (16 male) met the inclusion and exclusion criterion. The mean age at the 
time of brain injury was 43 (Range 17-70 years, SD 13 years). The mean age of the 





study population at the time of re-assessment was 49 (Range 21-73 years, SD 12 
years).  
The causes of brain injury were: anoxic brain injury in 15 patients; cerebrovascular 
accident in 13 patients (subarachnoid haemorrhage in 11 patients and massive 
ischaemic stroke in two patients); traumatic brain injury (TBI) in six patients. 27 (79%) 
of the patients had a diagnosis of VS on the initial SMART assessment, with seven 
(21%) diagnosed as being in the MCS. Time from brain injury to initial formal DOC 
diagnosis with SMART assessment varied between five and 38 months (Mean=10.9, 
SD=7.1 months). The diagnosis remained same at the time from completion of SMART 
assessment and admission to long term care facility as patients were under constant 
review and continued to receive monitoring assessments during period of 
rehabilitation.  
The time from brain injury to re-assessment was between 2 and 16 years. Mean 
duration of follow-up from brain injury was 6 years. (SD 3 years). Mean time from the 
initial SMART assessment to re-assessment was 5 years (SD 3.17 years). The time 
interval between the brain injury and re-assessment was 5.9 (SD 3.4 years, range 2-
























Mean Age(SD) 38.5(10.9) 49.2(12.5) 53.6(9.2) 58(21.2) 49.2(12.4) 
Mean Months BI to 
SMART (SD) 
10.2(2.8) 12.9(10.1) 9.19(3.3) 8.5(2.1) 10.9(7.2) 
Mean Years BI to 
CRS-R (SD) 




VS  4  15 8 0 27 
MCS 2 0 3 2 7 
Exit 
MCS 




VS 2 12 2 1 17 
MCS 4 3 8 1 16 
Exit 
MCS 
0 0 1 0 1 
Improvement 33% (2/6)  20% (3/15)  46% (6/13) 32% (11/34) 
TBI= Traumatic Brain Injury, VS= Vegetative State, MCS, Minimally Conscious State, CRS-R= Coma Recovery 
Scale- Revised, SMART= Sensory Modality Assessment Rehabilitation Technique, SD= Standard Deviation 
The results of the re-assessment using CRS-R showed that all patients remained 
severely disabled. However, 32% of the patients showed improvement of awareness 
with development of more complex responses than they had during initial assessment.  
The CRS-R scores and responses of the patients who showed improvement in their 
awareness state are shown in table 2 where we show the patient outcome data 
categorized by aetiology and on a scale of VS, MCS and exit MCS. Most of the late 
recoveries occurred in patients with cerebrovascular accidents (6/13, 46%). The ages 





of patients within the late recovery group (Mean=45, SD=11.4) and non-recovery 
group (Mean+43.5, SD=15.5) were not statistically different (p=0.76).  
Only one patient, who suffered from severe subarachnoid haemorrhage and was 
previously in minimally conscious state, progressed to the level of functional verbal 
communication and object use which is the criteria for exit MCS/ emergence from 
DOC. Eight patients had changes of diagnosis (VS to MCS) between initial 
assessment and re-assessment (table 2).  
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None Attention 12(MCS) 
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None Attention 11 (MCS) 
Patient 5 
M/ 38/ Anoxia 
12 2 Inconsistent 
focusing on a 
familiar face, 













None Attention 15 (MCS) 
Patient 6 
F/ 45/ SAH 
















None Attention 13 (MCS) 





Table 3: CRS-R Scores of patients with improvement of awareness 
TBI= Traumatic Brain Injury, VS= Vegetative State, MCS, Minimally Conscious State, SAH=Subarachnoid Haemorrhage, CRS-R= Coma Recovery Scale- Revised, SMART= Sensory 
Modality Assessment Rehabilitation Technique, F=Female, M=Male
Patient 7 
F/ 65/ Anoxia 











None Attention 10 (MCS) 
Patient 8 
M/ 43/ Infarct 



















M/ 57/ Anoxia 
10 2 Visual startle 













8 (VS/ MCS 
minus) 
Patient 10 
F/ 70/ SAH 
12 2 No localization 












Attention 16 (MCS) 
Patient 11 
F/ 43/ SAH 













None Attention 17 (MCS) 





This study shows that late improvements in awareness are not exceptional in 
non-traumatic VS and MCS patients, regardless of age. Previous studies have 
reported better outcomes in traumatic VS patients than in our study.  However, 
our study included only four traumatic VS patients and two traumatic MCS 
patients. The improvement rate was 33% within this subgroup but it is not 
possible to comment further on how aetiology differentially affects outcome 
due to the small subgroup sample size. The most significant finding of the 
present study is that approximately a third of patients in late phase of recovery 
from severe brain injury showed measurable improvements in their level of 
awareness.  These changes were found in both VS and MCS patients 
including patients who suffered from non-traumatic brain injuries.   
The main methodological difference between this study and previously 
published work is that all patients included in our study were initially diagnosed 
at the attached specialist brain injury rehabilitation unit by highly experienced 
clinical staff using at least two different validated assessment techniques 
(SMART, WHIM 28). In our study, the timeline between the brain injury and re-
assessment using CRS-R varied between 2 and 16 years.  In comparison to 
previous studies this is an unusually long time window between validated 
assessments.  During this time, very slow processes of neural recovery may 
have taken place including re-establishment of disrupted brain networks 
essential for consciousness. The care pathway within the Royal Hospital for 
Neuro-disability is that patients are initially assessed and treated within a 
specialist brain injury rehabilitation unit; typically for a period of 4 months.  If 




the patient is stable yet showing no consistent improvement in their DOC they 
are then transferred to a specialist nursing home environment where they 
continue to have maintenance level therapy input along with interventions to 
prevent complications such as pressure sores and contractures. They also are 
involved with group activities including music therapy. The current study did 
not aim to investigate the influence of access to specialist rehabilitation or the 
specialist nursing home settings; however, the rehabilitation and the care 
received by this cohort of patients may have some bearing on unexpectedly 
high percentages of improvement of awareness. 
In our study only one patient emerged from disorders of consciousness and 8 
out of 11 patients with improvement of awareness had a diagnosis change of 
VS to MCS. This may have significant ethical and legal implications. For 
example, in the United Kingdom, for the purposes of the law and withdrawal 
of treatment decisions, the distinction between VS and MCS is important. For 
people in VS, when considering applications for declaratory relief for 
withdrawal of clinically assisted nutrition and hydration, the English Courts 
work on the principal assumption of life-sustaining treatment is not in their best 
interests and favour withdrawal of life-sustaining treatment. Whereas, for the 
people in MCS, the decisions are made using a balance sheet approach where 
perceived benefits from continuation of treatment will be weighed against 
countervailing disadvantages.29 As the differentiation between VS and MCS is 
the cornerstone of decision-making in English courts; regular assessments 
with validated assessment tools such as SMART, Wessex Head Injury Matrix, 
CRS-R is necessary and will inform clinicians and families of the patients when 
considering best interests of the patients with disorders of consciousness.  




Our study has some limitations. Firstly, this is a cross-sectional cohort study 
with 34 patients in one particular long term care setting; hence the results may 
not be generalizable to the whole PDOC patient population. Second, this was 
not designed as a prospective follow up study, therefore, fails to provide 
evidence for possible influential factors for recovery of consciousness as well 
as how fast and when recovery occur. Another methodological limitation of this 
study was use of different assessment tools at the time of initial diagnosis and 
re-assessment (SMART and CRS-R retrospectively). However, both 
assessment tools are validated diagnostic tools for DOC and both use clear 
and stringent techniques to assess same modalities. Finally, this study has not 
captured data on the patients who died while resident in the long term care 
setting. 
Conclusions 
This study highlights the importance of long term follow up of patients with 
disorders of consciousness, regardless of the aetiology, age of the patient and 
time passed since the brain injury. Recovery of awareness in a third of patients 
over a long period of time, albeit with a poor functional outcome, supports the 
findings of recent studies showing that late recovery is possible14 and it 
provides behavioural support for the concept that there may be long term 
axonal regrowth and neural plasticity in disorders of consciousness. 30,31  Our 
results further increase the ethical dilemmas faced by staff involved in making 
treatment decisions in this vulnerable patient group. The phenomenon of very 
late recovery of awareness has an important bearing on questions of 
withdrawal of artificial nutrition and hydration. Our study raises the question as 




to whether the word ‘permanent’ is being used appropriately in the diagnostic 
term “Permanent Vegetative State” as reported in the recent Royal College of 
Physicians Guidelines.  Prospective multi-centre studies that involve a variety 
of rehabilitation and long term care settings are now needed in order to 
comprehend long term prognostic outcomes and mechanisms of recovery in 
severe PDOC states.  
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